{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:09 23:24:50.411",
            "Expression": "mesenchymal allogenic",
            "NStudiesAvail": 430269,
            "NStudiesFound": 475,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 475,
            "FieldList": [
                  "InterventionArmGroupLabel",
                  "InterventionBrowseBranchAbbrev",
                  "InterventionBrowseBranchName",
                  "InterventionBrowseLeafAsFound",
                  "InterventionBrowseLeafId",
                  "InterventionBrowseLeafName",
                  "InterventionBrowseLeafRelevance",
                  "InterventionDescription",
                  "InterventionMeshId",
                  "InterventionMeshTerm",
                  "InterventionName",
                  "InterventionOtherName",
                  "InterventionType",
                  "IsFDARegulatedDevice",
                  "IsFDARegulatedDrug",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "InterventionArmGroupLabel": [
                              "AloCELYVIR"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Mesenchymal allogenic cells + ICOVIR-5: 500.000 cells/kg"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AloCELYVIR"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04758533"
                        ]
                  },
                  {
                        "Rank": 2,
                        "InterventionArmGroupLabel": [
                              "Single Dose"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "adAMSC will be administered in the perilesional adipose tissue, through a laparoscopic procedure"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Adipose derived allogenic mesenchymal stem cells (adAMSC)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05521672"
                        ]
                  },
                  {
                        "Rank": 3,
                        "InterventionArmGroupLabel": [
                              "Allogenic Mesenchymal Stem Cell"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Expanded in-Vitro Allogenic Mesenchymal Stem Cell (authorized by Spain, \"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios\" with number 06-076)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogenic Mesenchymal Stem Cell"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Genetic"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01956903"
                        ]
                  },
                  {
                        "Rank": 4,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal Stem Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogenic Human Bone Marrow Mesenchymal Stem Cells (ex-vivo expanded in pooled human platelet lysate)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [
                              "Allogenic Bone Marrow MSCs"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02824653"
                        ]
                  },
                  {
                        "Rank": 5,
                        "InterventionArmGroupLabel": [
                              "osseointegration using Allogenic MSC's"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogenic mesenchymal stem cells are introduced during placement of dental implants."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogenic Mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [
                              "Transchymal"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02731586"
                        ]
                  },
                  {
                        "Rank": 6,
                        "InterventionArmGroupLabel": [
                              "INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "ANeo",
                              "ARhu",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Antineoplastic Agents",
                              "Antirheumatic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M5879"
                        ],
                        "InterventionBrowseLeafName": [
                              "Cyclophosphamide"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02213705"
                        ]
                  },
                  {
                        "Rank": 7,
                        "InterventionArmGroupLabel": [
                              "Allogeneic Mesenchymal Stromal Cell",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "AdjAn",
                              "CNSDep",
                              "PsychDr",
                              "All",
                              "Analg"
                        ],
                        "InterventionBrowseBranchName": [
                              "Adjuvants, Anesthesia",
                              "Central Nervous System Depressants",
                              "Psychotropic Drugs",
                              "All Drugs and Chemicals",
                              "Analgesics"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M10997",
                              "M7570"
                        ],
                        "InterventionBrowseLeafName": [
                              "Midazolam",
                              "Fentanyl"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Intramuscular allogeneic BM-MSC injection: MSCs will be extracted from BM of healthy volunteers, expanded with human platelet lysate, and stored. Patients will receive intramuscular allogeneic BM-MSC injections at 30 sites in the lower leg of the ischemic limb. Blinded syringes are provided and cell suspensions will be injected intramuscularly by an experienced operator into multiple sites (30 sites, 1-1.5cm in depth, volume of 1.0mL containing 5*10^6 MSC per site; total 150*10^6 BM-MSCs) in the ischemic lower extremity. Injections will be performed under IV analgesia (fentanyl) and sedation (midazolam) if necessary.",
                              "Intramuscular placebo injections. Patients will receive intramuscular placebo injections at 30 prespecified sites in the lower leg of the ischemic limb. Blinded syringes are provided and will be injected intramuscularly by an experienced operator into multiple sites (30 sites, 1-1.5cm in depth, volume of 1.0mL placebo per site) in the ischemic lower extremity. Injections will be performed under IV analgesia (fentanyl) and sedation (midazolam) if necessary."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Mesenchymal Stromal Cell",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic bone marrow-derived mesenchymal stromal cells",
                              "Allogeneic bone marrow-derived mesenchymal stem cells",
                              "Allogeneic BM-MSC"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03042572"
                        ]
                  },
                  {
                        "Rank": 8,
                        "InterventionArmGroupLabel": [
                              "Allogenic mesenchymal stromal cells injection",
                              "Hyaluronic acid (Durolane)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Ratio"
                        ],
                        "InterventionBrowseLeafId": [
                              "M9030",
                              "M2780",
                              "M9353",
                              "M27448",
                              "M21022"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hyaluronic Acid",
                              "Adjuvants, Immunologic",
                              "Immunologic Factors",
                              "Viscosupplements",
                              "Protective Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Mesenchymal stem cells prepared from bone marrow of healthy donors and expanded for 3-4 weeks according to our procedure described in PEI Num. 10-134, authorized by the Spanish Medicine Agency",
                              "Intra-articular injection of 60 mg of hyaluronic acid (Durolane) in a single injection (3 ml)"
                        ],
                        "InterventionMeshId": [
                              "D000006820"
                        ],
                        "InterventionMeshTerm": [
                              "Hyaluronic Acid"
                        ],
                        "InterventionName": [
                              "Allogenic mesenchymal stromal cells injection",
                              "Hyaluronic Acid"
                        ],
                        "InterventionOtherName": [
                              "MSV",
                              "Mesenchymal Stem Cells",
                              "MSC",
                              "Hyaluronic acid, durolane, CE mark:516407"
                        ],
                        "InterventionType": [
                              "Other",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01586312"
                        ]
                  },
                  {
                        "Rank": 9,
                        "InterventionArmGroupLabel": [
                              "mesenchymal stem cells",
                              "control",
                              "mesenchymal stem cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogenic pooled olfactory mucosa-derived mesenchymal stem cells",
                              "Standard treatment according to the Clinical protocols"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogenic pooled olfactory mucosa-derived mesenchymal stem cells",
                              "Standard treatment according to the Clinical protocols"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04382547"
                        ]
                  },
                  {
                        "Rank": 10,
                        "InterventionArmGroupLabel": [
                              "Pilot"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Peri-fistula injections"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs)"
                        ],
                        "InterventionOtherName": [
                              "allo-hMSCs"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02677350"
                        ]
                  },
                  {
                        "Rank": 11,
                        "InterventionArmGroupLabel": [
                              "Allogenic Mesenchymal Stromal Cells",
                              "Mepivacaine"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "CNSDep",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Central Nervous System Depressants",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Hourly"
                        ],
                        "InterventionBrowseLeafId": [
                              "M10752",
                              "M3259",
                              "M3261"
                        ],
                        "InterventionBrowseLeafName": [
                              "Mepivacaine",
                              "Anesthetics",
                              "Anesthetics, Local"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [],
                        "InterventionMeshId": [
                              "D000008619"
                        ],
                        "InterventionMeshTerm": [
                              "Mepivacaine"
                        ],
                        "InterventionName": [
                              "Allogenic Mesenchymal Stromal Cells",
                              "Mepivacaine"
                        ],
                        "InterventionOtherName": [
                              "Mesenchymal stem cells (MSC)",
                              "MSC injection",
                              "MSV (MSV=MSC prepared following Valladolid IBGM procedure)",
                              "Sham-treated comparator",
                              "Mepivacaine is also known as Carbocaine",
                              "Mepivacaine is also known as Polocaine"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01860417"
                        ]
                  },
                  {
                        "Rank": 12,
                        "InterventionArmGroupLabel": [
                              "Allogenic Mesenchymal stem cells",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All",
                              "Hemat"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals",
                              "Hematinics"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013",
                              "M10262"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions",
                              "Liver Extracts"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Cell therapy",
                              "Serum without stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogenic mesenchymal stem cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02857010"
                        ]
                  },
                  {
                        "Rank": 13,
                        "InterventionArmGroupLabel": [
                              "Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) isolated from hematogenous bone marrow",
                              "Placebo for Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03522545"
                        ]
                  },
                  {
                        "Rank": 14,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stem cell receipients",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Injection of adipose derived mesenchymal stem cell in the site of tibia fracture ."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stem cell injection",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "stem cell transplantation"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02140528"
                        ]
                  },
                  {
                        "Rank": 15,
                        "InterventionArmGroupLabel": [
                              "High dose of allogeneic MSC",
                              "Low dose of allogeneic MSC",
                              "Medium dose of allogeneic MSC"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Subconjunctival Injection of Allogeneic Mesenchymal Stromal Cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic MSC"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04626583"
                        ]
                  },
                  {
                        "Rank": 16,
                        "InterventionArmGroupLabel": [
                              "Stem cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Patients will receive intravenously one dose of 0.5-1.5 million cells per kg of allogeneic adult mesenchymal bone marrow stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic adult mesenchymal bone marrow stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01297413"
                        ]
                  },
                  {
                        "Rank": 17,
                        "InterventionArmGroupLabel": [
                              "Normal Saline Placebo",
                              "Allogeneic Mesenchymal Precursor Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Mesenchymal Precursor Cells",
                              "Normal Saline"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01851070"
                        ]
                  },
                  {
                        "Rank": 18,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic mesenchymal stem cells will be infused intravenously (single dose, 10^6 cells/kg body weight)."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Mesenchymal Stem Cells (AlloMSC)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00953485"
                        ]
                  },
                  {
                        "Rank": 19,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal progenitor cells Dosage 1",
                              "Mesenchymal progenitor cells Dosage 2",
                              "Mesenchymal progenitor cells Dosage 3"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Biological: Allogenic Adipose tissue-derived mesenchymal progentior cells administrated for intra-articular use"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal progenitor cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02641860"
                        ]
                  },
                  {
                        "Rank": 20,
                        "InterventionArmGroupLabel": [
                              "Experimental"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Two doses of 80 million adipose-tissue derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04366323"
                        ]
                  },
                  {
                        "Rank": 21,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal progenitor cells Dosage 1",
                              "Mesenchymal progenitor cells Dosage 2",
                              "No mesenchymal progenitor cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogenic Adipose tissue-derived mesenchymal progentior cells administrated for intra- articular use",
                              "No mesenchymal progenitor cells for intra- articular use"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal progenitor cells",
                              "No mesenchymal progenitor cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04208646"
                        ]
                  },
                  {
                        "Rank": 22,
                        "InterventionArmGroupLabel": [
                              "Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01775774"
                        ]
                  },
                  {
                        "Rank": 23,
                        "InterventionArmGroupLabel": [
                              "Control",
                              "Stem Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Allogeneic mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01770613"
                        ]
                  },
                  {
                        "Rank": 24,
                        "InterventionArmGroupLabel": [
                              "Allogeneic Human Mesenchymal Stem Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "This will be a dose escalation study. The first 3 subjects will receive a single dose of 1 x 10^6 cells/kg or a maximum dose of 1 x 10^8 total cells IV 4 days prior to undergoing a planned prostatectomy.\n\nThe remaining subjects will receive a single dose of 2 x 10^6 cells/kg or a maximum dose of 2 x 10^8 total cells IV either 4 or 6 days prior to the planned prostatectomy, and if additional doses of MSCs are able to be expanded, up to 6 additional men will be enrolled with a plan to treat them 8 days prior to the prostatectomy."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Human Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01983709"
                        ]
                  },
                  {
                        "Rank": 25,
                        "InterventionArmGroupLabel": [
                              "mesenchymal stem cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic Umbilical Cord derived-MSCs injected by slow intravenous infusion according to the weight of the recipient and patient groups in the study, at doses of:\n\n1.10^6 CSM / kg\n2.10^6 CSM / kg\n4.10^6 CSM / kg 1 injection during 30min to 1h by Intravenous infusion"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03562065"
                        ]
                  },
                  {
                        "Rank": 26,
                        "InterventionArmGroupLabel": [
                              "Allogeneic Mesenchymal Bone Marrow Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Subjects in Part 1, Cohorts 1-3 will receive a 1550 nm Fraxel laser (6-8 mJ, Level 2) treatment on the face followed by a single intravenous infusion of 0.5, 1.0, or 1.5 million mesenchymal cells per kg of body weight, not to exceed 150 million cells. Subjects in Part 2 will receive a 1550 Fraxel laser (6-8 mJ, Level 2) treatment on the face followed by a single intravenous infusion of mesenchymal cells at the Maximum Tolerated Dose, as determined by the safety results of Part 1. The dose in Part 2 is 1.5 million cells per kg, not to exceed a total of 150 million cells."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Mesenchymal Bone Marrow Cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01771679"
                        ]
                  },
                  {
                        "Rank": 27,
                        "InterventionArmGroupLabel": [
                              "Group A: Allogeneic Mesenchymal Stem Cells (MSCs) Group",
                              "Group 2: Placebo Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All",
                              "ANeo"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals",
                              "Antineoplastic Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M85407",
                              "M8814"
                        ],
                        "InterventionBrowseLeafName": [
                              "Plasma-lyte 148",
                              "Altretamine"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "1 single intravenous infusion",
                              "Placebo delivered via peripheral intravenous infusion"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "100 million Allogeneic Mesenchymal Human Stem Cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "allo-human Mesenchymal Stem Cells (hMSCs)",
                              "stem cells"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04776239"
                        ]
                  },
                  {
                        "Rank": 28,
                        "InterventionArmGroupLabel": [
                              "SLE patients MSC treatment",
                              "SLE patients MSC treatment",
                              "SLE patients standard treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Pooled allogenic mesenchymal stem cell derived from olfactory mucosa",
                              "Standard SLE treatment according to the Clinical protocols approved by the Ministry of healthcare of Republic of Belarus"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Pooled mesenchymal stem cell",
                              "Standard treatment according to the Clinical protocols"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04184258"
                        ]
                  },
                  {
                        "Rank": 29,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stem cell group",
                              "Active control (fibrin glue) group",
                              "Control (normal saline )group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Coag",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Coagulants",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Cobicistat"
                        ],
                        "InterventionBrowseLeafId": [
                              "M17443",
                              "M8728",
                              "M5411"
                        ],
                        "InterventionBrowseLeafName": [
                              "Fibrin Tissue Adhesive",
                              "Hemostatics",
                              "Coagulants"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Intervention will be done with stem cell injection, 0.5cc (Total: 10 million cells), fibrin glue injection 0.5cc and range of motion exercise.",
                              "Total 1cc of fibin glue and normal saline mixture injection and range of motion exercise",
                              "Total 1cc of normal saline injection and range of motion exercise"
                        ],
                        "InterventionMeshId": [
                              "D000015718"
                        ],
                        "InterventionMeshTerm": [
                              "Fibrin Tissue Adhesive"
                        ],
                        "InterventionName": [
                              "allogenic adipose stem cell injection",
                              "fibrin glue/normal saline injection",
                              "normal saline injection"
                        ],
                        "InterventionOtherName": [
                              "experimental group",
                              "active control group",
                              "placebo group"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02298023"
                        ]
                  },
                  {
                        "Rank": 30,
                        "InterventionArmGroupLabel": [
                              "Allogeneic hMSCs",
                              "Pilot - Allogeneic hMSCs",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M85407"
                        ],
                        "InterventionBrowseLeafName": [
                              "Plasma-lyte 148"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "a single administration of allogeneic Human Mesenchymal Stem Cell (hMSCs): 100 x 10^6 (100 million) allo-hMSCs of cells",
                              "a placebo administration consisting of 1% human albumin serum in Plasma-Lyte A"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allo-hMSCs",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic Human Mesenchymal Stem Cells",
                              "Stem Cells"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02675556"
                        ]
                  },
                  {
                        "Rank": 31,
                        "InterventionArmGroupLabel": [
                              "Human Allogeneic Mesenchymal Stem Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All",
                              "Infe"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals",
                              "Anti-Infective Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M9336",
                              "M3377",
                              "M1804"
                        ],
                        "InterventionBrowseLeafName": [
                              "Immunoglobulins",
                              "Antibodies",
                              "Carbamide Peroxide"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "A single dose, one time infusion (in the vein) of one of the following doses of hMSCs: 1 x 10^6, 3 x 10^6 or 5 x 10^6 hMSCs/kg body weight during Visit 2. A traditional 3+3 design will be utilized.\n\nAllogeneic MSCs will be derived from bone marrow aspirates from a healthy donor whose serum tests negative for cytomegalovirus (CMV) antibodies. Healthy donors will undergo tests for infectious disease and screening for 41 common CFTR mutations. In addition, the MSCs will be validated for in vitro and in vivo efficacy and potency using the in vivo murine pre-clinical model of CF lung infection and inflammation."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [
                              "MSCs"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02866721"
                        ]
                  },
                  {
                        "Rank": 32,
                        "InterventionArmGroupLabel": [
                              "1 million cells/ml of ALLO-ASC",
                              "10 million cells/ml of ALLO-ASC"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ALLO-ASC(allogeneic adipose derived mesenchymal stem cell) injection"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01856140"
                        ]
                  },
                  {
                        "Rank": 33,
                        "InterventionArmGroupLabel": [
                              "Allogeneic mesenchymal stem/stromal cell therapy"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Culture expanded allogeneic adipose derived stem/stromal cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic adipose derived stem/stromal cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03874572"
                        ]
                  },
                  {
                        "Rank": 34,
                        "InterventionArmGroupLabel": [
                              "UC-Mesenchymal Stem Cell"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Mesenchymal Stem Cell + NaCl 0,9% 2ml"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cell"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04501354"
                        ]
                  },
                  {
                        "Rank": 35,
                        "InterventionArmGroupLabel": [
                              "Stem Cells",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "human Allogeneic Low Oxygen mesenchymal stem cells; Ischemia tolerant",
                              "Lactated Ringer's Solution"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Stem cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic Low Oxygen mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02672267"
                        ]
                  },
                  {
                        "Rank": 36,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Participants will be treated with one intravenous (IV) infusion of 200 million allogeneic human mesenchymal stem cells (Allo-hMSCs), lasting from 40-90 minutes following an acute ischemic stroke within 9 days after stroke symptom onset."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic human mesenchymal stem cells (Allo-hMSCs)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT05522569"
                        ]
                  },
                  {
                        "Rank": 37,
                        "InterventionArmGroupLabel": [
                              "Group 2 - Allogeneic Human Mesenchymal Stem Cells (hMSCs)",
                              "Group A - Allogeneic Human Mesenchymal Stem Cells (hMSCs)",
                              "Group 1 - Placebo",
                              "Group B - Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "AnArAg",
                              "ChanBlk",
                              "CNSDep",
                              "All",
                              "PhSol",
                              "Infl",
                              "Resp"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Arrhythmia Agents",
                              "Channel Blockers",
                              "Central Nervous System Depressants",
                              "All Drugs and Chemicals",
                              "Pharmaceutical Solutions",
                              "Anti-Inflammatory Agents",
                              "Respiratory System Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M10166",
                              "M21013",
                              "M4061",
                              "M4062",
                              "M229281",
                              "M259082",
                              "M248671"
                        ],
                        "InterventionBrowseLeafName": [
                              "Lidocaine",
                              "Pharmaceutical Solutions",
                              "Betamethasone",
                              "Betamethasone Valerate",
                              "Betamethasone-17,21-dipropionate",
                              "Betamethasone benzoate",
                              "Betamethasone sodium phosphate"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "A single administration of 20 million allogeneic mesenchymal stem cell delivered intra-facet via 6 injections of 1.5 mL per injection, total of 9 to 12ml.",
                              "A single administration of 1 cc of 1% lidocaine with 1 cc of 2% Ropivicaine and 0.5 cc of betamethasone soluspan (celestone) solution delivered via intra-facet injection."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Human Mesenchymal Stem Cells (hMSCs)",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "allo-hMSCs",
                              "stem cells"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03487731"
                        ]
                  },
                  {
                        "Rank": 38,
                        "InterventionArmGroupLabel": [
                              "mesenchymal stromal cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "2 doses of 1-2x10^6 allogeneic bone marrow derives MSCs IV per/kg body weight at weeks 25 and 26 after transplantation"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "mesenchymal stromal cells"
                        ],
                        "InterventionOtherName": [
                              "MSC",
                              "bone marrow derived mesenchymal stromal cells"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02387151"
                        ]
                  },
                  {
                        "Rank": 39,
                        "InterventionArmGroupLabel": [
                              "mesenchymal stem cells (MSCs)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic bone marrow derived mesenchymal stem cells (MSCs) direct injection to an ileal pouch fistula in the setting of Crohn's disease of the pouch"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "mesenchymal stem cells (MSCs)"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic Bone Marrow Derived Mesenchymal Stem Cells"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04073472"
                        ]
                  },
                  {
                        "Rank": 40,
                        "InterventionArmGroupLabel": [
                              "Treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Two serial doses of 1.5 million adipose-tissue derived mesenchymal stem cells per kg"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04348461"
                        ]
                  },
                  {
                        "Rank": 41,
                        "InterventionArmGroupLabel": [
                              "Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Allogeneic Mesenchymal Bone Marrow Cells (aMBMC) 1.5 million cells/kg",
                              "1.5 mL/kg Lactated Ringer's Solution"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03925324"
                        ]
                  },
                  {
                        "Rank": 42,
                        "InterventionArmGroupLabel": [
                              "Interstitial Lung Disease with Connective Tissue Disorder"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Subjects will be treated with regular standard of care plus 0.5-1 million MSC/Kg intravenously."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03929120"
                        ]
                  },
                  {
                        "Rank": 43,
                        "InterventionArmGroupLabel": [
                              "Allogeneic Mesenchymal Precursor Cells",
                              "Control Treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M9336",
                              "M3377"
                        ],
                        "InterventionBrowseLeafName": [
                              "Immunoglobulins",
                              "Antibodies"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Rexlemestrocel-L consists of human bone marrow-derived allogeneic MPCs isolated from bone mononuclear cells with anti-STRO-3 antibodies, expanded ex vivo, and cryopreserved",
                              "The sham procedure will be staged to script and will not include actual cardiac mapping or delivery of rexlemestrocel-L."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Mesenchymal Precursor Cells (MPCs)",
                              "Sham Comparator"
                        ],
                        "InterventionOtherName": [
                              "MPCs",
                              "rexlemestrocel-L"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02032004"
                        ]
                  },
                  {
                        "Rank": 44,
                        "InterventionArmGroupLabel": [
                              "Autologous Adipose MSC Group",
                              "Allogeneic Umbilical Cord MSC Group",
                              "Allogeneic Umbilical Cord MSC and Adipose Secretome Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "CNSDep",
                              "All",
                              "Ot"
                        ],
                        "InterventionBrowseBranchName": [
                              "Central Nervous System Depressants",
                              "All Drugs and Chemicals",
                              "Other Dietary Supplements"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M4006",
                              "M20124",
                              "T433"
                        ],
                        "InterventionBrowseLeafName": [
                              "Benzocaine",
                              "Hepatitis C Antibodies",
                              "Tannic Acid"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Before taking adipose tissue, each subject was screened including HbSAg, Anti HbS, Anti HCV, HIC, MCV and syphilis tests.\n\nAdipose tissue was taken through 5 grams of subcutaneous fat biopsy from the abdomen of each subject and put into a transport medium and then sent to the RSCM-FKUI cGMP IPT Stem Cells Laboratory for immediate isolation of mesenchymal stem cells.\n\nMSC that has been isolated will be cultured using the appropriate medium until it reaches the desired passage and the number of cells.\n\nThe viability and proliferation ability of cultured cells were evaluated, then characterization of cell antigen expression was carried out using flow cytometry to confirm the success of MSC culture.\n\nThe MSC to be injected into the subject will be prepared in 2cc physiological NaCl transport medium just before implantation.\n\nThe adipose secretion used is prepared in whole form as much as 10cc in a 10cc syringe.",
                              "Before taking the umbilical cord tissue, a pregnant woman's donor was screened including HbSAg, Anti HbS, Anti HCV, HIC, MCV and syphilis tests.\n\nImmediately after delivery, the umbilical cord was collected and stored in a sterile specimen plate containing 0.9% NaCl at 4\u2070C.\n\nThe umbilical cord is transported to the GMP standard culture laboratory at the UPT TK Stem Cells RSCM-FKUI for isolation process of mesenchymal stem cells. Sample processing was carried out within 8 hours of delivery to maintain cell viability.\n\nMSC that has been isolated will be cultured using the appropriate medium until it reaches the desired passage and the number of cells.\n\nThe viability and proliferation ability of cultured cells were evaluated, then characterization of cell antigen expression was carried out using flow cytometry to confirm the success of MSC culture.\n\nThe MSC to be injected into the subject will be prepared in a suitable transport medium just prior to implantation.",
                              "Before taking adipose and umbilical cord tissue, each subject was screened. -For Adipose tissue : The adipose secretion used is prepared in whole form as much as 10cc in a 10cc syringe.\n\n-Uc-MSC : Immediately after delivery, the umbilical cord was collected and stored in a sterile specimen plate containing 0.9% NaCl at 4\u2070C.\n\nThe umbilical cord is transported to the GMP standard culture laboratory to have isolation process of mesenchymal stem cells. Sample processing was carried out within 8 hours of delivery to maintain cell viability.\n\nLater it will be cultured using the appropriate medium until it reaches the desired passage and the number of cells.The viability and proliferation ability of cultured cells were evaluated, then characterization of cell antigen expression was carried out using flow cytometry to confirm the success of MSC culture."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Autologous Adipose Mesenchymal Stem Cell Implantation",
                              "Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation",
                              "Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04876326"
                        ]
                  },
                  {
                        "Rank": 45,
                        "InterventionArmGroupLabel": [
                              "Conventional treatment plus high dose: 3x10e6 cells / Kg.",
                              "Conventional treatment plus low dose: 1x10e6 cells / Kg",
                              "Conventional treatment plus high dose: 3x10e6 cells / Kg.",
                              "Conventional treatment plus low dose: 1x10e6 cells / Kg"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "ARhu",
                              "Derm",
                              "All",
                              "Infl",
                              "ANeo"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Antirheumatic Agents",
                              "Dermatologic Agents",
                              "All Drugs and Chemicals",
                              "Anti-Inflammatory Agents",
                              "Antineoplastic Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M18113",
                              "M5882",
                              "M18102",
                              "M13273"
                        ],
                        "InterventionBrowseLeafName": [
                              "Cyclosporine",
                              "Cyclosporins",
                              "Tacrolimus",
                              "Prednisone"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue. Low dose: 1 x10e6 / Kg.\n\nConventional treatment:Gradually descending dosage of prednisone and cyclosporin or tacrolimus for at least 46 weeks. Starting dose: 1 mg/Kg/24 h prednisone and 3 mg/Kg/12 h cyclosporin.",
                              "Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue. High dose: 3 x10e6/Kg.\n\nConventional treatment:Gradually descending dosage of prednisone and cyclosporin or tacrolimus for at least 46 weeks. Starting dose: 1 mg/Kg/24 h prednisone and 3 mg/Kg/12 h cyclosporin."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.",
                              "Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue."
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01222039"
                        ]
                  },
                  {
                        "Rank": 46,
                        "InterventionArmGroupLabel": [
                              "ALLO-ASC group",
                              "Normal saline group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Coag",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Coagulants",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Cobicistat"
                        ],
                        "InterventionBrowseLeafId": [
                              "M17443",
                              "M8728",
                              "M5411"
                        ],
                        "InterventionBrowseLeafName": [
                              "Fibrin Tissue Adhesive",
                              "Hemostatics",
                              "Coagulants"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Allogenic-adipose-derived mesenchymal stem cells (ALLO-ASC) injection to the anal sphincter of patients with fecal incontinence",
                              "0.9% normal saline with fibrin glue injection to the anal sphincter of patients with fecal incontinence"
                        ],
                        "InterventionMeshId": [
                              "D000015718"
                        ],
                        "InterventionMeshTerm": [
                              "Fibrin Tissue Adhesive"
                        ],
                        "InterventionName": [
                              "ALLO-ASC injection",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "ALLO-ASC",
                              "Normal saline with fibrin glue injection"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02384499"
                        ]
                  },
                  {
                        "Rank": 47,
                        "InterventionArmGroupLabel": [
                              "Human Mesenchymal Stromal Cells (hMSCs)",
                              "Plasma-Lyte A (placebo)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "DOAC"
                        ],
                        "InterventionBrowseLeafId": [
                              "M85407",
                              "M11966",
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Plasma-lyte 148",
                              "Ophthalmic Solutions",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells was administered intravenously over approximately 60-80 minutes.",
                              "Plasma-Lyte A placebo was administered intravenously over approximately 60-80 minutes."
                        ],
                        "InterventionMeshId": [
                              "C000012499"
                        ],
                        "InterventionMeshTerm": [
                              "Plasma-lyte 148"
                        ],
                        "InterventionName": [
                              "Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells",
                              "Plasma-Lyte A"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02097641"
                        ]
                  },
                  {
                        "Rank": 48,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stem cell (MSC)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00447460"
                        ]
                  },
                  {
                        "Rank": 49,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "1.000.000(one million) cells/kg, IV (1/2 of dose in the Peripheral vein and 1/2 of dose into the right hepatic artery)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "allogeneic mesenchymal stem cell transplantation"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Genetic"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01378182"
                        ]
                  },
                  {
                        "Rank": 50,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal Stromal Cells (MSCs)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "This study is a pilot phase 1 study of patients with moderately to severely active Crohn Disease (CD) and ulcerative colitis (UC) (\u2265 18 years, Mayo score: \u22656 or CDAI: \u02c3 220; <18 years, Pediatric Crohn's Disease Activity Index (PCDAI) :> 30) or Pediatric Ulcerative Colitis Activity Index (PUCAI) : >34). A fixed dose will be studied: 1 x 106 cells/kg administered intravenously (IV) weekly for 4 consecutive weeks, with the option of an additional 4 weeks of treatment, at the discretion of the principal investigator."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic bone marrow-derived mesenchymal stromal cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02150551"
                        ]
                  },
                  {
                        "Rank": 51,
                        "InterventionArmGroupLabel": [
                              "Bone marrow-derived MSC transplantation (1 x 10 6 MSC/kg)",
                              "Bone marrow-derived MSC transplantation (3 x 10 6 MSC/kg)",
                              "Bone marrow-derived MSC transplantation (6 x 10 6 MSC/kg)",
                              "Bone marrow-derived MSC transplantation (10 x 10 6 MSC/kg)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Bone marrow-derived allogeneic MSCs will be delivered intravenously in escalating doses of 1 x 10 6 MSC/kg, 3 x 10 6 MSC/kg, 6 x 10 6 MSC/kg, or 10 x 10 6 MSC/kg of body weight to a population of patients with idiopathic Parkinson's disease (iPD).",
                              "Bone marrow-derived allogeneic MSCs will be delivered intravenously in escalating doses of 1 x 10 6 MSC/kg, 3 x 10 6 MSC/kg, 6 x 10 6 MSC/kg, or 10 x 10 6 MSC/kg of body weight to a population of patients with idiopathic Parkinson's disease (iPD).",
                              "Bone marrow-derived allogeneic MSCs will be delivered intravenously in escalating doses of 1 x 10 6 MSC/kg, 3 x 10 6 MSC/kg, 6 x 10 6 MSC/kg, or 10 x 10 6 MSC/kg of body weight to a population of patients with idiopathic Parkinson's disease (iPD).",
                              "Bone marrow-derived allogeneic MSCs will be delivered intravenously in escalating doses of 1 x 10 6 MSC/kg, 3 x 10 6 MSC/kg, 6 x 10 6 MSC/kg, or 10 x 10 6 MSC/kg of body weight to a population of patients with idiopathic Parkinson's disease (iPD)."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg)",
                              "Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg)",
                              "Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg)",
                              "Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02611167"
                        ]
                  },
                  {
                        "Rank": 52,
                        "InterventionArmGroupLabel": [
                              "MNC & MSC",
                              "MNC & MSC with Control",
                              "MNC & MSC",
                              "MNC & MSC with Control",
                              "MNC & MSC with Control"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Hematopoietic stem cells derived from allogenic umbilical cord",
                              "Mesenchymal cells derived from allogenic umbilical cord",
                              "control group without injection and appearance simulating lumbar puncture without awareness of the patients and evaluators , but rehabilitation continued ."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MNC",
                              "MSC",
                              "Control"
                        ],
                        "InterventionOtherName": [
                              "Hematopoietic stem cells",
                              "Mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03795974"
                        ]
                  },
                  {
                        "Rank": 53,
                        "InterventionArmGroupLabel": [
                              "implantation group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "subjects are implanted with allogenic mesenchymal stem cells from umbilical cord/ bone marrow/ adipose"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MSC"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02307435"
                        ]
                  },
                  {
                        "Rank": 54,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal Stem Cells",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Direct injection of adult allogeneic bone marrow derived mesenchymal stem cell product, at a dose of 75 million cells into perianal fistula(s)",
                              "Normal saline"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04519671"
                        ]
                  },
                  {
                        "Rank": 55,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal cells",
                              "Standard of care"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "1 infusion of undifferentiated allogeneic mesenchymal cells derived from umbilical cord tissue",
                              "Best treatment option for COVID-19 according to investigator criteria"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal cells",
                              "Standard of care"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04366271"
                        ]
                  },
                  {
                        "Rank": 56,
                        "InterventionArmGroupLabel": [
                              "Allogeneic stem cells from adipose tissue",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogenic mesenchymal stem cells from adipose tissue",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01678534"
                        ]
                  },
                  {
                        "Rank": 57,
                        "InterventionArmGroupLabel": [
                              "Pilot Phase 20 million allogeneic hMSCs",
                              "Randomized Phase 20 million allogeneic hMSCs",
                              "Pilot Phase 100 million hMSCs",
                              "Randomized Phase 100 million allogeneic hMSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "1 single intravenous infusion",
                              "1 single intravenous infusion"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "20 million Allogeneic Mesenchymal Human Stem Cells",
                              "100 million Allogeneic Mesenchymal Human Stem Cells"
                        ],
                        "InterventionOtherName": [
                              "allo-hMSCs",
                              "stem cells",
                              "allo-hMSCs",
                              "stem cells"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02886884"
                        ]
                  },
                  {
                        "Rank": 58,
                        "InterventionArmGroupLabel": [
                              "Cartistem",
                              "standard treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "HB",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Herbal and Botanical",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "T63"
                        ],
                        "InterventionBrowseLeafName": [
                              "Astragalus"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Cartistem is allogenic umbilical cord blood-derived stem cell product. Cartistem is 500uL/cm2 applied according to the lesion."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Cartistem"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02338375"
                        ]
                  },
                  {
                        "Rank": 59,
                        "InterventionArmGroupLabel": [
                              "Autologous Mesenchymal Stromal Cells (MSC)",
                              "Allogenic Mesenchymal Stromal Cells (MSC)",
                              "Active Control"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Ratio"
                        ],
                        "InterventionBrowseLeafId": [
                              "M9030",
                              "M2780",
                              "M9353",
                              "M27448",
                              "M21022"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hyaluronic Acid",
                              "Adjuvants, Immunologic",
                              "Immunologic Factors",
                              "Viscosupplements",
                              "Protective Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Intra-articular injection 40 million/4 ml.",
                              "Intra-articular injection 40 million/4 ml.",
                              "Intra-articular injection 60mg / 3 ml ."
                        ],
                        "InterventionMeshId": [
                              "D000006820"
                        ],
                        "InterventionMeshTerm": [
                              "Hyaluronic Acid"
                        ],
                        "InterventionName": [
                              "Autologous MSCs",
                              "Allogenic MSCs",
                              "Hyaluronic Acid"
                        ],
                        "InterventionOtherName": [
                              "Hyaluronic Acid 20 mg/ml"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05086939"
                        ]
                  },
                  {
                        "Rank": 60,
                        "InterventionArmGroupLabel": [
                              "A1",
                              "A2",
                              "B1",
                              "B2",
                              "C1",
                              "C2"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "25 M allogeneic MPCs by transendocardial injection",
                              "Standard-of-care treatment with NOGA\u00ae mapping and staged injections.",
                              "75 M allogeneic MPCs by transendocardial injection",
                              "Standard-of-care treatment with NOGA\u00ae mapping and staged injections.",
                              "150 M allogeneic MPCs by transendocardial injection",
                              "Standard-of-care treatment with NOGA\u00ae mapping and staged injections."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Mesenchymal Precursor Cells (MPCs)",
                              "Standard-of-care treatment with NOGA\u00ae mapping and staged injections.",
                              "Allogeneic Mesenchymal Precursor Cells (MPCs)",
                              "Standard-of-care treatment with NOGA\u00ae mapping and staged injections.",
                              "Allogeneic Mesenchymal Precursor Cells (MPCs)",
                              "Standard-of-care treatment with NOGA\u00ae mapping and staged injections."
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Genetic",
                              "Procedure",
                              "Genetic",
                              "Procedure",
                              "Genetic",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00555828"
                        ]
                  },
                  {
                        "Rank": 61,
                        "InterventionArmGroupLabel": [
                              "allogenic mesenchymal stem cells (MSCs)",
                              "Control group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "ARhu",
                              "Derm",
                              "All",
                              "Infl",
                              "ANeo",
                              "AnEm",
                              "NeuroAg",
                              "Gast",
                              "Hemat"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Antirheumatic Agents",
                              "Dermatologic Agents",
                              "All Drugs and Chemicals",
                              "Anti-Inflammatory Agents",
                              "Antineoplastic Agents",
                              "Antiemetics",
                              "Neuroprotective Agents",
                              "Gastrointestinal Agents",
                              "Hematinics"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Term",
                              "Term",
                              "Diffusion"
                        ],
                        "InterventionBrowseLeafId": [
                              "M18113",
                              "M5882",
                              "M8199",
                              "M13272",
                              "M1833",
                              "M10901",
                              "M10902",
                              "M229437",
                              "M211896",
                              "M248768",
                              "M5879",
                              "M10262",
                              "M9364",
                              "M9353",
                              "M3406",
                              "M5404",
                              "M10948",
                              "M3366",
                              "M6226",
                              "M19757",
                              "M29605",
                              "M8941",
                              "M8940"
                        ],
                        "InterventionBrowseLeafName": [
                              "Cyclosporine",
                              "Cyclosporins",
                              "Glucocorticoids",
                              "Prednisolone",
                              "Methylprednisolone Acetate",
                              "Methylprednisolone",
                              "Methylprednisolone Hemisuccinate",
                              "Prednisolone acetate",
                              "Prednisolone hemisuccinate",
                              "Prednisolone phosphate",
                              "Cyclophosphamide",
                              "Liver Extracts",
                              "Immunosuppressive Agents",
                              "Immunologic Factors",
                              "Antifungal Agents",
                              "Clotrimazole",
                              "Miconazole",
                              "Anti-Infective Agents",
                              "Dermatologic Agents",
                              "Antirheumatic Agents",
                              "Calcineurin Inhibitors",
                              "Hormones",
                              "Hormone Antagonists"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "high",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Mesenchymal stem cells, 1-2\u00d7107, bone marrow injection, once a week for the first four weeks; whether to continue after four weeks depends on patients' symptoms.",
                              "Calmodulin inhibitors such as cyclosporine, combined with Glucocorticoid 0.5-1mg/kg/d ,to the end of the study."
                        ],
                        "InterventionMeshId": [
                              "D000016572",
                              "D000003524",
                              "D000005938"
                        ],
                        "InterventionMeshTerm": [
                              "Cyclosporine",
                              "Cyclosporins",
                              "Glucocorticoids"
                        ],
                        "InterventionName": [
                              "Biological: mesenchymal stem cell",
                              "Cyclosporine and Glucocorticoid"
                        ],
                        "InterventionOtherName": [
                              "Regenerative medicine: MSCs",
                              "Calmodulin inhibitors combined with Glucocorticoid"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01526850"
                        ]
                  },
                  {
                        "Rank": 62,
                        "InterventionArmGroupLabel": [
                              "Ex- vivo cultured adult allogeneic MSCs",
                              "Plasmalyte-A"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All",
                              "PhSol"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "AKT"
                        ],
                        "InterventionBrowseLeafId": [
                              "M9030",
                              "M85407",
                              "M11966",
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hyaluronic Acid",
                              "Plasma-lyte 148",
                              "Ophthalmic Solutions",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Single intraarticular dose of allogeneic MSCs suspended in 2ml Plasmalyte followed by 2ml of Hyaluronan",
                              "Single intraarticular dose of 2ml Plasmalyte followed by 2ml Hyaluronan"
                        ],
                        "InterventionMeshId": [
                              "C000012499"
                        ],
                        "InterventionMeshTerm": [
                              "Plasma-lyte 148"
                        ],
                        "InterventionName": [
                              "Ex- vivo cultured adult allogeneic MSCs",
                              "Plasmalyte-A"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01453738"
                        ]
                  },
                  {
                        "Rank": 63,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stem cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Direct injection of 75 million allogeneic bone marrow derived mesenchymal stem cells at baseline and again after 3 months if not completely healed"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04791878"
                        ]
                  },
                  {
                        "Rank": 64,
                        "InterventionArmGroupLabel": [
                              "allogenic mesenchymal stem cells (MSCs)",
                              "ursodeoxycholic acid (UDCA)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Gast",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Gastrointestinal Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Empowerment"
                        ],
                        "InterventionBrowseLeafId": [
                              "M16481",
                              "M8033"
                        ],
                        "InterventionBrowseLeafName": [
                              "Ursodeoxycholic Acid",
                              "Gastrointestinal Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Mesenchymal stem cells,5-50 million/kg, Intravenous infusion, One dosage\uff0cwhether to give another dosage depending on patients' condition",
                              "13-15 mg/kg/day, to the end of the study"
                        ],
                        "InterventionMeshId": [
                              "D000014580"
                        ],
                        "InterventionMeshTerm": [
                              "Ursodeoxycholic Acid"
                        ],
                        "InterventionName": [
                              "Biological: mesenchymal stem cell",
                              "ursodeoxycholic acid"
                        ],
                        "InterventionOtherName": [
                              "regenerative medicine:MSCs",
                              "UDCA"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01440309"
                        ]
                  },
                  {
                        "Rank": 65,
                        "InterventionArmGroupLabel": [
                              "umbilical cord mesenchymal stem cell"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "allogeneic umbilical cord mesenchymal stem cell transplantation by intravenous injection"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "umbilical cord mesenchymal stem cell"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02763423"
                        ]
                  },
                  {
                        "Rank": 66,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic mesenchymal stem cells will be infused intravenously (single dose, 10^6 cells/kg body weight)."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Mesenchymal Stem Cells (AlloMSC)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00962923"
                        ]
                  },
                  {
                        "Rank": 67,
                        "InterventionArmGroupLabel": [
                              "Intra parenchymal injection",
                              "Intra parenchymal injection & Intra-arterial infusion",
                              "Intra-arterial infusion"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Injection of Allogeneic adipose derived mesenchymal stem cells into the Kidney allograft"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic adipose derived mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04388761"
                        ]
                  },
                  {
                        "Rank": 68,
                        "InterventionArmGroupLabel": [
                              "Group A - Allo-hMSCs",
                              "Group B"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic Human Mesenchymal Stem Cells",
                              "Placebo"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allo-hMSCs",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "stem cells; Allogeneic Human Mesenchymal Stem Cells",
                              "Placebo comparator"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02398604"
                        ]
                  },
                  {
                        "Rank": 69,
                        "InterventionArmGroupLabel": [
                              "Group 1",
                              "Group 2"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "intravenous infusion of bone marrow-derived allogeneic stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "hMSCs"
                        ],
                        "InterventionOtherName": [
                              "allogeneic mesenchymal stem cell"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02625246"
                        ]
                  },
                  {
                        "Rank": 70,
                        "InterventionArmGroupLabel": [
                              "exosome or vesicle"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "allogenic mesenchymal stem cells derived exosome enriched by miR-124"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "exosome"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03384433"
                        ]
                  },
                  {
                        "Rank": 71,
                        "InterventionArmGroupLabel": [
                              "allogeneic human mesenchymal stem cells (allo-hMSCs)",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "CNSDep",
                              "All",
                              "PhSol"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Central Nervous System Depressants",
                              "All Drugs and Chemicals",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M2929",
                              "M85407"
                        ],
                        "InterventionBrowseLeafName": [
                              "Ethanol",
                              "Plasma-lyte 148"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Single administration of allogeneic hMSCs: 100 x 106 (100 million) allo-hMSCs of cells delivered via a single peripheral intravenous infusion.",
                              "Placebo administration consisting of 1% human albumin serum in Plasma-Lyte A delivered via a single peripheral intravenous infusion."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "allogeneic human mesenchymal stem cells (allo-hMSCs)",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03265808"
                        ]
                  },
                  {
                        "Rank": 72,
                        "InterventionArmGroupLabel": [
                              "MSC week 12 and 11 before LVRS2",
                              "MSC week 4 and 3 before LVRS2",
                              "Placebo week 12 and 11 before LVRS2",
                              "Placebo week 4 and 3 before LVRS2"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "These MSCs will originate from bone marrow that will be aspirated from healthy volunteer donors screened by a trained physician of the center for stem cell therapy of LUMC",
                              "The placebo will be an equivalent volume NaCl 0,9% and DMSO 5%"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic MSC",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Genetic",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04918706"
                        ]
                  },
                  {
                        "Rank": 73,
                        "InterventionArmGroupLabel": [
                              "Allogeneic Mesenchymal Stromal Cell infusion"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intravenous MSCs 1.2-1.5 x 10^6 cells/kg on Days 1 and 3 after study enrollment"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Mesenchymal Stromal Cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05286255"
                        ]
                  },
                  {
                        "Rank": 74,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stem cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Mesenchymal stem cells will be intravenously infused via a central venous catheter,at a dose of 1\u00d710^6 cells/kg, over 15 min. The vital signs of all patients will be closely monitored during and for 24h after MSCs administration. If the NEU and PLT levels do not attain the completely response(CR)standards within 14d, a second course of MSCs treatment will be given."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01763086"
                        ]
                  },
                  {
                        "Rank": 75,
                        "InterventionArmGroupLabel": [
                              "composite group",
                              "conditioned medium group",
                              "control group",
                              "stem cells group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Coag",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Coagulants",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M17443"
                        ],
                        "InterventionBrowseLeafName": [
                              "Fibrin Tissue Adhesive"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "rabbit with posterior cruciate ligament rupture and treated with fibrin glue mix with adypose mesenchymal stem cells in hypoxic culture and ligament derived conditioned medium"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "adypose mesenchymal conditioned medium and ligament derived conditioned medium"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04889963"
                        ]
                  },
                  {
                        "Rank": 76,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal Stem Cells",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Adult allogeneic bone marrow derived mesenchymal stem cells for the treatment of rectovaginal fistulas in the setting of Crohn's disease.",
                              "Normal Saline"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04519697"
                        ]
                  },
                  {
                        "Rank": 77,
                        "InterventionArmGroupLabel": [
                              "XCEL-MT-OSTEO-ALPHA",
                              "Standard treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Isolation and \"ex-vivo\" expansion of mesenchymal stem cells (MSC) obtained from each patient's bone marrow under GMP conditions at Xcelia, Divisi\u00f3n de Terapias Avanzadas delBanc de Sang i Teixits. After expansion, MSCs are fixed in allogenic bone tissue and implanted in instrumented spinal fusion.",
                              "Instrumented spinal fusion together with patient's bone iliac crest"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "XCEL-MT-OSTEO-ALPHA",
                              "Standard treatment"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01552707"
                        ]
                  },
                  {
                        "Rank": 78,
                        "InterventionArmGroupLabel": [
                              "Dose 1 mil/kg",
                              "Dose 10 mil/kg"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogenic adipose-derived mesenchymal cells with autologous bone marrow mononuclear cells will be injected."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Adipose mesenchymal cells with bone marrow mononuclear cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT02940418"
                        ]
                  },
                  {
                        "Rank": 79,
                        "InterventionArmGroupLabel": [
                              "Group 1",
                              "Group 2",
                              "Group 3"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intraarticular administration of 20x10^6 MSCs"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Human allogeneic mesenchymal bone marrow derived stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03602872"
                        ]
                  },
                  {
                        "Rank": 80,
                        "InterventionArmGroupLabel": [
                              "Control",
                              "Intervention 1",
                              "Intervention 2",
                              "Intervention 3",
                              "Intervention 1",
                              "Intervention 2",
                              "Intervention 1",
                              "Intervention 3"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Ratio"
                        ],
                        "InterventionBrowseLeafId": [
                              "M9030",
                              "M250495",
                              "M2780",
                              "M9353",
                              "M27448",
                              "M21022"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hyaluronic Acid",
                              "Hylan",
                              "Adjuvants, Immunologic",
                              "Immunologic Factors",
                              "Viscosupplements",
                              "Protective Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [],
                        "InterventionMeshId": [
                              "D000006820"
                        ],
                        "InterventionMeshTerm": [
                              "Hyaluronic Acid"
                        ],
                        "InterventionName": [
                              "Hyaluronic Acid",
                              "Umbilical Cord Mesenchymal Stem Cell",
                              "Recombinant Human Somatropin"
                        ],
                        "InterventionOtherName": [
                              "Hyaluronan"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT03800810"
                        ]
                  },
                  {
                        "Rank": 81,
                        "InterventionArmGroupLabel": [
                              "Stem cells implantation"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic stem cells implantation"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01759212"
                        ]
                  },
                  {
                        "Rank": 82,
                        "InterventionArmGroupLabel": [
                              "allogeneic ASCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All",
                              "HB"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals",
                              "Herbal and Botanical"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013",
                              "T120"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions",
                              "Cola"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "The cells will be given in different sites within the affected colonic submucosa at a total dose of 60 million cells with the use of a colonoscope."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic adipose tissue-derived mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [
                              "Cx-601 (company code)"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01914887"
                        ]
                  },
                  {
                        "Rank": 83,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stem cells",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic bone marrow derived mesenchymal stem cells",
                              "Normal Saline"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stem cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04519684"
                        ]
                  },
                  {
                        "Rank": 84,
                        "InterventionArmGroupLabel": [
                              "Human umbilical cord mesenchymal stem cells (UC-MSCs)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "All patients to receive 1st dose of 125 million UC-MSCs and the 2nd dose of 150 million UC-MSCs only if patients have no clinical improvement post 24 weeks after 1st dose"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Human umbilical cord mesenchymal stem cells (UC-MSCs)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05039411"
                        ]
                  },
                  {
                        "Rank": 85,
                        "InterventionArmGroupLabel": [
                              "High dose treatment arm",
                              "Low dose treatment arm",
                              "Control arm"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic mesenchymal stromal cells derived from adipose tissue administered intramuscularly",
                              "Allogeneic mesenchymal stromal cells derived from adipose tissue administered intramuscularly",
                              "0,9% physiological saline"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "High dose allogeneic mesenchymal stromal cells",
                              "Low dose allogeneic mesenchymal stromal cells",
                              "Placebos"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04466007"
                        ]
                  },
                  {
                        "Rank": 86,
                        "InterventionArmGroupLabel": [
                              "Control Group",
                              "Study Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Culture expanded mesenchymal stem cells isolated from a patient's own abdominal fat tissue"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic adipose-derived stem cells"
                        ],
                        "InterventionOtherName": [
                              "Celltex-AdMSCs"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05017298"
                        ]
                  },
                  {
                        "Rank": 87,
                        "InterventionArmGroupLabel": [
                              "allogeneic mesenchymal stromal cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "The allogeneic mesenchymal stromal cells will be administered intravenously."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic mesenchymal stromal cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02421484"
                        ]
                  },
                  {
                        "Rank": 88,
                        "InterventionArmGroupLabel": [
                              "Group A",
                              "Group A",
                              "Group A"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "All",
                              "Hemat"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "All Drugs and Chemicals",
                              "Hematinics"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M3466",
                              "M10262"
                        ],
                        "InterventionBrowseLeafName": [
                              "Antiviral Agents",
                              "Liver Extracts"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Thirty of the enrolled patients were assigned to Group B to receive comprehensive treatment, as well as allogeneic bone marrow mesenchymal stem cells transplantation by peripheral vein(2\u00d7105/Kg, once a week, 4 times).",
                              "Thirty of the enrolled patients were assigned to Group B to receive comprehensive treatment, as well as allogeneic bone marrow mesenchymal stem cells transplantation by peripheral vein(1\u00d7106/Kg, once a week, 4 times).",
                              "Thirty of the enrolled patients were assigned to Group B to receive comprehensive treatment, as well as allogeneic bone marrow mesenchymal stem cells transplantation by peripheral vein(5\u00d7106/Kg, once a week, 4 times)."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Group 1",
                              "Group 2",
                              "Group 3"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other",
                              "Other",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01322906"
                        ]
                  },
                  {
                        "Rank": 89,
                        "InterventionArmGroupLabel": [
                              "Cellular therapy",
                              "Cellular therapy"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Coag",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Coagulants",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M7464"
                        ],
                        "InterventionBrowseLeafName": [
                              "Factor VIII"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "bone marrow derived mesenchymal stem cells for normal subjects will be separated and induced to adopt the hepatocyte phenotype then injected through the portal vein to hemophilia patients",
                              "Allogenic bone marrow derived MSCs will be isolated and subjected to induction of hepatic phenotype. After proof of in vitro secretion of albumin and factor 8 from the cell population. It will be injected into the portal vein via the spleen"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Cellular therapy",
                              "cellular therapy"
                        ],
                        "InterventionOtherName": [
                              "hepatocyte-like MSC"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02108132"
                        ]
                  },
                  {
                        "Rank": 90,
                        "InterventionArmGroupLabel": [
                              "100 million hMSCs",
                              "20 million hMSCs",
                              "200 million hMSCs",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "CNSDep",
                              "All",
                              "PhSol",
                              "ANeo"
                        ],
                        "InterventionBrowseBranchName": [
                              "Central Nervous System Depressants",
                              "All Drugs and Chemicals",
                              "Pharmaceutical Solutions",
                              "Antineoplastic Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M7286",
                              "M85407",
                              "M8814"
                        ],
                        "InterventionBrowseLeafName": [
                              "Ether",
                              "Plasma-lyte 148",
                              "Altretamine"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "The placebo will be 25 ml of Plasma-Lyte A with 1% HSA in a Cryostore bag."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs)",
                              "matched placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02013700"
                        ]
                  },
                  {
                        "Rank": 91,
                        "InterventionArmGroupLabel": [
                              "Dose Arm 2",
                              "Dose Arm 1"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Single MSC infusion of 150x10^6 cells at time zero; intravenous delivery",
                              "Two MSC infusions of 75x10^6 cells at time zero and three months; intravenous delivery"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single Infusion",
                              "Allogeneic adipose-derived mesenchymal stem cells (MSC)-Two Infusions"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04869761"
                        ]
                  },
                  {
                        "Rank": 92,
                        "InterventionArmGroupLabel": [
                              "Debridement and microfracture in LOC + Cells",
                              "Debridement and microfracture in LOC",
                              "Debridement and microfracture in LOC + Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "HB",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Herbal and Botanical",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "T63"
                        ],
                        "InterventionBrowseLeafName": [
                              "Astragalus"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Platelet-poor plasma (PPP) scaffold embedded in allogenic stromal mesenchymal cells derived from the umbilical cord added to the traditional treatment for osteochondral lesions of the talus",
                              "Debridement and microfracture in LOC is the traditional treatment for osteochondral lesions of the talus"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogenic stromal mesenchymal cells derived from the umbilical cord",
                              "Debridement and microfracture"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03905824"
                        ]
                  },
                  {
                        "Rank": 93,
                        "InterventionArmGroupLabel": [
                              "FURESTEM-CD Inj"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "3.0 x 106 cells/kg, IV, Total of 3 doses every 2weeks"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Human Umbilical Cord Blood-derived Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [
                              "hUCB-MSCs",
                              "FURESTEM-CD Inj"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04520022"
                        ]
                  },
                  {
                        "Rank": 94,
                        "InterventionArmGroupLabel": [
                              "Ex- vivo cultured adult allogeneic MSCs",
                              "Plasmalyte-A"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All",
                              "PhSol"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "AKT"
                        ],
                        "InterventionBrowseLeafId": [
                              "M9030",
                              "M85407",
                              "M11966",
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hyaluronic Acid",
                              "Plasma-lyte 148",
                              "Ophthalmic Solutions",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Single intraarticular dose of allogeneic MSCs suspended in 2ml Plasmalyte followed by 2ml of Hyaluronan",
                              "Single intraarticular dose of 2ml Plasmalyte followed by 2ml Hyaluronan"
                        ],
                        "InterventionMeshId": [
                              "C000012499"
                        ],
                        "InterventionMeshTerm": [
                              "Plasma-lyte 148"
                        ],
                        "InterventionName": [
                              "Ex- vivo cultured adult allogeneic MSCs",
                              "Plasmalyte-A"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01448434"
                        ]
                  },
                  {
                        "Rank": 95,
                        "InterventionArmGroupLabel": [
                              "mesenchymal stromal cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "mesenchymal stromal cells in a collagen scaffold"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "mesenchymal stromal cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03509870"
                        ]
                  },
                  {
                        "Rank": 96,
                        "InterventionArmGroupLabel": [
                              "Adipose tissue-derived mesenchymal stem cells (ASCs)",
                              "Placebo (vehicle, Cryostor CS10)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "ASCs expanded from healthy donors. The ASC product contains 22 million ASCs/ml.",
                              "CryoStor\u00ae CS10 freeze medium"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ASCs",
                              "Cryostor CS10"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic adipose-derived mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04615455"
                        ]
                  },
                  {
                        "Rank": 97,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stem cell (MSC)",
                              "Control group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "ARhu",
                              "Derm",
                              "All",
                              "ANeo",
                              "Infl",
                              "AnEm",
                              "NeuroAg",
                              "Gast",
                              "Repr"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Antirheumatic Agents",
                              "Dermatologic Agents",
                              "All Drugs and Chemicals",
                              "Antineoplastic Agents",
                              "Anti-Inflammatory Agents",
                              "Antiemetics",
                              "Neuroprotective Agents",
                              "Gastrointestinal Agents",
                              "Reproductive Control Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "CGE",
                              "CGE",
                              "Benefit",
                              "Pelvic",
                              "Saline"
                        ],
                        "InterventionBrowseLeafId": [
                              "M18113",
                              "M5882",
                              "M11280",
                              "M13272",
                              "M1833",
                              "M10901",
                              "M10902",
                              "M229437",
                              "M211896",
                              "M248768",
                              "M18102",
                              "M10855",
                              "M13273",
                              "M9364",
                              "M3369",
                              "M8199",
                              "M8941",
                              "M8940",
                              "M20119",
                              "M9353",
                              "M3406",
                              "M5404",
                              "M10948",
                              "M3366",
                              "M6226",
                              "M19757",
                              "M29605",
                              "M3374",
                              "M3376",
                              "M3463"
                        ],
                        "InterventionBrowseLeafName": [
                              "Cyclosporine",
                              "Cyclosporins",
                              "Mycophenolic Acid",
                              "Prednisolone",
                              "Methylprednisolone Acetate",
                              "Methylprednisolone",
                              "Methylprednisolone Hemisuccinate",
                              "Prednisolone acetate",
                              "Prednisolone hemisuccinate",
                              "Prednisolone phosphate",
                              "Tacrolimus",
                              "Methotrexate",
                              "Prednisone",
                              "Immunosuppressive Agents",
                              "Anti-Inflammatory Agents",
                              "Glucocorticoids",
                              "Hormones",
                              "Hormone Antagonists",
                              "Antineoplastic Agents, Hormonal",
                              "Immunologic Factors",
                              "Antifungal Agents",
                              "Clotrimazole",
                              "Miconazole",
                              "Anti-Infective Agents",
                              "Dermatologic Agents",
                              "Antirheumatic Agents",
                              "Calcineurin Inhibitors",
                              "Anti-Bacterial Agents",
                              "Antibiotics, Antitubercular",
                              "Antitubercular Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "high",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "high",
                              "low",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Experimental:Mesenchymal stem cell(MSC). Patients with newly diagnosed extensive cGVHD: prednisone 1mg/kg + cyclosporine or tacrolimus and MSC 2\u00d71,000,000 MSC/kg, IV twice a week for the first two weeks and weekly for the following two weeks(6 doses totally).\n\nRefractory extensive cGVHD: receive primary treatment (prednisone + cyclosporine or tacrolimus, or plus mycophenolate mofetil, or plus methotrexate ) and MSC2\u00d71,000,000 MSC/kg, IV twice a week for the first two weeks and weekly for the following two weeks(6 doses totally).",
                              "Patients with newly diagnosed extensive cGVHD: prednisone 1mg/kg + cyclosporine or tacrolimus\n\nPatients with refractory extensive cGVHD: primary treatment (eg.prednisone 1mg/kg + cyclosporine or tacrolimus,or plus mycophenolate mofetil, or methotrexate.)"
                        ],
                        "InterventionMeshId": [
                              "D000016572",
                              "D000009173",
                              "D000011241",
                              "D000003524",
                              "D000016559"
                        ],
                        "InterventionMeshTerm": [
                              "Cyclosporine",
                              "Mycophenolic Acid",
                              "Prednisone",
                              "Cyclosporins",
                              "Tacrolimus"
                        ],
                        "InterventionName": [
                              "Mesenchymal stem cell (MSC)",
                              "Prednisone and cyclosporine or primary therapies"
                        ],
                        "InterventionOtherName": [
                              "Medrol",
                              "Sandimmun Neoral",
                              "FK506,prograf",
                              "Cellcept",
                              "MTX",
                              "Medral",
                              "Sandimmun Neoral",
                              "FK506,Prograf",
                              "Cellcept,MMF",
                              "MTX"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00972660"
                        ]
                  },
                  {
                        "Rank": 98,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stem cells",
                              "Normal saline"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intramuscular injection",
                              "Intramuscular injection"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stem cells",
                              "Normal saline"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03239535"
                        ]
                  },
                  {
                        "Rank": 99,
                        "InterventionArmGroupLabel": [
                              "Intervention"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intravenous 1*10E6 MSCs/kg body weight Mesenchymal Stromal Cells infusion"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stromal Cells infusion"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04467047"
                        ]
                  },
                  {
                        "Rank": 100,
                        "InterventionArmGroupLabel": [
                              "Addendum B - Antibiotic free cell Group",
                              "Pilot Phase - Group 2",
                              "Pilot Phase - Group 3",
                              "Pilot phase - Group 1",
                              "Randomized Phase - Group A",
                              "Randomized Phase - Group C",
                              "Randomized phase - Group B",
                              "Randomized Phase - Group C",
                              "Addendum B - Antibiotic free cell Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Body surface",
                              "Benchmark"
                        ],
                        "InterventionBrowseLeafId": [
                              "M3374",
                              "M12469",
                              "M3376",
                              "M15249",
                              "M3366"
                        ],
                        "InterventionBrowseLeafName": [
                              "Anti-Bacterial Agents",
                              "Penicillins",
                              "Antibiotics, Antitubercular",
                              "Streptomycin",
                              "Anti-Infective Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "high",
                              "low",
                              "high",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) administered by peripheral intravenous infusion",
                              "Placebo administered by peripheral intravenous infusion.",
                              "Penicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) administered by peripheral intravenous infusion."
                        ],
                        "InterventionMeshId": [
                              "D000010406",
                              "D000013307"
                        ],
                        "InterventionMeshTerm": [
                              "Penicillins",
                              "Streptomycin"
                        ],
                        "InterventionName": [
                              "Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)",
                              "Placebo",
                              "Penicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02065245"
                        ]
                  },
                  {
                        "Rank": 101,
                        "InterventionArmGroupLabel": [
                              "Allogeneic Mesenchymal Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Study treatment consists of Mesenchymal Stem Cell (MSC) derived from donors adipose tissue and expanded in vitro in a specific medium with platelet lysate without addition of animal derived products.\n\nSubjects will receive four sequential IV dose of Mesenchymal stem cells.\n\nSequential doses:\n\nDay 1: 0.7-1 x 106 MSC / kg Day 4: 0.7-1 x 106 MSC / kg Day 11: 0.7-1 x 106 MSC / kg Day 18: 0.7-1 x 106 MSC / kg"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Adult Allogeneic Mesenchymal cells from adipose tissue."
                        ],
                        "InterventionOtherName": [
                              "MSC for the treatment of graft -versus -host disease"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02687646"
                        ]
                  },
                  {
                        "Rank": 102,
                        "InterventionArmGroupLabel": [
                              "Group 1: 20 million Allogeneic hMSCs",
                              "Group 2: 100 million Allogeneic hMSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic hMSCs"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic Adult Human Mesenchymal Stem Cells (MSCs)"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02013674"
                        ]
                  },
                  {
                        "Rank": 103,
                        "InterventionArmGroupLabel": [
                              "Adipose tissue-derived mesenchymal stem cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "CSCC_ASC(22), a ready-to-use suspension containing 22 million adipose tissue-derived mesenchymal stem cells per millilitre"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Adipose tissue-derived mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03878628"
                        ]
                  },
                  {
                        "Rank": 104,
                        "InterventionArmGroupLabel": [
                              "Active/Treatment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "CNSDep",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Central Nervous System Depressants",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M3259"
                        ],
                        "InterventionBrowseLeafName": [
                              "Anesthetics"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Injection of HLA-A2+ and/or gender mismatched allogeneic MSCs above the site of amputation and into the anterior tibialis muscle (ATM) of patients scheduled for semi-elective lower extremity major amputation at 7 days before amputation."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic bone marrow derived mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [
                              "cBMA",
                              "MSCs"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02685098"
                        ]
                  },
                  {
                        "Rank": 105,
                        "InterventionArmGroupLabel": [
                              "intravenous injection of UC-MSC"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Hemat",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Hematinics",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M10262"
                        ],
                        "InterventionBrowseLeafName": [
                              "Liver Extracts"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "All research samples will be treated by Intravenous injection of allogeneic mesenchymal stem cells and hemodynamic observation will be done for 24 hours after treated. Periodic post-treatment observation will be done on 1st month, 3rd month, and 6th month after therapy. The Independent variable in this research is Child-Pugh B Cirrhosis caused by Hepatitis B, while the dependent variable is the degree of liver function damage consisting of an examination of liver function, Child-Pugh score, and MELD score."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Umbilical Cord Mesenchymal Stem Cell"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04357600"
                        ]
                  },
                  {
                        "Rank": 106,
                        "InterventionArmGroupLabel": [
                              "High dose",
                              "Low dose",
                              "Medium dose"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Hypo",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Hypoglycemic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M9517",
                              "M172956"
                        ],
                        "InterventionBrowseLeafName": [
                              "Insulin",
                              "Insulin, Globin Zinc"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "ProTrans is an pooled allogenic mesenchymal stromal cell treatment"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ProTrans"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03973827"
                        ]
                  },
                  {
                        "Rank": 107,
                        "InterventionArmGroupLabel": [
                              "High Dose Allogenic MSC",
                              "Low Dose Allogenic MSC",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Hypoxia-cultured human bone marrow derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogenic MSC",
                              "Normal saline"
                        ],
                        "InterventionOtherName": [
                              "Biochymal"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT02336646"
                        ]
                  },
                  {
                        "Rank": 108,
                        "InterventionArmGroupLabel": [
                              "Treatment",
                              "Control"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Allogenic umbilical cord-derived mesenchymal stem cell (UCMSC) from normoxic, culture condition, administered through intravenousinfusion at dose 1x10^6 cells MSC/kg body weight. The treatment will be administered three times, at three days intervals (day 0, day 3, and day 6)",
                              "Sterile saline solution and adminastered through intravenous infusion three times, at three day intervals (day 0, day 3, and day 6)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Normoxic Allogenic UCMSC",
                              "Normal saline solution"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05132972"
                        ]
                  },
                  {
                        "Rank": 109,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05152290"
                        ]
                  },
                  {
                        "Rank": 110,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05147675"
                        ]
                  },
                  {
                        "Rank": 111,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05158127"
                        ]
                  },
                  {
                        "Rank": 112,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05147701"
                        ]
                  },
                  {
                        "Rank": 113,
                        "InterventionArmGroupLabel": [
                              "AllogeneicHumanUmbilicalCordTissue-DerivedMesenchymalStemCells",
                              "AllogeneicHumanUmbilicalCordTissue-DerivedMesenchymalStemCells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Super selective intravenous administration of 50 million Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (UC-MSC) and intrathecal administration of UC-MSCs in dose of 100 million along with liberation therapy (when associated with CCSVI)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells",
                              "Liberation therapy"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02587715"
                        ]
                  },
                  {
                        "Rank": 114,
                        "InterventionArmGroupLabel": [
                              "AllogeneicHumanUmbilicalCordTissue-DerivedMesenchymalStemCells",
                              "AllogeneicHumanUmbilicalCordTissue-DerivedMesenchymalStemCells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Super selective intravenous administration of 50 million Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (UC-MSC) and intrathecal administration of UC-MSCs in dose of 100 million along with liberation therapy (when associated with CCSVI)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells",
                              "Liberation therapy"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02418325"
                        ]
                  },
                  {
                        "Rank": 115,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05018858"
                        ]
                  },
                  {
                        "Rank": 116,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05158933"
                        ]
                  },
                  {
                        "Rank": 117,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05158101"
                        ]
                  },
                  {
                        "Rank": 118,
                        "InterventionArmGroupLabel": [
                              "Treatment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05003960"
                        ]
                  },
                  {
                        "Rank": 119,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05147766"
                        ]
                  },
                  {
                        "Rank": 120,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05158439"
                        ]
                  },
                  {
                        "Rank": 121,
                        "InterventionArmGroupLabel": [
                              "Treatment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05003908"
                        ]
                  },
                  {
                        "Rank": 122,
                        "InterventionArmGroupLabel": [
                              "Treatment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05147688"
                        ]
                  },
                  {
                        "Rank": 123,
                        "InterventionArmGroupLabel": [
                              "Treatment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05018819"
                        ]
                  },
                  {
                        "Rank": 124,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05152394"
                        ]
                  },
                  {
                        "Rank": 125,
                        "InterventionArmGroupLabel": [
                              "Treatment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05003388"
                        ]
                  },
                  {
                        "Rank": 126,
                        "InterventionArmGroupLabel": [
                              "Group receiving 100 million hMSCs",
                              "Group receiving 20 million hMSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "intravenous infusion of bone marrow-derived allogeneic stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "hMSCs"
                        ],
                        "InterventionOtherName": [
                              "allogeneic mesenchymal stem cell"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03137199"
                        ]
                  },
                  {
                        "Rank": 127,
                        "InterventionArmGroupLabel": [
                              "Treatment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05003934"
                        ]
                  },
                  {
                        "Rank": 128,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05152381"
                        ]
                  },
                  {
                        "Rank": 129,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05018832"
                        ]
                  },
                  {
                        "Rank": 130,
                        "InterventionArmGroupLabel": [
                              "Treatment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05018767"
                        ]
                  },
                  {
                        "Rank": 131,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05018845"
                        ]
                  },
                  {
                        "Rank": 132,
                        "InterventionArmGroupLabel": [
                              "Treatment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05016804"
                        ]
                  },
                  {
                        "Rank": 133,
                        "InterventionArmGroupLabel": [
                              "Treatment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05003947"
                        ]
                  },
                  {
                        "Rank": 134,
                        "InterventionArmGroupLabel": [
                              "Treatment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05016817"
                        ]
                  },
                  {
                        "Rank": 135,
                        "InterventionArmGroupLabel": [
                              "Treatment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05003921"
                        ]
                  },
                  {
                        "Rank": 136,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05158114"
                        ]
                  },
                  {
                        "Rank": 137,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Mesenchymal Stem Cells from Wharton \u0301s jellyintravenous infusion of Mesenchymal Stem Cells from Wharton \u0301s jelly"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cells from Wharton \u0301s jellyintravenous infusion of Mesenchymal Stem Cells from Wharton \u0301s jelly"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT04432545"
                        ]
                  },
                  {
                        "Rank": 138,
                        "InterventionArmGroupLabel": [
                              "High Dose MSCTC-0010",
                              "Low Dose MSCTC-0010",
                              "Medium Dose MSCTC-0010"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "MSCTC-0010 is a suspension product for infusion. The active ingredient is the umbilical cord-derived allogeneic mesenchymal stem cells (US-MSCs)."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MSCTC-0010"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04385056"
                        ]
                  },
                  {
                        "Rank": 139,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stromal cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stromal cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02215811"
                        ]
                  },
                  {
                        "Rank": 140,
                        "InterventionArmGroupLabel": [
                              "Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)",
                              "Marrow cellution (standard treatment)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Human umbilical cord-derived mesenchymal stem cells",
                              "Patients will undergo marrow cellution surgical procedure."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)",
                              "Marrow cellution"
                        ],
                        "InterventionOtherName": [
                              "Chondrocell-EX"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05016011"
                        ]
                  },
                  {
                        "Rank": 141,
                        "InterventionArmGroupLabel": [
                              "Cellgram-CKD"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Allogeneic bone marrow-derived mesenchymal stem cell therapy for the treatment of chronic kidney disease"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Cellgram-CKD"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05042206"
                        ]
                  },
                  {
                        "Rank": 142,
                        "InterventionArmGroupLabel": [
                              "HAM and HUMCWJ Injections (Group 1)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "SURGENEX SurForce\u00ae (1cc) allograft placental based tissue matrix, will be injected using a 22 gauge, 2-inch needle. The injection site (medial, lateral, patellar) will be determined based on the side with the most joint space from the findings of the most recent x-rays. The Physician will insert the needle fully into the joint space and begin to expel the fluid. He will achieve a continuous injection flow as he withdraws the needle back out of joint space. Immediately following the SURGENEX SurForce\u00ae injection, an injection of Predictive Biotech CORECYTE(TM) (1 cc) allograft umbilical cord-derived Warton's Jelly tissue matrix will be administered. This will be done using the exact same protocol as the SURGENEX SurForce\u00ae injection."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "HAM and HUMCWJ Injections"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03337243"
                        ]
                  },
                  {
                        "Rank": 143,
                        "InterventionArmGroupLabel": [
                              "human amniotic mesenchymal stem cell treatment group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "human amniotic mesenchymal stem cell (hA-MSC) for the treatment of lupus nephritis patients with WHO class III, IV or V LN were given hA-MSC (Peripheral intravenous infusion, dose 1\u00d7106/kg cells, once every month for three times)."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "human amniotic mesenchymal stem cell"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04318600"
                        ]
                  },
                  {
                        "Rank": 144,
                        "InterventionArmGroupLabel": [
                              "Experimental: Human (aMBMC)",
                              "Placebo:Lactated Ringer's Solution (LRS)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "One time infusion Allogeneic Mesenchymal Bone Marrow Cells (aMBMC) 1.5 million cells/kg.",
                              "One time infusion 1.5mL/kg"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)",
                              "Lactated Ringer's Solution"
                        ],
                        "InterventionOtherName": [
                              "Mesenchymal Stem Cells, (MSC) Marrow Stromal Cells.",
                              "(LRS)"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02467387"
                        ]
                  },
                  {
                        "Rank": 145,
                        "InterventionArmGroupLabel": [
                              "Injection of Umbilical cord derived UC- MSCs",
                              "injection of UC- MSCs and SPT",
                              "Supervised Physical Therapy (SPT)",
                              "injection of UC- MSCs and SPT"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogenic umbilical cord derived stem cells which are to be injected intrathecally as a treatment option for consenting MS patients",
                              "A combined physical therapy program of Balance, strengthening and endurance exercises"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical cord derived Mesenchymal Stem Cells",
                              "Supervised physical therapy"
                        ],
                        "InterventionOtherName": [
                              "UC-MSCs",
                              "SPT"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03326505"
                        ]
                  },
                  {
                        "Rank": 146,
                        "InterventionArmGroupLabel": [
                              "Genotype A administered with hMSC Group",
                              "Genotype B administered with hMSC Group",
                              "Genotype C administered with hMSC Group",
                              "Genotype A administered with placebo Group",
                              "Genotype B administered with placebo Group",
                              "Genotype C administered with placebo Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All",
                              "ANeo"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals",
                              "Antineoplastic Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M85407",
                              "M8814"
                        ],
                        "InterventionBrowseLeafName": [
                              "Plasma-lyte 148",
                              "Altretamine"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "allo-hMSCs, 16-20 million cells/ml delivered at a dose of 0.5 ml/ injection x 10 injections for a total of 80-100 million allo-hMSCs",
                              "Placebo will be administered as injections of plasmalyte A supplemented with 1% of 25% human serum albumin (HSA). 0.5 ml/ injection x 10 injections"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "allogeneic human mesenchymal stem cells (hMSCs)",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04476901"
                        ]
                  },
                  {
                        "Rank": 147,
                        "InterventionArmGroupLabel": [
                              "hDPSCs group",
                              "Control group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Intravenous injection of 3.0x10e7 human dental pulp stem cells solution (30ml) on day 1, day 4 and day 7, based on routine treatment of COVID-19",
                              "Intravenous injection of 3ml of 0.9% saline on day 1, day 4 and day 7, based on routine treatment of COVID-19"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC)",
                              "Intravenous saline injection (Placebo)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04336254"
                        ]
                  },
                  {
                        "Rank": 148,
                        "InterventionArmGroupLabel": [
                              "Stem cells high dose",
                              "Stem cells intermediate dose",
                              "Stem cells low dose"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Hemat",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Hematinics",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M10262"
                        ],
                        "InterventionBrowseLeafName": [
                              "Liver Extracts"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "High dose of Bone Marrow Derived Allogeneic Mesenchymal Stem Cells will be administered through the hepatic artery",
                              "Intermediate dose of Bone Marrow Derived Allogeneic Mesenchymal Stem Cells will be administered through the hepatic artery",
                              "Low dose of Bone Marrow Derived Allogeneic Mesenchymal Stem Cells will be administered through the hepatic artery"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Mesenchymal Stem Cells",
                              "Allogeneic Mesenchymal Stem Cells",
                              "Allogeneic Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01591200"
                        ]
                  },
                  {
                        "Rank": 149,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal Stromal Stem Cell Treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic bone marrow derived mesenchymal stromal stem cells (MSCs)."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stromal Stem Cells - KI-MSC-PL-205"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic Bone Marrow Derived Mesenchymal Stem Cells"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04447833"
                        ]
                  },
                  {
                        "Rank": 150,
                        "InterventionArmGroupLabel": [
                              "Adipose derived Mesenchymal Stem cell"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic Adipose derived Mesenchymal Stem cell transplant"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Adipose derived mesenchymal stem cell"
                        ],
                        "InterventionOtherName": [
                              "Cell Therapy"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02855112"
                        ]
                  },
                  {
                        "Rank": 151,
                        "InterventionArmGroupLabel": [
                              "Ex vivo cultured adult allogenic MSCs",
                              "Plasmalyte-A"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "AKT"
                        ],
                        "InterventionBrowseLeafId": [
                              "M85407",
                              "M11966",
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Plasma-lyte 148",
                              "Ophthalmic Solutions",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Single IV dose of allogenic MSCs",
                              "Single IV dose of Plasmalyte-A"
                        ],
                        "InterventionMeshId": [
                              "C000012499"
                        ],
                        "InterventionMeshTerm": [
                              "Plasma-lyte 148"
                        ],
                        "InterventionName": [
                              "Ex vivo cultured adult allogenic MSCs",
                              "Plasmalyte-A"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01091701"
                        ]
                  },
                  {
                        "Rank": 152,
                        "InterventionArmGroupLabel": [
                              "A1",
                              "B1",
                              "C1",
                              "A2",
                              "B2",
                              "C2"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "25 M allogeneic MPCs by transendocardial injection and mapping.",
                              "75 M allogeneic MPCs by transendocardial injection and mapping.",
                              "150 M allogeneic MPCs by transendocardial injection",
                              "Mock",
                              "Mock",
                              "Mock"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Precursor Cells (MPCs)",
                              "Mesenchymal Precursor Cells (MPCs)",
                              "Mesenchymal Precursor Cells (MPCs)",
                              "standard-of-care treatment with mock mapping and injection procedures.",
                              "standard-of-care treatment with mock mapping and injection procedures.",
                              "standard-of-care treatment with mock mapping and injection procedures."
                        ],
                        "InterventionOtherName": [
                              "Revascor",
                              "Revascor",
                              "Revascor"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Biological",
                              "Procedure",
                              "Procedure",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00721045"
                        ]
                  },
                  {
                        "Rank": 153,
                        "InterventionArmGroupLabel": [
                              "Patients with cytopenia after allo-HSCT"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Sequential infusion of allogeneic mesenchymal stem cells expanded \"in vitro\""
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02104440"
                        ]
                  },
                  {
                        "Rank": 154,
                        "InterventionArmGroupLabel": [
                              "Allogenic limbal stem cell Transplant",
                              "Bone Marrow mesenchymal stem cell"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Single stem cell expansion in amniotic membrane transplant"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Stem Cell with Amniotic Membrane Transplant"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01562002"
                        ]
                  },
                  {
                        "Rank": 155,
                        "InterventionArmGroupLabel": [
                              "Stem Cells",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Intravenous administration",
                              "Intravenous administration"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Human Mesenchymal Stem Cells and Lactated Riunger's Solution",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02833792"
                        ]
                  },
                  {
                        "Rank": 156,
                        "InterventionArmGroupLabel": [
                              "Remestemcel-L (150 million cells)",
                              "Remestemcel-L (300 million cells)",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "Infl",
                              "All",
                              "HB"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Anti-Inflammatory Agents",
                              "All Drugs and Chemicals",
                              "Herbal and Botanical"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Rimegepant"
                        ],
                        "InterventionBrowseLeafId": [
                              "M186752",
                              "M3369",
                              "M3466",
                              "M3366",
                              "T120"
                        ],
                        "InterventionBrowseLeafName": [
                              "Remestemcel-l",
                              "Anti-Inflammatory Agents",
                              "Antiviral Agents",
                              "Anti-Infective Agents",
                              "Cola"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "An ex vivo culture-expanded adult allogeneic bone marrow derived mesenchymal stem cell product for the treatment of medically refractory ulcerative colitis",
                              "An ex vivo culture-expanded adult allogeneic bone marrow derived mesenchymal stem cell product for the treatment of medically refractory ulcerative colitis",
                              "Normal saline"
                        ],
                        "InterventionMeshId": [
                              "C000711674"
                        ],
                        "InterventionMeshTerm": [
                              "Remestemcel-l"
                        ],
                        "InterventionName": [
                              "Remestemcel-L",
                              "Remestemcel-L",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04543994"
                        ]
                  },
                  {
                        "Rank": 157,
                        "InterventionArmGroupLabel": [
                              "XCEL-MT-OSTEO-ALPHA and surgery",
                              "Autologous iliac crest and surgery",
                              "Autologous iliac crest and surgery",
                              "XCEL-MT-OSTEO-ALPHA and surgery"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "\"ex-vivo\" expanded autologous mesenchymal stromal cells fixed in allogenic bone tissue in association with open surgery",
                              "Autologous iliac crest in association with surgery",
                              "Standard surgery for non-union fractures"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "XCEL-MT-OSTEO-ALPHA",
                              "autologous iliac crest",
                              "Surgery"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Other",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02230514"
                        ]
                  },
                  {
                        "Rank": 158,
                        "InterventionArmGroupLabel": [
                              "CS20AT04"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Step -1 dose : 1.0x10^6cells/kg Step 1 dose : 2.0x10^6cells/kg Step 2 dose : 3.0x10^6cells/kg The single injection of CS20AT04 Inj. in the peripheral veins.(IV) The duration of follow up study following the single dose of CS20AT04 is 28 days"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "allogenic bone marrow derived mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [
                              "CS20AT04"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03174587"
                        ]
                  },
                  {
                        "Rank": 159,
                        "InterventionArmGroupLabel": [
                              "MSC group",
                              "Control Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Intravenous infusion of MSC suspension, pre-conditioned under 1% oxygen, in the amount of 200 mln. cells per 400 mL of sodium chloride physiological solution"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stem cells",
                              "Reference therapy: 400 mL of 0.9% NaCl solution"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01849159"
                        ]
                  },
                  {
                        "Rank": 160,
                        "InterventionArmGroupLabel": [
                              "Chondrochymal\u00ae 1 x 10^7 cells",
                              "Chondrochymal\u00ae 10 x 10^7 cells",
                              "Chondrochymal\u00ae 5 x 10^7 cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic Bone Marrow Derived Mesenchymal Stem Cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Chondrochymal\u00ae"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03589287"
                        ]
                  },
                  {
                        "Rank": 161,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal Stem Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical Cord Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02235844"
                        ]
                  },
                  {
                        "Rank": 162,
                        "InterventionArmGroupLabel": [
                              "Experimental",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intravenous injection of 1 million MSV cells/Kg diluted in 100 ml saline",
                              "Intravenous injection of 100 ml saline containing no cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stromal Cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "MSV"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04361942"
                        ]
                  },
                  {
                        "Rank": 163,
                        "InterventionArmGroupLabel": [
                              "Allogeneic transplantation with WJMSCs",
                              "Sham transplantation (placebo)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Hypo",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Hypoglycemic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M9517",
                              "M172956"
                        ],
                        "InterventionBrowseLeafName": [
                              "Insulin",
                              "Insulin, Globin Zinc"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "The drug is a cell suspension with allogeneic mesenchymal stromal cells derived from umbilical cord tissue.",
                              "Placebo treatment"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ProTrans: Allogeneic transplantation with WJMSCs",
                              "Placebos"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03406585"
                        ]
                  },
                  {
                        "Rank": 164,
                        "InterventionArmGroupLabel": [
                              "MSC+placebo",
                              "MSC",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "2 infusions of 10 X 10^6 MSC/kg and 1 placebo every 3 months.",
                              "3 infusions of 10 X 10^6 MSC/kg every 3 months.",
                              "3 infusions of placebo every 3 months. Placebo will be identical to the investigational product but will not contain MSCs."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MSC+placebo",
                              "MSC",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "allogeneic mesenchymal stem cell or similar placebo",
                              "allogeneic mesenchymal stem cell",
                              "Similar placebo"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04506073"
                        ]
                  },
                  {
                        "Rank": 165,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stem cells(MSC) treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Patients will receive intravenously one dose of 5-7x10^7 cells of allogeneic adipose-derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic adult adipose-derived mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01649687"
                        ]
                  },
                  {
                        "Rank": 166,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stromal cells (MSC)",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Endovenous injection of MSV in saline",
                              "Endovenous injection of saline without cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stromal cells (MSC)",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "MSV, GMP-compliant MSC manufactured by IBGM in Valladolid",
                              "Saline"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03673748"
                        ]
                  },
                  {
                        "Rank": 167,
                        "InterventionArmGroupLabel": [
                              "UMSC01",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "UMSC01 cells will be IV infusion followed by IT infusion with 12 months of follow up after treatment.",
                              "Normal saline will be IV infusion followed by sham-IT infusion with 12 months of follow up after treatment."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic umbilical cord mesenchymal stem cells",
                              "Control group"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05532943"
                        ]
                  },
                  {
                        "Rank": 168,
                        "InterventionArmGroupLabel": [
                              "UMSC01",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "UMSC01 cells will be IV infusion with 12 months of follow up after treatment.",
                              "Normal saline will be IV infusion with 12 months of follow up after treatment."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic umbilical cord mesenchymal stem cells",
                              "Controlled normal saline"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05501418"
                        ]
                  },
                  {
                        "Rank": 169,
                        "InterventionArmGroupLabel": [
                              "remestemcel-L (150 million cells)",
                              "remestemcel-L (300 million cells)",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "Infl",
                              "All",
                              "HB"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Anti-Inflammatory Agents",
                              "All Drugs and Chemicals",
                              "Herbal and Botanical"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Rimegepant"
                        ],
                        "InterventionBrowseLeafId": [
                              "M186752",
                              "M3369",
                              "M3466",
                              "M3366",
                              "T120"
                        ],
                        "InterventionBrowseLeafName": [
                              "Remestemcel-l",
                              "Anti-Inflammatory Agents",
                              "Antiviral Agents",
                              "Anti-Infective Agents",
                              "Cola"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "adult allogeneic bone marrow derived mesenchymal stem cell product for the treatment of medically refractory Crohn's colitis",
                              "adult allogeneic bone marrow derived mesenchymal stem cell product for the treatment of medically refractory Crohn's colitis",
                              "Normal saline"
                        ],
                        "InterventionMeshId": [
                              "C000711674"
                        ],
                        "InterventionMeshTerm": [
                              "Remestemcel-l"
                        ],
                        "InterventionName": [
                              "Remestemcel-L",
                              "Remestemcel-L",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04548583"
                        ]
                  },
                  {
                        "Rank": 170,
                        "InterventionArmGroupLabel": [
                              "XCEL-MT-OSTEO-ALPHA",
                              "Standard Treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Core decompression plus XCEL-MT-OSTEO-ALPHA",
                              "Isolated core decompression"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "XCEL-MT-OSTEO-ALPHA",
                              "Standard treatment"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01605383"
                        ]
                  },
                  {
                        "Rank": 171,
                        "InterventionArmGroupLabel": [
                              "Control group",
                              "Cohort 1",
                              "Cohort 2",
                              "Cohort 3"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Patients will undergo surgical localization, curettage of the fistulous tract and closure of the internal opening, without injection of MSCs.",
                              "Patients will undergo surgical localization, curettage of the fistulous tract and closure of the internal opening, with local injection of indicated dose of MSCs"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Localization, curettage of the fistulous tract and closure of the internal opening without MSC injection.",
                              "Localization, curettage of the fistulous tract and closure of the internal opening with local MSC injection."
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01144962"
                        ]
                  },
                  {
                        "Rank": 172,
                        "InterventionArmGroupLabel": [
                              "Allogeneic HB-adMSCs 100MM",
                              "Allogeneic HB-adMSCs 200MM",
                              "Allogeneic HB-adMSCs 50MM",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Hope Biosciences allogeneic adipose-derived mesenchymal stem cells",
                              "Saline"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "HB-adMSCs",
                              "Placebos"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04348435"
                        ]
                  },
                  {
                        "Rank": 173,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stem cell arm",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stem cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Intravenous saline infusion will be designated as placebo."
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01902082"
                        ]
                  },
                  {
                        "Rank": 174,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "During bone marrow harvest, an additional 10 mL sample will be collected for the study."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "bone marrow harvest"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03967275"
                        ]
                  },
                  {
                        "Rank": 175,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [
                              "Gast",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Gastrointestinal Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21707",
                              "M12266"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pancrelipase",
                              "Pancreatin"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Culture-expanded, adipose-derived mesenchymal stem cells donated by first blood relative"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "HB-adMSCs"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT04087889"
                        ]
                  },
                  {
                        "Rank": 176,
                        "InterventionArmGroupLabel": [
                              "Allogeneic ADSC cells in fibrin solution",
                              "Standard care in diabetic foot ulcer with aplication of fibrin gel to cover wound surface."
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Chronic wounds in diabetic foot ulcer will be covered with ADSC suspended in fibrin gel - single dose will be administered followed by weekly wound control.",
                              "Chronic wounds in diabetic foot ulcer will be covered with fibrin gel followed by weekly wound control."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Application of allogeneic ADSC stem cells in fibrin gel",
                              "Standard care in diabetic foot ulcer"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03865394"
                        ]
                  },
                  {
                        "Rank": 177,
                        "InterventionArmGroupLabel": [
                              "Human Mesenchymal Stromal Cells",
                              "Cell Reconstitution Media"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "AnCoag",
                              "BlSubst",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anticoagulants",
                              "Blood Substitutes",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M6258"
                        ],
                        "InterventionBrowseLeafName": [
                              "Dextrans"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Immediately prior to administration, the study product will be thawed and diluted 1:1 with reconstitution media (1:1 mix of 5% human serum albumin and 10% Dextran 40). Additional reconstitution media is added to a final product volume of 300 mL.",
                              "300 mL of reconstitution media (1:1 mix of 5% human serum albumin and 10% Dextran 40)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Human Mesenchymal Stromal Cells",
                              "Cell Reconstitution Media"
                        ],
                        "InterventionOtherName": [
                              "hMSCs",
                              "Placebo"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03818854"
                        ]
                  },
                  {
                        "Rank": 178,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal Stem Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "HB",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Herbal and Botanical",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "T248"
                        ],
                        "InterventionBrowseLeafName": [
                              "Passionflower"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "One dose of 50x10^6 bone marrow-derived allogeneic MSCs via the nasal route as soon as possible after confirmation of the stroke (in the middle cerebral artery), but within the first week of onset of presenting clinical symptoms. Within 30 minutes after cleaning the nose with saline, using standard procedures operative at the Neonatal Intensive Care Unit, the MSC will be delivered."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [
                              "Bone Marrow-derived Allogeneic Mesenchymal Cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03356821"
                        ]
                  },
                  {
                        "Rank": 179,
                        "InterventionArmGroupLabel": [
                              "AD-MSC"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intravenous injection of AD-MSC to the patients with FSGS"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Intravenous injection"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02382874"
                        ]
                  },
                  {
                        "Rank": 180,
                        "InterventionArmGroupLabel": [
                              "High dose",
                              "Low dose",
                              "Medium dose"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "MSCs"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "intravenous delivery of allogeneic bone marrow-derived MSCs"
                        ],
                        "InterventionOtherName": [
                              "allogeneic NK1R+MSC"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05491681"
                        ]
                  },
                  {
                        "Rank": 181,
                        "InterventionArmGroupLabel": [
                              "Treatment group",
                              "Placebo group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Concentration of the cells: 10 million cells / ml",
                              "Placebo intravenous solution, same appearance stem cells solution"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Alogenic adipose tissue-derived stem cells",
                              "Placebo solution"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04280003"
                        ]
                  },
                  {
                        "Rank": 182,
                        "InterventionArmGroupLabel": [
                              "1"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "ANeo",
                              "ARhu",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Antineoplastic Agents",
                              "Antirheumatic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M5879"
                        ],
                        "InterventionBrowseLeafName": [
                              "Cyclophosphamide"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Intervention:\n\nCyclophosphamide will be administered intravenously at at total dose of 0.8-1.8g 24 hours before transplantation.\n\nAllogeneic bone marrow derived mesenchymal stem cells (matched family donors)will be infused intravenously at 106 cells/kg body weight"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic MSC (AlloMSC)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00698191"
                        ]
                  },
                  {
                        "Rank": 183,
                        "InterventionArmGroupLabel": [
                              "AD-MSCs group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "AD-MSCs(adipose-derived multipotent mesenchymal stem cells) were infused intravenously at a dose of 0.5 million cells/kg."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "adipose-derived multipotent mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [
                              "AD-MSCs"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03265613"
                        ]
                  },
                  {
                        "Rank": 184,
                        "InterventionArmGroupLabel": [
                              "AGLE-102"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "In this protocol, 2nd degree burn wounds will receive direct application of EVs derived from bone marrow MSCs. We have observed success with this type of approach in the past using bone marrow stem cells including MSCs. We have evidence that EVs derived from MSCs are responsible for many of the healing effects produced by MSCs and may be a safer, more reliable alternative to allogeneic cell therapy. This protocol is designed to develop a safe and ideal method of administering bone marrow cell Extracellular Vesicles to wounds."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AGLE-102"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05078385"
                        ]
                  },
                  {
                        "Rank": 185,
                        "InterventionArmGroupLabel": [
                              "Allogenic transplant of BM-MSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Coag",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Coagulants",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M15828"
                        ],
                        "InterventionBrowseLeafName": [
                              "Thrombin"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "The implant of BM-MSC/MSC-Endo/PRP in a clean and shaped root canal from patients with immature apexes and pulpal necroses and apical periodontitis"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogenic transplant of BM-MSC in a root canal from patients with immature apexes and pulpar necrosis and apical periodontitis"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04545307"
                        ]
                  },
                  {
                        "Rank": 186,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05152368"
                        ]
                  },
                  {
                        "Rank": 187,
                        "InterventionArmGroupLabel": [
                              "Allogeneic Umbilical Cord Blood",
                              "Natural History",
                              "Cord Tissue Mesenchymal Stromal Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Subjects will receive a single infusion of allogeneic umbilical cord blood at the baseline visit.",
                              "Subjects will receive 3 infusions of MSCs (baseline, 3 months and 6 months)."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Infusion of allogeneic umbilical cord blood",
                              "Infusion of MSCs"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03473301"
                        ]
                  },
                  {
                        "Rank": 188,
                        "InterventionArmGroupLabel": [
                              "High concentration of Allo-ASC group",
                              "Low concentration of Allo-ASC group",
                              "High concentration of Allo-ASC group",
                              "Low concentration of Allo-ASC group",
                              "Placebo Comparator (Fibrin) group",
                              "Placebo Comparator (Fibrin) group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All",
                              "Coag"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals",
                              "Coagulants"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Cobicistat"
                        ],
                        "InterventionBrowseLeafId": [
                              "M21013",
                              "M17443",
                              "M8728",
                              "M5411"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions",
                              "Fibrin Tissue Adhesive",
                              "Hemostatics",
                              "Coagulants"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "10 million cells of Allo-ASC 0.5cc",
                              "1 million cells of Allo-ASC 0.5cc",
                              "Fibrin glue 0.5cc",
                              "Normal saline 0.5cc"
                        ],
                        "InterventionMeshId": [
                              "D000015718"
                        ],
                        "InterventionMeshTerm": [
                              "Fibrin Tissue Adhesive"
                        ],
                        "InterventionName": [
                              "High concentration of Allo-ASC",
                              "Low concentration of Allo-ASC",
                              "Fibrin glue",
                              "Normal saline"
                        ],
                        "InterventionOtherName": [
                              "Fibrin sealant",
                              "0.9% Sodium Chloride Solution"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03449082"
                        ]
                  },
                  {
                        "Rank": 189,
                        "InterventionArmGroupLabel": [
                              "Treatment Group (AlloRx)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "cultured allogeneic adult umbilical cord derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AlloRx"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05147779"
                        ]
                  },
                  {
                        "Rank": 190,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "1-2X10^6 MSC per kg"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MSC transplantation"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00749164"
                        ]
                  },
                  {
                        "Rank": 191,
                        "InterventionArmGroupLabel": [
                              "allogeneic MMSCs infusion",
                              "allogeneic MMSCs infusion",
                              "allogeneic MMSCs infusion",
                              "allogeneic MMSCs infusion"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "High-dose chemotherapy will be performed according to protocols ICE and BEAM (standard scheme)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Peripheral blood stem cell mobilisation and collection",
                              "High-dose chemotherapy",
                              "Bone marrow derived allogeneic MMSCs infusion",
                              "Autologous peripheral blood stem cells infusion"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure",
                              "Drug",
                              "Drug",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02145923"
                        ]
                  },
                  {
                        "Rank": 192,
                        "InterventionArmGroupLabel": [
                              "ALLO-ASCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M3374",
                              "M3376"
                        ],
                        "InterventionBrowseLeafName": [
                              "Anti-Bacterial Agents",
                              "Antibiotics, Antitubercular"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "1). Cryopreserved cell suspension of early passages of cultured allogeneic MSCs isolated from SVF obtained from lipoaspirate, a total of 10 mln. of cultured cells; 2).The TE-construct consisting of collagen- or fibrin-derived hydrogels and cells of early passages (up to P5) suspension of allogeneic cultured MSCs isolated from SVF obtained from lipoaspirate; Biological is applied by surface application over perforated (1:3) autologous skin graft following the covering with hypoadhesive bandage. This procedure is carried out twice - once simultaneously with a skin grafting procedure and 2-3 days following autodermoplasty, while bandaging."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ALLO-ASCs"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic adipose-derived stem cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03113747"
                        ]
                  },
                  {
                        "Rank": 193,
                        "InterventionArmGroupLabel": [
                              "double dose",
                              "simple dose",
                              "placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Injection of mesenchymal stem cells",
                              "Placebo injection"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "allogeneic umbilical cord-derived mesenchymal stem cells",
                              "Placebo (NaCl)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03994666"
                        ]
                  },
                  {
                        "Rank": 194,
                        "InterventionArmGroupLabel": [
                              "COVI-MSC 1 vial",
                              "COVI-MSC 2 vials"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "COVI-MSC are allogeneic culture-expanded adipose-derived mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "COVI-MSC"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04909892"
                        ]
                  },
                  {
                        "Rank": 195,
                        "InterventionArmGroupLabel": [
                              "stem cells",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "AKT"
                        ],
                        "InterventionBrowseLeafId": [
                              "M85407",
                              "M11966",
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Plasma-lyte 148",
                              "Ophthalmic Solutions",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "IV infusion of stem cells",
                              "IV infusion"
                        ],
                        "InterventionMeshId": [
                              "C000012499"
                        ],
                        "InterventionMeshTerm": [
                              "Plasma-lyte 148"
                        ],
                        "InterventionName": [
                              "Stem cell",
                              "Plasmalyte A"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00883727"
                        ]
                  },
                  {
                        "Rank": 196,
                        "InterventionArmGroupLabel": [
                              "Experimental group",
                              "Control group",
                              "Experimental group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "ANeo",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Antineoplastic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Learning"
                        ],
                        "InterventionBrowseLeafId": [
                              "M1697",
                              "M3433"
                        ],
                        "InterventionBrowseLeafName": [
                              "Decitabine",
                              "Antimetabolites"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Experimental group receive Allogeneic umbilical cord mesenchymal stem cell\uff0ci.v (SCLnow 19#)",
                              "Decitabine\uff0c20mg/m^2/d"
                        ],
                        "InterventionMeshId": [
                              "D000077209"
                        ],
                        "InterventionMeshTerm": [
                              "Decitabine"
                        ],
                        "InterventionName": [
                              "Allogeneic umbilical cord mesenchymal stem cells",
                              "Decitabine"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03184935"
                        ]
                  },
                  {
                        "Rank": 197,
                        "InterventionArmGroupLabel": [
                              "mesenchymal stem cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Procedure: Selected patients were randomly divided into a cell therapy group and a control group.\n\nUmbilical Cord Blood Derived Mesenchymal Stem Cells at a dose of 150-250 million."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01946048"
                        ]
                  },
                  {
                        "Rank": 198,
                        "InterventionArmGroupLabel": [
                              "MSCs",
                              "placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Bone marrow will be harvested in healthy donors followed by separation and cultivation of MSCs. Before infusion cells will be suspended in 400 mL saline",
                              "intravenous infusion of 400 mL saline"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Bone marrow mesenchymal stem cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02594839"
                        ]
                  },
                  {
                        "Rank": 199,
                        "InterventionArmGroupLabel": [
                              "Group 1",
                              "Group 1",
                              "Group 2"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#) will be injected through surgery tunnel, 2*10^7 cells,",
                              "The surgery will drill into the femoral neck (hip bone) and through the necrotic area of the bone that died from the lack of blood flow, take out partial osseous tissue."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)",
                              "core decompression"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03180463"
                        ]
                  },
                  {
                        "Rank": 200,
                        "InterventionArmGroupLabel": [
                              "Umbilical cord mesenchymal stem cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical cord mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02192749"
                        ]
                  },
                  {
                        "Rank": 201,
                        "InterventionArmGroupLabel": [
                              "Group 1",
                              "Group 1",
                              "Group 2"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Antipy",
                              "Infl",
                              "ARhu",
                              "FiAg",
                              "Analg",
                              "PlAggInh",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Antipyretics",
                              "Anti-Inflammatory Agents",
                              "Antirheumatic Agents",
                              "Fibrinolytic Agents",
                              "Analgesics",
                              "Platelet Aggregation Inhibitors",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Dietary Supplement"
                        ],
                        "InterventionBrowseLeafId": [
                              "M3700",
                              "M3369",
                              "M3370",
                              "M3184",
                              "M19939",
                              "M19757",
                              "M7625",
                              "M13017",
                              "M18361",
                              "M28329"
                        ],
                        "InterventionBrowseLeafName": [
                              "Aspirin",
                              "Anti-Inflammatory Agents",
                              "Anti-Inflammatory Agents, Non-Steroidal",
                              "Analgesics",
                              "Analgesics, Non-Narcotic",
                              "Antirheumatic Agents",
                              "Fibrinolytic Agents",
                              "Platelet Aggregation Inhibitors",
                              "Cyclooxygenase Inhibitors",
                              "Antipyretics"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Allogeneic umbilical cord mesenchymal stem cells will transfusion into by forearm intravenous transplantation, 0.5 - 1 *10^6/kg. once a month, total 3 times.",
                              "Drug: Aspirin Tablet, 100 mg/d"
                        ],
                        "InterventionMeshId": [
                              "D000001241"
                        ],
                        "InterventionMeshTerm": [
                              "Aspirin"
                        ],
                        "InterventionName": [
                              "Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)",
                              "Aspirin Tablet"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03186456"
                        ]
                  },
                  {
                        "Rank": 202,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal Stem Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013",
                              "M85407"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions",
                              "Plasma-lyte 148"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Participants receive a maximum dose of 3 x 10^6 cell/Kg by vein one time on Day 1."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cells (MSCs)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02804945"
                        ]
                  },
                  {
                        "Rank": 203,
                        "InterventionArmGroupLabel": [
                              "Allo-MSCs",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "20 transendocardial injections of 0.4ml allo-MSCs administered to the left ventricle via NOGA Myostar injection catheter (single procedure)",
                              "20 transendocardial injections of 0.4ml Buminate solution administered to the left ventricle via NOGA Myostar injection catheter (single procedure)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allo-MSCs",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic Mesenchymal Stem Cells",
                              "Buminate solution"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02509156"
                        ]
                  },
                  {
                        "Rank": 204,
                        "InterventionArmGroupLabel": [
                              "cord blood transplant"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "One or two cord blood transplants with co-infusion of third-party mesenchymal stem cells after pre-transplant preparative regimen"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "cord blood transplantation"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01092026"
                        ]
                  },
                  {
                        "Rank": 205,
                        "InterventionArmGroupLabel": [
                              "1"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Infusion of mesenchymal stem cells on the same day as hematopoietic stem cell infusion."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stem cell infusion"
                        ],
                        "InterventionOtherName": [
                              "Mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00504803"
                        ]
                  },
                  {
                        "Rank": 206,
                        "InterventionArmGroupLabel": [
                              "Allogeneic WJ-MSCs injection"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Human allogeneic Wharton's jelly-derived mesenchymal stem cell transplantation in ALS patients."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Biological: Cell-based therapy"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02881476"
                        ]
                  },
                  {
                        "Rank": 207,
                        "InterventionArmGroupLabel": [
                              "15ml of ExoFlo at Day 0, 2, 4 Week 2, 6, and every 4 weeks after that to week 46",
                              "15ml of ExoFlo at Day 0, 2, 4 Week 2, 6, and every 8 weeks after that to week 46"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "ExoFlo 15ml, IV"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Bone Marrow MSC Derived Extracellular Vesicle Isolate"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05130983"
                        ]
                  },
                  {
                        "Rank": 208,
                        "InterventionArmGroupLabel": [
                              "HCR040 (Phase 1)",
                              "Control group (Phase 2)",
                              "HCR040 (Phase 2)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "All",
                              "PhSol"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "All Drugs and Chemicals",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Levcromakalim"
                        ],
                        "InterventionBrowseLeafId": [
                              "M9070",
                              "M21013",
                              "M3366",
                              "M3367"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hydrogen Peroxide",
                              "Pharmaceutical Solutions",
                              "Anti-Infective Agents",
                              "Anti-Infective Agents, Local"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "(Phase 1) Intravenous administration. Open label dose escalation, 3 patients in cohort 1 (1 million cells/kg) and 3 patients in cohort 2 (2 million cells/kg)",
                              "(Phase 2) Intravenous administration of vehicle solution",
                              "(Phase 2) Intravenous administration of the maximum tolerated dose (1 million cells/kg or 2 million cells/kg)"
                        ],
                        "InterventionMeshId": [
                              "D000006861"
                        ],
                        "InterventionMeshTerm": [
                              "Hydrogen Peroxide"
                        ],
                        "InterventionName": [
                              "HCR040 (Phase 1)",
                              "Placebo (Phase 2)",
                              "HCR040 (Phase 2)"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic adipose-derived adult mesenchymal stem cells expanded and pulsed with H2O2",
                              "Saline solution",
                              "Allogeneic adipose-derived adult mesenchymal stem cells expanded and pulsed with H2O2"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04289194"
                        ]
                  },
                  {
                        "Rank": 209,
                        "InterventionArmGroupLabel": [
                              "Treatment group",
                              "Control group",
                              "Treatment group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "NaAg",
                              "All",
                              "CaAg",
                              "VaDiAg",
                              "PlAggInh"
                        ],
                        "InterventionBrowseBranchName": [
                              "Natriuretic Agents",
                              "All Drugs and Chemicals",
                              "Cardiotonic Agents",
                              "Vasodilator Agents",
                              "Platelet Aggregation Inhibitors"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M7936",
                              "M21096",
                              "M3286",
                              "M28069",
                              "M2823"
                        ],
                        "InterventionBrowseLeafName": [
                              "Furosemide",
                              "Milrinone",
                              "Angiotensin-Converting Enzyme Inhibitors",
                              "Angiotensin Receptor Antagonists",
                              "Adrenergic beta-Antagonists"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Allogeneic umbilical cord mesenchymal stem cells will transfusion by intravenous transplantation.",
                              "The drug and usage will be determined based on patient's condition, including milrinone, furosemide, beta-blocker blues, Angiotensin-Converting Enzyme Inhibitors (ACEI), angiotension receptor blocker (ARB), or antiplatelet aggregation etc."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)",
                              "conventional treatment"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03180450"
                        ]
                  },
                  {
                        "Rank": 210,
                        "InterventionArmGroupLabel": [
                              "COVI-MSC",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "2, 4 or 6 MSC vials (approximately 15 million cells/vial) will be intravenously infused on Day 0, Day 2, or Day 4 depending on assignment to treatment group.\n\nGroup A: 2 MSC vials infused on D0 and 2 vials of placebo on D2 and D4\n\nGroup B: 2 MSC vials infused on D0 and D2 and 2 vials of placebo on D4\n\nGroup C: 2 MSC vials infused on D0 and D4 and 2 vials of placebo on D2\n\nGroup D: 2 MSC vials infused on D0, D2 and D4",
                              "6 vials of placebo will be intravenously infused on Day 0, Day 2, or Day 4."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "COVI-MSC",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04992247"
                        ]
                  },
                  {
                        "Rank": 211,
                        "InterventionArmGroupLabel": [
                              "Low dose",
                              "Intermediate dose"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Single intramuscular administration of low dose of stem cells",
                              "Single intramuscular administration of intermediate dose of stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Mesenchymal Stem Cells",
                              "Allogeneic Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [
                              "Stempeucel - CLI",
                              "Stempeucel - CLI"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01484574"
                        ]
                  },
                  {
                        "Rank": 212,
                        "InterventionArmGroupLabel": [
                              "Experimental group",
                              "Control group",
                              "Experimental group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Antipy",
                              "Infl",
                              "ARhu",
                              "FiAg",
                              "Analg",
                              "PlAggInh",
                              "All",
                              "Lipd",
                              "BDCA"
                        ],
                        "InterventionBrowseBranchName": [
                              "Antipyretics",
                              "Anti-Inflammatory Agents",
                              "Antirheumatic Agents",
                              "Fibrinolytic Agents",
                              "Analgesics",
                              "Platelet Aggregation Inhibitors",
                              "All Drugs and Chemicals",
                              "Lipid Regulating Agents",
                              "Bone Density Conservation Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Dietary Supplement",
                              "Diabetes",
                              "Glomerular"
                        ],
                        "InterventionBrowseLeafId": [
                              "M3700",
                              "M4533",
                              "M351",
                              "M4550",
                              "M8941",
                              "M3369",
                              "M3370",
                              "M3184",
                              "M19939",
                              "M19757",
                              "M7625",
                              "M13017",
                              "M18361",
                              "M28329",
                              "M3395",
                              "M3430",
                              "M3433",
                              "M28036",
                              "M20308"
                        ],
                        "InterventionBrowseLeafName": [
                              "Aspirin",
                              "Calcium",
                              "Atorvastatin",
                              "Calcium, Dietary",
                              "Hormones",
                              "Anti-Inflammatory Agents",
                              "Anti-Inflammatory Agents, Non-Steroidal",
                              "Analgesics",
                              "Analgesics, Non-Narcotic",
                              "Antirheumatic Agents",
                              "Fibrinolytic Agents",
                              "Platelet Aggregation Inhibitors",
                              "Cyclooxygenase Inhibitors",
                              "Antipyretics",
                              "Anticholesteremic Agents",
                              "Hypolipidemic Agents",
                              "Antimetabolites",
                              "Lipid Regulating Agents",
                              "Hydroxymethylglutaryl-CoA Reductase Inhibitors"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "high",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Experimental group receive Allogeneic umbilical cord mesenchymal stem cell\uff0ci.v (SCLnow 19#)",
                              "Aspirin Enteric-coated Tablets, 0.1g/d by mouth; Atorvastatin Calcium, 20mg/d by mouth."
                        ],
                        "InterventionMeshId": [
                              "D000001241",
                              "D000069059",
                              "D000002118"
                        ],
                        "InterventionMeshTerm": [
                              "Aspirin",
                              "Atorvastatin",
                              "Calcium"
                        ],
                        "InterventionName": [
                              "Allogeneic umbilical cord mesenchymal stem cell",
                              "Aspirin Enteric-coated Tablets & Atorvastatin Calcium"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03176498"
                        ]
                  },
                  {
                        "Rank": 213,
                        "InterventionArmGroupLabel": [
                              "COVI-MSC",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "COVI-MSC are allogeneic culture-expanded adipose-derived mesenchymal stem cells",
                              "Excipient solution"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "COVI-MSC",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04905836"
                        ]
                  },
                  {
                        "Rank": 214,
                        "InterventionArmGroupLabel": [
                              "Adult Population",
                              "Pediatric Population"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "ANeo",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Antineoplastic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Inhibitor",
                              "Whole blood"
                        ],
                        "InterventionBrowseLeafId": [
                              "M9559",
                              "M9558",
                              "M3466",
                              "M3366"
                        ],
                        "InterventionBrowseLeafName": [
                              "Interferons",
                              "Interferon-gamma",
                              "Antiviral Agents",
                              "Anti-Infective Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "To determine the maximal dose, initially adult subjects will receive a single infusion of third party, freshly ex vivo expanded, IFN\u03b3-primed MSCs at a dose of 2 x 106 cells/kg of ideal body weight on Day +1 (the day after infusion of the hematopoietic cell graft). The dose will be escalated to 5 x 106 and then 10 x 106 cells/kg. In absence of any dose limiting toxicity, 10 x 106 cells/kg will be accepted as the maximal dose.\n\nSubsequent participants in the adult and pediatric cohorts will receive the maximal dose as determined by the initial adult participants.\n\nParticipants will receive the infusion in an inpatient setting. MSCs will be intravenously infused through a central line or a large bore peripheral IV using standard blood product tubing within 4 hours of release. The product will be infused by IV push or syringe pump over approximately 30-60 minutes or to gravity depending on product volume."
                        ],
                        "InterventionMeshId": [
                              "D000007372",
                              "D000007371"
                        ],
                        "InterventionMeshTerm": [
                              "Interferons",
                              "Interferon-gamma"
                        ],
                        "InterventionName": [
                              "Interferon gamma (IFN\u03b3)-primed human bone marrow-derived mesenchymal stromal cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04328714"
                        ]
                  },
                  {
                        "Rank": 215,
                        "InterventionArmGroupLabel": [
                              "AstroStem-V"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogenic adipose tissue-derived mesenchymal stem cells (AdMSCs)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AstroStem-V"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04527224"
                        ]
                  },
                  {
                        "Rank": 216,
                        "InterventionArmGroupLabel": [
                              "COVI-MSC",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "COVI-MSC are allogeneic culture-expanded adipose-derived mesenchymal stem cells",
                              "Excipient solution"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "COVI-MSC",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04909879"
                        ]
                  },
                  {
                        "Rank": 217,
                        "InterventionArmGroupLabel": [
                              "Control group (Nerve transfer procedure)",
                              "Experimental group (Nerve transfer with HAM-AdMSC composite wrapping)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Identification of potential donor nerves: phrenic nerve, accessory nerve, intercostal nerve, motor branch nerve innervating long head of triceps muscle, motor branch of ulnar nerve innervating flexor carpi ulnaris (FCU) muscle, and motor branch of median nerve innervating flexor carpi radialis (FCR) muscle.\nDonor nerve is checked for its viability with an electric stimulator during surgery\nViable donor nerve is dissected, transferred to the recipient area, and sutured with end-to-end anastomosis.",
                              "When the nerve transfer procedure is finished, the end-to-end anastomosis is wrapped by a composite consisted of human amniotic membrane and allogeneic adipose-derived mesenchymal stem cells (HAM-AdMSC)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Nerve transfer procedure",
                              "Nerve transfer with HAM-AdMSC composite wrapping"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04654286"
                        ]
                  },
                  {
                        "Rank": 218,
                        "InterventionArmGroupLabel": [
                              "Stem cells implantation"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intramyocardial implantation of a novel mesenchymal precursor cell type (iMP)."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Intramyocardial implantation of of a novel mesenchymal precursor cell type (iMP)."
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01753440"
                        ]
                  },
                  {
                        "Rank": 219,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal Stromal cells",
                              "Control group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Administration of one single dose of allogenic Mesenchymal stromal cells",
                              "Administration of placebo (solution identical to experimental treatment, without the MSC)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stromal cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04615429"
                        ]
                  },
                  {
                        "Rank": 220,
                        "InterventionArmGroupLabel": [
                              "COVI-MSC",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "1 x 10^6 MSCs/kg or 1.5 x 10^6 MSCs/kg, depending on CRP level",
                              "Equivalent volume of placebo will be administered"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "COVI-MSC",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04728698"
                        ]
                  },
                  {
                        "Rank": 221,
                        "InterventionArmGroupLabel": [
                              "ALLO-ASC-SHEET",
                              "Hydrogel SHEET(Vehicle control)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Hydrogel sheet containing Allogenic Mesenchymal Stem Cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ALLO-ASC-SHEET"
                        ],
                        "InterventionOtherName": [
                              "Hydrogel sheet containing Allogenic Mesenchymal Stem Cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04497805"
                        ]
                  },
                  {
                        "Rank": 222,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stem cells",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intravenous infusion of 4 doses of adipose tissue derived allogeneic adult mesenchymal stem cells (1 million MSCs/Kg, weeks 0-4-8-20).",
                              "Infusion of placebo (weeks 0-4-8-20)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Infusion of MSC",
                              "Infusion of placebo"
                        ],
                        "InterventionOtherName": [
                              "Placebo"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT02290041"
                        ]
                  },
                  {
                        "Rank": 223,
                        "InterventionArmGroupLabel": [
                              "MSCs-Exos Dosage 1",
                              "MSCs-Exos Dosage 2",
                              "MSCs-Exos Dosage 3"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Dosage\uff1a5\u03bcg MSCs-Exos,Total volume\uff1a 1ml Frequency\uff1aTwice a week Duration\uff1a12 weeks",
                              "Dosage\uff1a10\u03bcg MSCs-Exos,Total volume\uff1a 1ml Frequency\uff1aTwice a week Duration\uff1a12 weeks",
                              "Dosage\uff1a20\u03bcg MSCs-Exos,Total volume\uff1a 1ml Frequency\uff1aTwice a week Duration\uff1a12 weeks"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "low dosage MSCs-Exos administrated for nasal drip",
                              "mild dosage MSCs-Exos administrated for nasal drip",
                              "high dosage MSCs-Exos administrated for nasal drip"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04388982"
                        ]
                  },
                  {
                        "Rank": 224,
                        "InterventionArmGroupLabel": [
                              "Dose Arm 1",
                              "Dose Arm 2"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Two intravenous infusions delivered systemically through a peripheral IV(over 30 minutes to 2 hours) of 100x10^6 cells at day 0 and day 84",
                              "Single intravenous infusion delivered systemically through a peripheral IV(over 30 minutes to 2 hours) of 200x10^6 cells at day 0"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic adipose-derived mesenchymal stem cells (MSC)",
                              "Allogeneic adipose-derived mesenchymal stem cells (MSC)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05362786"
                        ]
                  },
                  {
                        "Rank": 225,
                        "InterventionArmGroupLabel": [
                              "UMSC01"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "UMSC01 cells will be one single IC infusion followed by one single IV infusion with 12 months of follow up after treatment."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic umbilical cord mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04056819"
                        ]
                  },
                  {
                        "Rank": 226,
                        "InterventionArmGroupLabel": [
                              "Single dose Allogenic Adiposse derived mesenchimal stem cells",
                              "Double dose Allogenic Adiposse derived mesenchimal stem cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Single Dose: Administration of 12,5 million allogeneic mesenchymal stem cells derived from adipose tissue by subcnjunctival injection and topical conjunctival injection.",
                              "Repetead Dose: Administration of 2 doses, separated by 14 days, of 12,5 million allogeneic mesenchymal stem cells derived from adipose tissue by subcnjunctival injection and topical conjunctival injection."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Single Dose",
                              "Double Dose"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05520086"
                        ]
                  },
                  {
                        "Rank": 227,
                        "InterventionArmGroupLabel": [
                              "UCMSCs",
                              "UCMSCs + CM",
                              "UCMSCs + CM",
                              "Standard Therapy"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "The umbilical cord was removed from the donor and brought to cell culture facility immediately. Upon arrival, pre-sterility sample testing was performed to ensure the sample was free from contaminant. Culture processes were conducted in a laboratory room where high sterility and safety were guaranteed. Every batch of the cells was monitored by a series of quality control testing to assure the quality of the product.",
                              "Conditioned medium collected from umbilical cord mesenchymal stem cell (UC-MSC) cultured. Every batch of the conditioned medium was monitored by a series of quality control testing to assure the quality of the product.",
                              "Standard therapy for cerebral palsy such as physiotherapy"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical Cord Mesenchymal Stem Cells",
                              "Conditioned Medium",
                              "Standard Therapy"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic Mesenchymal Stem Cells",
                              "Umbilical Cord Mesenchymal Stem Cells derived Conditioned Medium",
                              "Physiotheraphy"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04314687"
                        ]
                  },
                  {
                        "Rank": 228,
                        "InterventionArmGroupLabel": [
                              "Ambulatory Patients",
                              "Non-Ambulatory Patients"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Biological: Umbilical Cord Based Allogenic Mesenchymal Stem Cell"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02484560"
                        ]
                  },
                  {
                        "Rank": 229,
                        "InterventionArmGroupLabel": [
                              "PSORI-CM01 group",
                              "Gu Ben Hua Yu group",
                              "Gu Ben Hua Yu group",
                              "PSORI-CM01 group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "PSORI-CM01 formula will be orally administrated once a day for 12 weeks excpet the day for the infusion of AD-MSCs",
                              "Gu Ben Hua Yu formula will be orally administrated once a day for 12 weeks excpet the day for the infusion of AD-MSCs",
                              "AD-MSCs (adipose-derived multipotent mesenchymal stem cells) will be infused intravenously at a dose of 2 million cells/kg"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "PSORI-CM01 formula",
                              "Gu Ben Hua Yu formula",
                              "adipose-derived multipotent mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [
                              "Chinese Herbal Medicine",
                              "Chinese Herbal Medicine",
                              "stem cells",
                              "AD-MSCs"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04785027"
                        ]
                  },
                  {
                        "Rank": 230,
                        "InterventionArmGroupLabel": [
                              "A"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "600 million to 1 billion cells will be infused through the portal vein over 30 minutes. Infusion will be done one time."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Cellular transplantation"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00515307"
                        ]
                  },
                  {
                        "Rank": 231,
                        "InterventionArmGroupLabel": [
                              "ASC",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "100 million allogeneic adipose-derived mesenchymal stromal cells diluted in 100 ml saline"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Stem Cell Product"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04341610"
                        ]
                  },
                  {
                        "Rank": 232,
                        "InterventionArmGroupLabel": [
                              "MSC+HSC"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Co-transplantation of MSCs during allogeneic HSCT"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Cotransplant with MSCs"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04247945"
                        ]
                  },
                  {
                        "Rank": 233,
                        "InterventionArmGroupLabel": [
                              "Assigned interventions"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Two intravenous infusions of CS20AT04 (2.0\u00d710^6cell/kg), on 0 day and on 12 weeks The target population of this study is subjects in South Korea with a diagnosis of either lupus nephritis or lupus cytopenia."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "CS20AT04 (allogenic bone marrow derived mesenchymal stem cell)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04835883"
                        ]
                  },
                  {
                        "Rank": 234,
                        "InterventionArmGroupLabel": [
                              "MSCs-derived Exosomes Treatment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "5 times aerosol inhalation of MSCs-derived exosomes (2.0*10E8 nano vesicles/3 ml at Day 1, Day 2, Day 3, Day 4, Day 5)."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MSCs-derived exosomes"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04276987"
                        ]
                  },
                  {
                        "Rank": 235,
                        "InterventionArmGroupLabel": [
                              "human umbilical cord derived MSC"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "human umbilical cord derived MSC transplantation for SLE"
                        ],
                        "InterventionOtherName": [
                              "Allogenic MSC derived from umbilical cord"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01741857"
                        ]
                  },
                  {
                        "Rank": 236,
                        "InterventionArmGroupLabel": [
                              "Bone marrow-derived mesenchymal stromal cell (BM-MSC)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic bone marrow-derived mesenchymal stromal cell (BM-MSC) delivery through cardiopulmonary bypass (CPB) using a homogeneous population of infants with congenital heart disease (CHD) who will be undergoing a two-ventricle repair within the first six months of life."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "BM-MSC"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04236479"
                        ]
                  },
                  {
                        "Rank": 237,
                        "InterventionArmGroupLabel": [
                              "LMSCs 10 million IV",
                              "LMSCs 20 million IV",
                              "LMSCs100 million IV",
                              "Placebo (Plasmalyte A,HSA) IV"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All",
                              "ANeo"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals",
                              "Antineoplastic Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M85407",
                              "M8814"
                        ],
                        "InterventionBrowseLeafName": [
                              "Plasma-lyte 148",
                              "Altretamine"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Peripheral Intravenous (IV) infusion of LMSCs"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Peripheral Intravenous (IV) infusion of LMSCs"
                        ],
                        "InterventionOtherName": [
                              "LMSCs",
                              "Biological"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02587572"
                        ]
                  },
                  {
                        "Rank": 238,
                        "InterventionArmGroupLabel": [
                              "MSC"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "MSC (1.5-2 cells/kg BW) IV injection, twice at 4 weeks apart"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cells (MSC)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01540292"
                        ]
                  },
                  {
                        "Rank": 239,
                        "InterventionArmGroupLabel": [
                              "XCEL-MT-OSTEO-BETA",
                              "Standard treatment",
                              "XCEL-MT-OSTEO-BETA"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Coag",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Coagulants",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M17443"
                        ],
                        "InterventionBrowseLeafName": [
                              "Fibrin Tissue Adhesive"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "XCEL-MT-OSTEO-BETA followed by endomedullary nailing",
                              "Isolated endomedullary nailing"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "XCEL-MT-OSTEO-BETA",
                              "Surgical treatment"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02630836"
                        ]
                  },
                  {
                        "Rank": 240,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal Stromal Cell Therapy"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Cryopreserved allogeneic umbilical cord tissue-derived mesenchymal stromal cells are thawed and administered intravenously."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04255147"
                        ]
                  },
                  {
                        "Rank": 241,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal Stromal Cells (MSCs)",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Cryopreserved Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously.",
                              "Placebo, with excipients, will be administered intravenously."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03369275"
                        ]
                  },
                  {
                        "Rank": 242,
                        "InterventionArmGroupLabel": [
                              "Infusion of 100 million ASC",
                              "Infusion of 200 million ASC",
                              "Infusion of placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intravenous infusion of cells",
                              "Intravenous infusion of saline"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "adipose derived mesenchymal stromal cells",
                              "Saline"
                        ],
                        "InterventionOtherName": [
                              "CSCC_ASC"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04714801"
                        ]
                  },
                  {
                        "Rank": 243,
                        "InterventionArmGroupLabel": [
                              "Treatment (UC-MSC trasnplatation)",
                              "Treatment (UC-MSC trasnplatation)",
                              "control arm"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Repr",
                              "Resp",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Reproductive Control Agents",
                              "Respiratory System Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M2919",
                              "M15648"
                        ],
                        "InterventionBrowseLeafName": [
                              "Albuterol",
                              "Terbutaline"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Patients assigned to UC-MSC administration groups will receive two administrations at a dose of 1 million cells/kg patient body weight via the IV route with a 3-month intervening interval",
                              "Salbutamol, Terbutaline"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical Cord Mesenchymal Stem Cells transplantation",
                              "drug therapy according to Vietnamese MOHS procedure"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04433104"
                        ]
                  },
                  {
                        "Rank": 244,
                        "InterventionArmGroupLabel": [
                              "PBSC & MSCs",
                              "PBSC & MSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "PBSC",
                              "MSCs"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02083718"
                        ]
                  },
                  {
                        "Rank": 245,
                        "InterventionArmGroupLabel": [
                              "Experimental group",
                              "Control Group",
                              "Experimental group",
                              "Control Group",
                              "Experimental group",
                              "Control Group",
                              "Experimental group",
                              "Control Group",
                              "Experimental group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infl",
                              "ANeo",
                              "AnEm",
                              "Gast",
                              "All",
                              "Infe",
                              "FiAg",
                              "AnCoag"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Inflammatory Agents",
                              "Antineoplastic Agents",
                              "Antiemetics",
                              "Gastrointestinal Agents",
                              "All Drugs and Chemicals",
                              "Anti-Infective Agents",
                              "Fibrinolytic Agents",
                              "Anticoagulants"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Was",
                              "Include",
                              "Matching",
                              "Retrospective",
                              "Atrophy",
                              "Matched",
                              "Dinner"
                        ],
                        "InterventionBrowseLeafId": [
                              "M6254",
                              "M8941",
                              "M3374",
                              "M235540",
                              "M19304",
                              "M3396",
                              "M3376",
                              "M136812",
                              "M19284",
                              "M4845",
                              "M3369",
                              "M3403",
                              "M8033",
                              "M8199",
                              "M8940",
                              "M20119",
                              "M3366",
                              "M7625"
                        ],
                        "InterventionBrowseLeafName": [
                              "Dexamethasone",
                              "Hormones",
                              "Anti-Bacterial Agents",
                              "Dexamethasone acetate",
                              "Enoxaparin",
                              "Anticoagulants",
                              "Antibiotics, Antitubercular",
                              "Enoxaparin sodium",
                              "Azithromycin",
                              "Ceftriaxone",
                              "Anti-Inflammatory Agents",
                              "Antiemetics",
                              "Gastrointestinal Agents",
                              "Glucocorticoids",
                              "Hormone Antagonists",
                              "Antineoplastic Agents, Hormonal",
                              "Anti-Infective Agents",
                              "Fibrinolytic Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "high",
                              "high",
                              "low",
                              "high",
                              "high",
                              "low",
                              "low",
                              "high",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "i/v infusions",
                              "per os",
                              "a moderate amount of dexamethasone i/v",
                              "Sub-Q",
                              "\u041exygen therapy, mechanical ventilation and other supportive therapies"
                        ],
                        "InterventionMeshId": [
                              "D000000900",
                              "D000017963",
                              "D000002443",
                              "D000003907",
                              "D000017984",
                              "D000000925",
                              "D000006728"
                        ],
                        "InterventionMeshTerm": [
                              "Anti-Bacterial Agents",
                              "Azithromycin",
                              "Ceftriaxone",
                              "Dexamethasone",
                              "Enoxaparin",
                              "Anticoagulants",
                              "Hormones"
                        ],
                        "InterventionName": [
                              "Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells",
                              "Antibiotics",
                              "Hormones",
                              "Anticoagulant Therapy",
                              "\u041exygen therapy"
                        ],
                        "InterventionOtherName": [
                              "P-MMSCs",
                              "ceftriaxone and azithromycin capsules",
                              "dexamethasone",
                              "\u0415noxaparin",
                              "\u041exygen insufflation"
                        ],
                        "InterventionType": [
                              "Procedure",
                              "Drug",
                              "Drug",
                              "Drug",
                              "Device"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04461925"
                        ]
                  },
                  {
                        "Rank": 246,
                        "InterventionArmGroupLabel": [
                              "Allogenic mesenchymal stem cells",
                              "Autologous mesenchymal stem cells",
                              "Stromal Vascular fraction"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "curettage, closure of the internal opening (IO) and cell injection in IO (50%) and fistula tract (50%)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cell injection"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03726255"
                        ]
                  },
                  {
                        "Rank": 247,
                        "InterventionArmGroupLabel": [
                              "Allogeneic HB-adMSCs.",
                              "Placebo",
                              "Allogeneic HB-adMSCs.",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All",
                              "PhSol"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M16512",
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Vaccines",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "HB-adMSCs will be administered intravenously to study participants who qualify.",
                              "Sterile Saline Solution 0.9%"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Biological/Vaccine: Allogeneic HB-adMSCs",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic Hope Biosciences adipose derived mesenchymal stem cells.",
                              "Placebo will be administered intravenously to study participants who qualify."
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04995081"
                        ]
                  },
                  {
                        "Rank": 248,
                        "InterventionArmGroupLabel": [
                              "Adipose Derived Mesenchymal Stem Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "The dose will be specifically tailored to each subject's vascular anatomy determined by the surgeon through ultrasound measurements. Approximately 3-5 million cells in 5ml Ringer Lactate (RL) Solution"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Adipose Derived Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [
                              "AMSC"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04392206"
                        ]
                  },
                  {
                        "Rank": 249,
                        "InterventionArmGroupLabel": [
                              "Intravenous infusion of 1 million allogenic MSC's/Kg",
                              "Intravenous infusion of 3 million allogeneic MSCs/kg",
                              "Intravenous infusion of Plasmalyte A (placebo)",
                              "Intravenous infusion of 1 million allogenic MSC's/Kg",
                              "Intravenous infusion of 3 million allogeneic MSCs/kg",
                              "Intravenous infusion of Plasmalyte A (placebo)",
                              "Intravenous infusion of 1 million allogenic MSC's/Kg",
                              "Intravenous infusion of 3 million allogeneic MSCs/kg",
                              "Intravenous infusion of Plasmalyte A (placebo)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infl",
                              "All",
                              "AAll",
                              "AnEm",
                              "CNSDep",
                              "Gast",
                              "Derm",
                              "PhSol"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Inflammatory Agents",
                              "All Drugs and Chemicals",
                              "Anti-Allergic Agents",
                              "Antiemetics",
                              "Central Nervous System Depressants",
                              "Gastrointestinal Agents",
                              "Dermatologic Agents",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "AKT"
                        ],
                        "InterventionBrowseLeafId": [
                              "M9064",
                              "M155022",
                              "M228602",
                              "M263157",
                              "M6490",
                              "M13420",
                              "M85407",
                              "M11966",
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hydrocortisone",
                              "Hydrocortisone 17-butyrate 21-propionate",
                              "Hydrocortisone acetate",
                              "Hydrocortisone hemisuccinate",
                              "Diphenhydramine",
                              "Promethazine",
                              "Plasma-lyte 148",
                              "Ophthalmic Solutions",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Intravenous infusion of 1 million allogeneic MSCs/kg.",
                              "Intravenous infusion of 3 million allogeneic MSCs/kg",
                              "Intravenous infusion of Plasmalyte A (placebo)"
                        ],
                        "InterventionMeshId": [
                              "C000012499"
                        ],
                        "InterventionMeshTerm": [
                              "Plasma-lyte 148"
                        ],
                        "InterventionName": [
                              "MSCs",
                              "MSCs",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Plasmalyte A"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02846883"
                        ]
                  },
                  {
                        "Rank": 250,
                        "InterventionArmGroupLabel": [
                              "With MSC"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Mesenchymal stem cells infusion"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [
                              "Mesenchymal stem cells infusion"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01941394"
                        ]
                  },
                  {
                        "Rank": 251,
                        "InterventionArmGroupLabel": [
                              "Phase 1: hMSC-Exos low dose",
                              "Phase 1: hMSC-Exos medium dose",
                              "Phase 1: hMSC-Exos high dose",
                              "Phase 2: hMSC-Exos dosage 1",
                              "Phase 2: hMSC-Exos dosage 2",
                              "Phase 2: control group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "basic treatment and 7 times aerosol inhalation of hMSC-Exos (2.0*10^8 particles at Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7)",
                              "basic treatment and 7 times aerosol inhalation of hMSC-Exos (8.0*10^8 particles at Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7)",
                              "basic treatment and 7 times aerosol inhalation of hMSC-Exos (16.0*10^8 particles at Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7)",
                              "basic treatment and 7 times aerosol inhalation of hMSC-Exos (a quarter of MTD/day at Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7)",
                              "basic treatment and 7 times aerosol inhalation of hMSC-Exos (MTD/day at Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7)",
                              "basic treatment and 7 times aerosol inhalation of normal saline (at Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "low dose hMSC-Exos",
                              "medium dose hMSC-Exos",
                              "high dose hMSC-Exos",
                              "Dosage 1of hMSC-Exos",
                              "Dosage 2 of hMSC-Exos",
                              "No hMSC-derived exosomes"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Biological",
                              "Biological",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04602104"
                        ]
                  },
                  {
                        "Rank": 252,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [],
                        "InterventionOtherName": [],
                        "InterventionType": [],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02829216"
                        ]
                  },
                  {
                        "Rank": 253,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stem from valladolid (MSV)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "A unique intravitreal injection of MSV in acute fase of NAION"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "intravitreal injection of MSV"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03173638"
                        ]
                  },
                  {
                        "Rank": 254,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [
                              "CNSDep",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Central Nervous System Depressants",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M3259"
                        ],
                        "InterventionBrowseLeafName": [
                              "Anesthetics"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "MSCs will be administered under local anesthesia to the iliac crests after receiving informed consent from the patient."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MSC administration (intraosseal)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03389919"
                        ]
                  },
                  {
                        "Rank": 255,
                        "InterventionArmGroupLabel": [
                              "Adipose tissue-derived stem/stromal cells",
                              "Daily 2000 UI of daily oral cholecalciferol"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All",
                              "BDCA",
                              "Micro",
                              "Hypo",
                              "Vi"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals",
                              "Bone Density Conservation Agents",
                              "Micronutrients",
                              "Hypoglycemic Agents",
                              "Vitamins"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Neck",
                              "Neck",
                              "Neck",
                              "Neck",
                              "Neck"
                        ],
                        "InterventionBrowseLeafId": [
                              "M4533",
                              "M9336",
                              "M16702",
                              "M8941",
                              "M9517",
                              "M172956",
                              "M3377",
                              "M4550",
                              "M5155",
                              "M16710",
                              "M9093",
                              "M4527",
                              "M20162",
                              "M16037",
                              "T479",
                              "T440",
                              "T442"
                        ],
                        "InterventionBrowseLeafName": [
                              "Calcium",
                              "Immunoglobulins",
                              "Vitamin D",
                              "Hormones",
                              "Insulin",
                              "Insulin, Globin Zinc",
                              "Antibodies",
                              "Calcium, Dietary",
                              "Cholecalciferol",
                              "Vitamins",
                              "Hydroxycholecalciferols",
                              "Calcifediol",
                              "Micronutrients",
                              "Trace Elements",
                              "Vitamin D3",
                              "Calciferol",
                              "Cholecalciferol"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "high",
                              "high",
                              "high"
                        ],
                        "InterventionDescription": [
                              "The investigators will acess area under the curve of C-peptide after a liquid mixed meal (Glucerna\u00ae), considering the time 0 (basal), 30, 60, 90 and 120 minutes in each follow-up outpatient visit (3 [T3], 6 [T6], 12 [T12], 18 [T18], and 24 [T24] months after the adipose tissue-derived stem/stromal cells infusion). Other Clinical and Pancreatic Function Evaluation that wil be assess are: Weight, height, body mass index (BMI), blood pressure, heart frequency, frequency of hypoglycemia and insulin dose/kg of body weight, blood count, lipids, renal and hepatic function, thyroid stimulating hormone, free tyroxine, antithyroglobulin antibody, calcium, phosphorus and 25-Hydroxy Vitamin D."
                        ],
                        "InterventionMeshId": [
                              "D000002762",
                              "D000014807"
                        ],
                        "InterventionMeshTerm": [
                              "Cholecalciferol",
                              "Vitamin D"
                        ],
                        "InterventionName": [
                              "Infusion of adipose tissue-derived stem/stromal cells and oral Cholecalciferol supplementation"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03920397"
                        ]
                  },
                  {
                        "Rank": 256,
                        "InterventionArmGroupLabel": [
                              "Intervention group",
                              "Control group",
                              "Intervention group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All",
                              "Infe",
                              "Derm",
                              "HB"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals",
                              "Anti-Infective Agents",
                              "Dermatologic Agents",
                              "Herbal and Botanical"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M8199",
                              "M21142",
                              "T120"
                        ],
                        "InterventionBrowseLeafName": [
                              "Glucocorticoids",
                              "Salicylic Acid",
                              "Cola"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "A-MSCs 5 x 10~7 diluted on 100 mL of normal saline",
                              "5-amino-salicylic acid or glucocorticoid"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Adipose-cord mesenchymal stromal cells (A-MSCs)",
                              "Conventional drugs"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03609905"
                        ]
                  },
                  {
                        "Rank": 257,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "ARhu",
                              "Derm",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Antirheumatic Agents",
                              "Dermatologic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M18113",
                              "M5882",
                              "M9364",
                              "M255749",
                              "M3431"
                        ],
                        "InterventionBrowseLeafName": [
                              "Cyclosporine",
                              "Cyclosporins",
                              "Immunosuppressive Agents",
                              "Thymoglobulin",
                              "Antilymphocyte Serum"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "After standard immunosuppressive therapy with rabbit antithymocyte globulin 3,5 mg/Kg/day during 5 days, allogeneic unrelated bone marrow derived mesenchymal stem cells will be infused intravenously. Oral cyclosporine 5 mg/Kg/day (with dose correction weekly to keep serum cyclosporine level between 150-250 mg/dl) up to 6 months will be added."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Intravenous bone marrow mesenchymal stem cells infusion"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01297972"
                        ]
                  },
                  {
                        "Rank": 258,
                        "InterventionArmGroupLabel": [
                              "Group1 :Conventional plus hUCMSCs treatment",
                              "Group 2: Conventional plus hCBMNCs and hUCMSCs therapy",
                              "Group 3:Conventional therapy"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Participants will be given conventional therapy plus hUCMSCs transplantation.",
                              "Participants will be given conventional therapy plus and hCBMNCs and hUCMSCs transplantation.",
                              "Participants will be given conventional therapy only."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "human umbilical cord mesenchymal stem cells",
                              "human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells",
                              "Conventional therapy"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01443689"
                        ]
                  },
                  {
                        "Rank": 259,
                        "InterventionArmGroupLabel": [
                              "Allogeneic Wharton's jelly-MSCs (WJ-MSC)",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All",
                              "ANeo"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals",
                              "Antineoplastic Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M6457",
                              "M8814"
                        ],
                        "InterventionBrowseLeafName": [
                              "Dimethyl Sulfoxide",
                              "Altretamine"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "The product is provided cryopreserved by NextCell Pharma. The cells are frozen in cryobags at a concentration of 2 \u00d7 107 cells/ml in 5% Human Serum Albumin (HSA) and 10% dimethylsulfoxide (DMSO). One cryobag contains one dose. The bags are frozen in a controlled rate freezer and directly transferred to -190 \u00baC for storage until the time of infusion.\n\nCryobags are thawed at bedside and diluted in 100 ml of saline prior to administration. Cells will be delivered at a rate of 5 million cells per minute over a total of 20 minutes.",
                              "Sodium chloride buffer supplemented with 5% HSA and 10% DMSO same volume and mode of administration as treatment group"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Wharton's jelly-MSCs (WJ-MSC)",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Protrans"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04869397"
                        ]
                  },
                  {
                        "Rank": 260,
                        "InterventionArmGroupLabel": [
                              "Placebo",
                              "Wharton's jelly derived mesenchymal stromal cells (Protrans)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Protrans consists of Wharton's jelly derived mesenchymal stromal cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "the ATMP Protrans"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05061030"
                        ]
                  },
                  {
                        "Rank": 261,
                        "InterventionArmGroupLabel": [
                              "Test Group 1 (Low Dose)",
                              "Test Group 2 (High Dose)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "CNSDep",
                              "All",
                              "PhSol"
                        ],
                        "InterventionBrowseBranchName": [
                              "Central Nervous System Depressants",
                              "All Drugs and Chemicals",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M3259",
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Anesthetics",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Dose: 1 x 10^7 cells/1 mL/vial (1,000 clusters of adipose-derived mesenchymal stem cells)",
                              "Dose: 1 x 10^8 cells/1 mL/vial (10,000 clusters of adipose-derived mesenchymal stem cells)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Clusters of adipose-derived mesenchymal stem cells (Dose: 1 x 10^7 cells/1 mL/vial)",
                              "Clusters of adipose-derived mesenchymal stem cells (Dose: 1 x 10^8 cells/1 mL/vial)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04661644"
                        ]
                  },
                  {
                        "Rank": 262,
                        "InterventionArmGroupLabel": [
                              "Arm I (hMSCs)",
                              "Arm II (standard of care drugs)",
                              "Arm I (hMSCs)",
                              "Arm II (standard of care drugs)",
                              "Arm I (hMSCs)",
                              "Arm II (standard of care drugs)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Correlative studies",
                              "Undergo mesenchymal stem cell infusion",
                              "Undergo mesenchymal stem cell infusion"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Laboratory Biomarker Analysis",
                              "Standard of Care",
                              "Mesenchymal Stem Cell Transplantation"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other",
                              "Other",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02408432"
                        ]
                  },
                  {
                        "Rank": 263,
                        "InterventionArmGroupLabel": [
                              "1"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "This is a pilot study of infusions of ex vivo expanded, gene marked donor bone marrow stromal cells following allogeneic bone marrow transplantation. The study is a within patient dose escalation safety evaluation. It is believed that this patient population may benefit from these donor stromal cell infusions.\n\nAs the stromal cells will be obtained from the original stem cell donor, no conditioning is required.\n\nPatients will receive two infusions of mesenchymal cells (MSC) approximately 14 to 21 days apart unless there is unacceptable toxicity after the first infusion. The first dose of cells to be given will be 1x10^6 MSC/kg and the second dose of cells will be 5x10^6 MSC/kg. The patients will be followed for approximately 28 days following the second infusion for any toxicity. Only after all six patients have safely completed both infusions will we consider 5 x 10^6 MSC/kg a safe dose of allogeneic mesenchymal stem cells for infusion."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Marrow stromal cell infusion"
                        ],
                        "InterventionOtherName": [
                              "Gene marking",
                              "mesenchymal cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00186914"
                        ]
                  },
                  {
                        "Rank": 264,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal Stem Cell"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Patients enrolled in Cipto Mangunkusumo Hospital with degenerative disc disease with no promising result after conventional treatment."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cell + NaCl 0,9% 2ml"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04499105"
                        ]
                  },
                  {
                        "Rank": 265,
                        "InterventionArmGroupLabel": [
                              "TH-SC01"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic Umbilical Cord-derived Mesenchymal Stem cells perilesional injection. Human TH-SC01 cell injection (human umbilical cord mesenchymal stem cells for injection, 5 million cells / ml, 6.0-10.0ml / bottle)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "TH-SC01"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04939337"
                        ]
                  },
                  {
                        "Rank": 266,
                        "InterventionArmGroupLabel": [
                              "hCT-MSC infusion"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All",
                              "ANeo"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals",
                              "Antineoplastic Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M85407",
                              "M8814"
                        ],
                        "InterventionBrowseLeafName": [
                              "Plasma-lyte 148",
                              "Altretamine"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Human Umbilical Cord Tissue-derived Mesenchymal Stromal Cells (hCT-MSC):\n\nhCT-MSCs is an allogeneic cell product manufactured from donated umbilical cord tissue that is digested and expanded in culture, cryopreserved and banked. Doses contain 2x10^6 cells/kg (up to a maximum dose of 100x10^6 cells) diluted in plasmalyte-A with 5% HSA to a volume of 20-40mL."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Human Cord Tissue Mesenchymal Stromal Cells (hCT-MSCs)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04549285"
                        ]
                  },
                  {
                        "Rank": 267,
                        "InterventionArmGroupLabel": [
                              "mesenchymal stem cells",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "AKT"
                        ],
                        "InterventionBrowseLeafId": [
                              "M85407",
                              "M11966",
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Plasma-lyte 148",
                              "Ophthalmic Solutions",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Intramuscular injection",
                              "Intramuscular injection"
                        ],
                        "InterventionMeshId": [
                              "C000012499"
                        ],
                        "InterventionMeshTerm": [
                              "Plasma-lyte 148"
                        ],
                        "InterventionName": [
                              "mesenchymal stem cells",
                              "Plasmalyte A"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00883870"
                        ]
                  },
                  {
                        "Rank": 268,
                        "InterventionArmGroupLabel": [
                              "BM-MNC experimental",
                              "UC-MSC"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Gast",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Gastrointestinal Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21707",
                              "M12266"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pancrelipase",
                              "Pancreatin"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Autologous bone-marrow mononuclear cells infused to the main blood vessels that supply the pancreas according to the results of previous pancreatic CT-scan, performed by interventional radiologist. The target is to distribute the BM-MNCs equally in all part of the pancreas. Dosage: 1 x 10^5 - 1 x 10^6 CD34 cells/kgBW",
                              "Allogeneic umbilical cord tissue-derived mesenchymal stem cells will be given via intravenous infusion. Dosage: 2 x 10^6 cells/kgBW, twice, with three months interval"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Bone-marrow aspiration, Intra-pancreatic Catheterisation of BM-MNC",
                              "Intravenous Infusion of UC-MSC"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04501341"
                        ]
                  },
                  {
                        "Rank": 269,
                        "InterventionArmGroupLabel": [
                              "HB-adMSCs",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Hope Biosciences allogeneic adipose-derived mesenchymal stem cells",
                              "Saline"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "HB-adMSC",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04362189"
                        ]
                  },
                  {
                        "Rank": 270,
                        "InterventionArmGroupLabel": [
                              "DMT1+MSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Hypo",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Hypoglycemic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M9517",
                              "M172956"
                        ],
                        "InterventionBrowseLeafName": [
                              "Insulin",
                              "Insulin, Globin Zinc"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "origin: bone marrow of healthy donor; manipulation: ex vivo expanded; via: intravenous; vehicle: 5% human recombinant albumin in physiological serum; dose: 2-3 millions/Kg; dosage: single"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MSCs"
                        ],
                        "InterventionOtherName": [
                              "mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02893306"
                        ]
                  },
                  {
                        "Rank": 271,
                        "InterventionArmGroupLabel": [
                              "Injection of MSCs differentiated into neural stem cells NSCs",
                              "Injection of Umbilical cord derived MSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogenic umbilical cord derived MSCs which are to be injected intrathecally and intravenously as a treatment option for consenting PD patients"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Injection of Umbilical cord derived MSCs"
                        ],
                        "InterventionOtherName": [
                              "injection of Umbilical cord derived MSCs differentiated into neural stem cells NSCs."
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03684122"
                        ]
                  },
                  {
                        "Rank": 272,
                        "InterventionArmGroupLabel": [
                              "15ml of ExoFlo at Day 0, 2, 4 Week 2, 6, and every 4 weeks after that to week 46",
                              "15ml of ExoFlo at Day 0, 2, 4 Week 2, 6, and every 8 weeks after that to week 46"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "A Phase I study of ExoFlo, an ex vivo culture-expanded adult allogeneic bone marrow mesenchymal stem cell derived extracellular vesicle product, for the treatment of medically refractory ulcerative colitis"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ExoFlo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05176366"
                        ]
                  },
                  {
                        "Rank": 273,
                        "InterventionArmGroupLabel": [
                              "MSC"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013",
                              "M9364"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions",
                              "Immunosuppressive Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "The product is packaged in bags suitable for the cryopreservation of cell products. Before administration the cells must be thawed and diluted in an appropriate vol:vol solution: made by saline 78%, human albumin 10%, Acyl-CoA dehydrogenase-A (ACD-A) 12%."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Cord-blood mesenchymal stromal cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04034316"
                        ]
                  },
                  {
                        "Rank": 274,
                        "InterventionArmGroupLabel": [
                              "CartiLage Auto/Allo IMplantation for Focal Hip Cartilage Defects"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Coag",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Coagulants",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Cobicistat"
                        ],
                        "InterventionBrowseLeafId": [
                              "M17443",
                              "M11052",
                              "M8728",
                              "M5411"
                        ],
                        "InterventionBrowseLeafName": [
                              "Fibrin Tissue Adhesive",
                              "Mitogens",
                              "Hemostatics",
                              "Coagulants"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Cartilage cells are being used from the rim of the defect in the hip and recycled to help make new cartilage in the hip. There are not enough cartilage cells to fill the defect so cartilage cells need to be mixed with MSCs. MSCs or Mesenchymal Stem Cells are naturally occurring cells that provide growth factors and cell signals that play a role in tissue repair. MSCs can be found in bone marrow and in the fatty tissues (i.e., area under the skin of the belly or breast) of patients. Fibrin glue is a product made from the naturally occurring compounds in blood which cause clotting. This glue hardens into a gel-like substance into which cells such as cartilage cells (chondrons) and AMSCs can be placed."
                        ],
                        "InterventionMeshId": [
                              "D000015718"
                        ],
                        "InterventionMeshTerm": [
                              "Fibrin Tissue Adhesive"
                        ],
                        "InterventionName": [
                              "Autologous Chondrocytes in their Pericellular Matrix (Chondrons) Coimplanted with Allogeneic Adipose-Derived Mesenchymal Stromal Cells (AMSCs) in a Fibrin Glue Carrier"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Combination Product"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05553132"
                        ]
                  },
                  {
                        "Rank": 275,
                        "InterventionArmGroupLabel": [
                              "Control group (Tendon repair)",
                              "Experimental group (Tendon repair augmented with AAdMSC-HAM composite)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Tendon repair procedure:\n\nSingle senior surgeon (HS) will perform mini-open surgery to decompress the acromioplasty and repair the supraspinatus tendon.\nSplicing is achieved by installing screw-type anchors on the insertional footprint of the humeral head greater tuberosity.\nThen, double suturing of the supraspinatus tendon is performed.",
                              "After double suturing of the supraspinatus tendon, the composite comprising freeze-dried HAM (2 cm x 2 cm x 0.002 cm) and AAdMSC (20 million cells) is placed on the upper surface of the splice and fixed with stitches at all four corners."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Tendon repair procedure",
                              "Tendon repair augmented with AAdMSC-HAM composite"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04670302"
                        ]
                  },
                  {
                        "Rank": 276,
                        "InterventionArmGroupLabel": [
                              "Autologous hMSCs",
                              "Allogeneic hMSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 2 (18 patients) Eighteen (18) patients will be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Autologous hMSCs",
                              "Allogeneic hMSCs"
                        ],
                        "InterventionOtherName": [
                              "Biosense Webster MyoStar NOGA Injection Catheter System.",
                              "Biosense Webster MyoStar NOGA Injection Catheter System."
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT01392625"
                        ]
                  },
                  {
                        "Rank": 277,
                        "InterventionArmGroupLabel": [
                              "Control Group",
                              "Experiment Group",
                              "Control Group",
                              "Experiment Group",
                              "Experiment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Matched",
                              "Take place"
                        ],
                        "InterventionBrowseLeafId": [
                              "M19284",
                              "M26299",
                              "M3374",
                              "M3366",
                              "M3466"
                        ],
                        "InterventionBrowseLeafName": [
                              "Azithromycin",
                              "Oseltamivir",
                              "Anti-Bacterial Agents",
                              "Anti-Infective Agents",
                              "Antiviral Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "high",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Current standardized treatment for Covid-19",
                              "Current standardized treatment for Covid-19",
                              "Adjuvant therapy on top of current standardized treatment (Oseltamivir + Azithromycin)"
                        ],
                        "InterventionMeshId": [
                              "D000017963",
                              "D000053139"
                        ],
                        "InterventionMeshTerm": [
                              "Azithromycin",
                              "Oseltamivir"
                        ],
                        "InterventionName": [
                              "Oseltamivir",
                              "Azithromycin",
                              "Umbilical Cord Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04457609"
                        ]
                  },
                  {
                        "Rank": 278,
                        "InterventionArmGroupLabel": [
                              "Allogeneic (MSC's) Application to the Burn Wounds"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic (MSC's) Application to the Burn Wounds. The first group of 5 will be started on the lowest dose. If there are no adverse reactions, the second group of 5 will receive a higher dose. This will be repeated for the third and fourth groups with each receiving a higher dose\n\nInitial dose level will be 2.5 x 10\u00b3 Allogeneic MSCs cells/square cm.\nSecond dose level 5 X 10\u00b3 Allogeneic MSCs cells/square cm.\nThird dose level 1 X 10\u2074 Allogeneic MSCs cells/square cm.\nFourth dose level 2 X 10\u2074 Allogeneic MSCs cells/square cm.\n\nUp to 2 administrations of cells will be allowed per dose level to be given over a period of no more than 8 weeks. Each administration of cells will be no less than ten days apart and no more than 6 weeks apart."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic (MSC's) Application to the Burn Wounds"
                        ],
                        "InterventionOtherName": [
                              "Stem Cells Application to the Burn Wounds"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02104713"
                        ]
                  },
                  {
                        "Rank": 279,
                        "InterventionArmGroupLabel": [
                              "Lactated Ringer's Solution",
                              "hMSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "IV administration"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "hMSC"
                        ],
                        "InterventionOtherName": [
                              "allogeneic mesenchymal bone marrow cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04780685"
                        ]
                  },
                  {
                        "Rank": 280,
                        "InterventionArmGroupLabel": [
                              "hMSC Treatment group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Umbilical cord-derived, allogeneic hMSC administered intravenously at a dose of approximately 100 million cells per infusion."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Approximately 100 million cells allogeneic hMSC"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04040348"
                        ]
                  },
                  {
                        "Rank": 281,
                        "InterventionArmGroupLabel": [
                              "allo-APZ2-ACLF"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All",
                              "Hemat"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals",
                              "Hematinics"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013",
                              "M10262"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions",
                              "Liver Extracts"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Administration of 2 x 10e6 allogeneic ABCB5-positive stem cells/kg bodyweight, each at Day 0, Day 5 (\u00b11) and Day 13 (\u00b11) into peripheral vein (arm) intravenously with a flow rate of 1-2 ml/min. Infusion of the product via a central venous catheter (CVC), a Port-a-Cath (Port) or a similar catheter is also possible. Allo-APZ2-ACLF will be in a concentration of 1 x 10e7 cells/mL in Human Serum Albumin/Ringer-Lactate/Glucose (HRG)-solution."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "allo-APZ2-ACLF"
                        ],
                        "InterventionOtherName": [
                              "Skin-derived ABCB5-positive mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03860155"
                        ]
                  },
                  {
                        "Rank": 282,
                        "InterventionArmGroupLabel": [
                              "First arm",
                              "Fourth arm",
                              "Second arm",
                              "Third arm"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "The treatment administration will be infused intravenously to the subjects after randomization:\n\nAn hour after the end of the eASCs administration, all subjects will be given an intravenous dose of LPS. Subjects will be allowed to leave in the evening once deemed clinically stable by the investigator."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Intravenous infusion of cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02328612"
                        ]
                  },
                  {
                        "Rank": 283,
                        "InterventionArmGroupLabel": [
                              "Auto-hMSCs",
                              "Allo-hMSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Auto-hMSCs",
                              "Allo-hMSCs"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01087996"
                        ]
                  },
                  {
                        "Rank": 284,
                        "InterventionArmGroupLabel": [
                              "1",
                              "2",
                              "3"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Mesenchymal Stem Cell infusion"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00603330"
                        ]
                  },
                  {
                        "Rank": 285,
                        "InterventionArmGroupLabel": [
                              "Intracoronary Group",
                              "Intravenous Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "The UC-MSCs from a donor will be cultured in a clinical grade laboratory with xeno-free medium. Maximum passage of expanded-UC MSCs was VI and doubling population is less than 30. To assure the quality of our expanded-UC MSCs at ProSTEM the following tests are done: cell adherence, cell surface marker, in vitro differentiation, cell viability, sterility, Mycoplasma, endotoxin, and karyotyping."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04340609"
                        ]
                  },
                  {
                        "Rank": 286,
                        "InterventionArmGroupLabel": [
                              "MSCs group",
                              "Control group",
                              "MSCs group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "ANeo",
                              "All",
                              "ARhu"
                        ],
                        "InterventionBrowseBranchName": [
                              "Antineoplastic Agents",
                              "All Drugs and Chemicals",
                              "Antirheumatic Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Peripheral",
                              "Two"
                        ],
                        "InterventionBrowseLeafId": [
                              "M376",
                              "M9336",
                              "M3377",
                              "M373",
                              "M18269",
                              "M7988",
                              "M19343",
                              "M1346",
                              "M9353",
                              "M19757"
                        ],
                        "InterventionBrowseLeafName": [
                              "Bortezomib",
                              "Immunoglobulins",
                              "Antibodies",
                              "Rituximab",
                              "Immunoglobulins, Intravenous",
                              "gamma-Globulins",
                              "Rho(D) Immune Globulin",
                              "Antineoplastic Agents, Immunological",
                              "Immunologic Factors",
                              "Antirheumatic Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "BM-MSCs are from third-party healthy donors, and have no HLA alleles similar to renal allograft donors or reacting to positive anti-HLA antibodies in recipients.",
                              "At least one drug or treatment is applied as desensitization therapy to decrease DSA, reduce B cells or inhibit plasma cells, depending on individual condition."
                        ],
                        "InterventionMeshId": [
                              "D000069283",
                              "D000069286"
                        ],
                        "InterventionMeshTerm": [
                              "Rituximab",
                              "Bortezomib"
                        ],
                        "InterventionName": [
                              "BM-MSCs",
                              "Desensitization therapy (PP, IVIG, rituximab or Bortezomib)"
                        ],
                        "InterventionOtherName": [
                              "allogeneic bone marrow-derived MSCs"
                        ],
                        "InterventionType": [
                              "Other",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02563340"
                        ]
                  },
                  {
                        "Rank": 287,
                        "InterventionArmGroupLabel": [
                              "Randomized: Cohort 1 Allo-hMSCs",
                              "Randomized: Cohort 2 Allo-hMSCs",
                              "Safety Run-In: Treatment 1 Allo-hMSCs",
                              "Safety Run-In: Treatment 2 Allo-hMSCs",
                              "Randomized: Cohort 3 Allo-hMSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All",
                              "ANeo"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals",
                              "Antineoplastic Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M85407",
                              "M8814"
                        ],
                        "InterventionBrowseLeafName": [
                              "Plasma-lyte 148",
                              "Altretamine"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "1 peripheral intravenous infusion of allogeneic human mesenchymal stem cells (hMSCs)",
                              "1 peripheral intravenous infusion"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allo-hMSCs",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Stem cells"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03058068"
                        ]
                  },
                  {
                        "Rank": 288,
                        "InterventionArmGroupLabel": [
                              "High dose of allogenic MSC drops",
                              "Low dose of allogenic MSC drops",
                              "Medium dose of allogenic MSC drops"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Phase II Study"
                        ],
                        "InterventionBrowseLeafId": [
                              "M11966",
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Ophthalmic Solutions",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low"
                        ],
                        "InterventionDescription": [
                              "MSC Secretome eye drop will be dispensed."
                        ],
                        "InterventionMeshId": [
                              "D000009883"
                        ],
                        "InterventionMeshTerm": [
                              "Ophthalmic Solutions"
                        ],
                        "InterventionName": [
                              "MSC Secretome Eye Drops"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05204329"
                        ]
                  },
                  {
                        "Rank": 289,
                        "InterventionArmGroupLabel": [
                              "CABG with hUC-MSC treatment group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "CNSDep",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Central Nervous System Depressants",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M3259"
                        ],
                        "InterventionBrowseLeafName": [
                              "Anesthetics"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "In CABG with hUC-MSC treatment group, 1\u00d710^7 Human Umbilical Cord Mesenchymal Stem Cells were injected at the edge of the myocardial infarction area at 20 points at the same time in CABG"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic Human Umbilical Cord Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04939077"
                        ]
                  },
                  {
                        "Rank": 290,
                        "InterventionArmGroupLabel": [
                              "Bone marrow-derived Mesenchymal Stromal Cells",
                              "Cryostor CS10"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Cells will be administered intravenously at 3 different doses (80, 160, or 240 x 10^6, fixed dose) over 10-20 minutes. Volume total of fluid infused: 40 ml",
                              "Volume total of fluid infused: 40 ml"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stromal Cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic Cellular Therapy (NEPHSTROM ORBCEL-M)",
                              "Cryostor CS10"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT02585622"
                        ]
                  },
                  {
                        "Rank": 291,
                        "InterventionArmGroupLabel": [
                              "CD25 Mc Ab & calcineurin inhibitors",
                              "Mesenchymal stem cells",
                              "CD25 Mc Ab & calcineurin inhibitors",
                              "Mesenchymal stem cells",
                              "Mesenchymal stem cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Followed by",
                              "Controlled",
                              "Maxilla"
                        ],
                        "InterventionBrowseLeafId": [
                              "M9336",
                              "M3382",
                              "M3377",
                              "M29605",
                              "M9353"
                        ],
                        "InterventionBrowseLeafName": [
                              "Immunoglobulins",
                              "Antibodies, Monoclonal",
                              "Antibodies",
                              "Calcineurin Inhibitors",
                              "Immunologic Factors"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "high",
                              "high",
                              "high",
                              "low"
                        ],
                        "InterventionDescription": [],
                        "InterventionMeshId": [
                              "D000000906",
                              "D000000911",
                              "D000065095"
                        ],
                        "InterventionMeshTerm": [
                              "Antibodies",
                              "Antibodies, Monoclonal",
                              "Calcineurin Inhibitors"
                        ],
                        "InterventionName": [
                              "CD25 monoclonal antibody",
                              "calcineurin inhibitors",
                              "MSCs"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02241018"
                        ]
                  },
                  {
                        "Rank": 292,
                        "InterventionArmGroupLabel": [
                              "MSCs group",
                              "Control group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "BM-MSCs are from third-party healthy volunteer donors.",
                              "Saline is the placebo of MSCs in this study."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "BM-MSCs",
                              "Saline"
                        ],
                        "InterventionOtherName": [
                              "allogeneic bone marrow-derived MSCs"
                        ],
                        "InterventionType": [
                              "Other",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02563366"
                        ]
                  },
                  {
                        "Rank": 293,
                        "InterventionArmGroupLabel": [
                              "Verum",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic dermal ABCB5-positive Mesenchymal Stromal Cells (ABCB5+ MSCs)",
                              "Placebo"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "allo-APZ2-OTS",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05464381"
                        ]
                  },
                  {
                        "Rank": 294,
                        "InterventionArmGroupLabel": [
                              "BM-MSC injections for low back pain"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Single bilateral intra-articular injection of manufactured cell cultured expanded allogeneic BM-MSCs for painful lumbar facet joint arthropathy"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Single bilateral intra-articular injection of allogeneic BM-MSCs for lumbar facet joint arthropathy"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04410731"
                        ]
                  },
                  {
                        "Rank": 295,
                        "InterventionArmGroupLabel": [
                              "Infusion of \u03b3MSCs",
                              "Infusion of \u03b3MSCs",
                              "Infusion of \u03b3MSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Repr",
                              "Resp",
                              "All",
                              "Infe",
                              "ANeo",
                              "Infl"
                        ],
                        "InterventionBrowseBranchName": [
                              "Reproductive Control Agents",
                              "Respiratory System Agents",
                              "All Drugs and Chemicals",
                              "Anti-Infective Agents",
                              "Antineoplastic Agents",
                              "Anti-Inflammatory Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Ivacaftor",
                              "Inhibitor",
                              "Saline",
                              "Whole blood"
                        ],
                        "InterventionBrowseLeafId": [
                              "M2919",
                              "M9559",
                              "M13273",
                              "M9558",
                              "M3369",
                              "M8199",
                              "M8941",
                              "M8940",
                              "M20119",
                              "M3466",
                              "M3366",
                              "M4421",
                              "M20116",
                              "M20290",
                              "M17021",
                              "M19899",
                              "M2822",
                              "M2825",
                              "M19657"
                        ],
                        "InterventionBrowseLeafName": [
                              "Albuterol",
                              "Interferons",
                              "Prednisone",
                              "Interferon-gamma",
                              "Anti-Inflammatory Agents",
                              "Glucocorticoids",
                              "Hormones",
                              "Hormone Antagonists",
                              "Antineoplastic Agents, Hormonal",
                              "Antiviral Agents",
                              "Anti-Infective Agents",
                              "Bronchodilator Agents",
                              "Anti-Asthmatic Agents",
                              "Respiratory System Agents",
                              "Tocolytic Agents",
                              "Adrenergic Agents",
                              "Adrenergic beta-Agonists",
                              "Adrenergic Agonists",
                              "Neurotransmitter Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "high",
                              "high",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Participants who experience symptoms of cough, dyspnea, chest tightness or wheezing will initiate use of albuterol (2 inhalations, 90 mcg/actuation) by metered dose inhaler (MDI) every 20 minutes for up to 1 hour and then every 4 hours if necessary.",
                              "IFN\u03b3-primed bone marrow MSCs at a dose level of 2x106 cells/kg and a dose level of 5x106 cells/kg",
                              "Prednisone is recommended if the participant uses more than 12 inhalations of albuterol in 24 hours (excluding preventive use before exercise), or if the patient has ongoing symptoms for 48 hours or longer. The recommended prednisone dose for acute exacerbations is 2 mg/kg/day (maximum 60 mg) as a single dose for two days followed by 1 mg/kg/day (maximum 30 mg) as a single dose for two days. All administered doses will be rounded down to the nearest 10 mg."
                        ],
                        "InterventionMeshId": [
                              "D000007372",
                              "D000007371",
                              "D000011241",
                              "D000000420"
                        ],
                        "InterventionMeshTerm": [
                              "Interferons",
                              "Interferon-gamma",
                              "Prednisone",
                              "Albuterol"
                        ],
                        "InterventionName": [
                              "Albuterol Sulfate",
                              "Interferon gamma-primed mesenchymal stromal cells (MSCs)",
                              "Prednisone"
                        ],
                        "InterventionOtherName": [
                              "Interferon gamma (IFN\u03b3)-primed human bone marrow-derived mesenchymal stromal cells"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05035862"
                        ]
                  },
                  {
                        "Rank": 296,
                        "InterventionArmGroupLabel": [
                              "Study Group A",
                              "Study Group B",
                              "Study Group C",
                              "Study Group D",
                              "Study Group E"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intravenously delivered",
                              "Intravenously delivered"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Longeveron Mesenchymal Stem Cells (LMSCs)",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03169231"
                        ]
                  },
                  {
                        "Rank": 297,
                        "InterventionArmGroupLabel": [
                              "Children with OI receiving Bone marrow-derived MSCs infusion"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Mesenchymal stromal cells (MSCs) are cells of non-hematopoietic stromal origin that reside in bone marrow and a variety of tissues. MSCs will be prepared in a GMP Cell Production facility and administered to children age 3-10 years (at time of enrollment) with Osteogenesis Imperfecta Type III."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Bone marrow-derived mesenchymal stromal cells (MSCs)"
                        ],
                        "InterventionOtherName": [
                              "MSC infusions"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05559801"
                        ]
                  },
                  {
                        "Rank": 298,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "1st infusion(1x1,000,000 hMSC/kg)IV, 2nd infusion(2x1,000,000 hMSC/kg)IV and 3rd infusion(3x1,000,000 hMSC/kg)IV if no complete response at 28 days."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Human umbilical cord blood-derived mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [
                              "PROMOSTEM\u00ae"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01549665"
                        ]
                  },
                  {
                        "Rank": 299,
                        "InterventionArmGroupLabel": [
                              "Bone-marrow derived MSCs",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic ex vivo expanded, bone marrow-derived mesenchymal stromal cells",
                              "Placebo product visually very similar to mesenchymal stromal cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Bone-marrow derived MSCs",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "MSC"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT02709343"
                        ]
                  },
                  {
                        "Rank": 300,
                        "InterventionArmGroupLabel": [
                              "ALLO-ASC-DFU",
                              "Vehicle Sheet"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Application of ALLO-ASC-DFU sheet to diabetic foot ulcer",
                              "Application of Vehicle sheet to diabetic foot ulcer"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ALLO-ASC-DFU",
                              "Vehicle sheet"
                        ],
                        "InterventionOtherName": [
                              "Hydrogel sheet containing allogenic mesenchymal stem cells",
                              "Hydrogel sheet without Allogenic mesenchymal stem cell"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03370874"
                        ]
                  },
                  {
                        "Rank": 301,
                        "InterventionArmGroupLabel": [
                              "MSCs&PBSC",
                              "MSCs",
                              "MSCs&PBSC"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "PBSC",
                              "MSCs"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02240992"
                        ]
                  },
                  {
                        "Rank": 302,
                        "InterventionArmGroupLabel": [
                              "Experimental group",
                              "Control group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "A matrix-cell construct (PeriCord) will be placed on the ischemic area of the non-candidate revascularization area during a surgery by sternotomy to perform the surgical revascularization of the arteries candidates for revascularization.",
                              "The patient will undergo surgery by sternotomy to perform the surgical revascularization of the arteries candidates for revascularization. No additional procedure will be performed only the by-pass."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton\u00b4s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.",
                              "Surgery by sternotomy"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Combination Product",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03798353"
                        ]
                  },
                  {
                        "Rank": 303,
                        "InterventionArmGroupLabel": [
                              "Corticosteroid therapy",
                              "Mesenchymal stromal cell therapy"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infl",
                              "ANeo",
                              "All",
                              "AnEm",
                              "NeuroAg",
                              "Gast"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Inflammatory Agents",
                              "Antineoplastic Agents",
                              "All Drugs and Chemicals",
                              "Antiemetics",
                              "Neuroprotective Agents",
                              "Gastrointestinal Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Hand"
                        ],
                        "InterventionBrowseLeafId": [
                              "M13272",
                              "M1833",
                              "M10901",
                              "M10902",
                              "M229437",
                              "M211896",
                              "M248768",
                              "M3369",
                              "M3403",
                              "M8033",
                              "M8199",
                              "M8941",
                              "M8940",
                              "M19926",
                              "M21022"
                        ],
                        "InterventionBrowseLeafName": [
                              "Prednisolone",
                              "Methylprednisolone Acetate",
                              "Methylprednisolone",
                              "Methylprednisolone Hemisuccinate",
                              "Prednisolone acetate",
                              "Prednisolone hemisuccinate",
                              "Prednisolone phosphate",
                              "Anti-Inflammatory Agents",
                              "Antiemetics",
                              "Gastrointestinal Agents",
                              "Glucocorticoids",
                              "Hormones",
                              "Hormone Antagonists",
                              "Neuroprotective Agents",
                              "Protective Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "One arm will be randomised to receive mesenchymal stromal cell therapy in addition to corticosteroid therapy"
                        ],
                        "InterventionMeshId": [
                              "D000008775"
                        ],
                        "InterventionMeshTerm": [
                              "Methylprednisolone"
                        ],
                        "InterventionName": [
                              "Mesenchymal stromal cell therapy"
                        ],
                        "InterventionOtherName": [
                              "Methylprednisolone",
                              "Mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01589549"
                        ]
                  },
                  {
                        "Rank": 304,
                        "InterventionArmGroupLabel": [
                              "ALLO-ASC-DFU",
                              "Hydrogel SHEET(Vehicle control)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Application of ALLO-ASC-DFU Sheet to diabetic foot ulcer",
                              "Application of Hydrogel SHEET to diabetic foot ulcer"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ALLO-ASC-DFU",
                              "Hydrogel SHEET(Vehicle control)"
                        ],
                        "InterventionOtherName": [
                              "Hydrogel sheet containing Allogenic Mesenchymal Stem Cells",
                              "Hydrogel sheet without Allogenic Mesenchymal Stem Cells"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03754465"
                        ]
                  },
                  {
                        "Rank": 305,
                        "InterventionArmGroupLabel": [
                              "MSC injections",
                              "Placebo injections"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "8 intramuscular injections at designated sites in the hand/forearm muscles of the most affected side. Blinded syringes will be used. Injections will be administered by an experienced clinician (plastic surgeon or hand surgeon).",
                              "8 intramuscular injections at designated sites in the hand/forearm muscles of the most affected side. Blinded syringes will be used. Injections will be administered by an experienced clinician (plastic surgeon or hand surgeon)."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stromal cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03211793"
                        ]
                  },
                  {
                        "Rank": 306,
                        "InterventionArmGroupLabel": [
                              "Drug: Low Dose Mesenchymal Stem Cells ( MSCs)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013",
                              "M85407"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions",
                              "Plasma-lyte 148"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Mesenchymal stromal/stem cells (MSCs) are cells that can be derived from umbilical cords, bone marrow, adipose tissue, and dental pulp, among other sites. MSCs have the ability to mediate a range of immuno-modulatory actions for both the innate and adaptive immune systems."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Low Dose Mesenchymal Stem Cells (MSCs)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03171194"
                        ]
                  },
                  {
                        "Rank": 307,
                        "InterventionArmGroupLabel": [
                              "Placebo",
                              "Mesenchymal Precursor Cells (MPC) 12.5 M",
                              "Mesenchymal Precursor Cells (MPC) 25 M"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Matching placebo solution for infusion.",
                              "MPC 12.5 M solution for infusion.",
                              "MPC 25 M solution for infusion."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Placebo",
                              "Mesenchymal Precursor Cells (MPC) 12.5 M",
                              "Mesenchymal Precursor Cells (MPC) 25 M"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT01781390"
                        ]
                  },
                  {
                        "Rank": 308,
                        "InterventionArmGroupLabel": [
                              "allo-APZ2-CVU (dose group 1: 1 x 10e6 cells/cm\u00b2)",
                              "allo-APZ2-CVU (dose group 2: 3 x 10e6 cells/cm\u00b2)",
                              "allo-APZ2-CVU (dose group 3: 6 x 10e6 cells/cm\u00b2)",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Suspension of ABCB5-positive dermal mesenchymal stromal cells. One topical application with a syringe.",
                              "One topical application with a syringe"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "allo-APZ2-CVU",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Skin-derived ABCB5-positive dermal mesenchymal stromal cells"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04971161"
                        ]
                  },
                  {
                        "Rank": 309,
                        "InterventionArmGroupLabel": [
                              "ALLO-ASC-DFU treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infl",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Inflammatory Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M3369",
                              "M11052",
                              "M17833"
                        ],
                        "InterventionBrowseLeafName": [
                              "Anti-Inflammatory Agents",
                              "Mitogens",
                              "Endothelial Growth Factors"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "ALLO-ASC-DFU is a hydrogel sheet containing allogenic adipose-derived mesenchymal stem cells. Adipose-derived stem cells have anti-inflammatory effect and release growth factors such as vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), which can enhance wound healing and regeneration of new tissue, finally may provide an new option in treating a diabetic foot ulcer.\n\nThis study is a follow-up study without intervention."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ALLO-ASC-DFU"
                        ],
                        "InterventionOtherName": [
                              "Allogenic adipose-derived mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT03183726"
                        ]
                  },
                  {
                        "Rank": 310,
                        "InterventionArmGroupLabel": [
                              "ALLO-ASC-CD injection"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "ALLO-ASC-CD is intravenous infusion containing allogenic adipose-derived mesenchymal stem cells. Adipose-derived stem cells are directed to injured tissue, and reduce inflammation. Furthermore their immunomodulatory effects are significant for treating immune-related disease. Finally, ALLO-ASC-CD may provide a new option in treating a crohn's disease. This study is a follow-up study without intervention."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ALLO-ASC-CD"
                        ],
                        "InterventionOtherName": [
                              "Allogenic adipose-derived mesenchymal stem cell"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT03183661"
                        ]
                  },
                  {
                        "Rank": 311,
                        "InterventionArmGroupLabel": [
                              "Intervention arm"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M11052"
                        ],
                        "InterventionBrowseLeafName": [
                              "Mitogens"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "TC-MSC: a cell product containing mesenchymal stromal cells. Mesenchymal stromal cells are adherent non-haematopoietic multipotent cells that are expanded from bone marrow from healthy donors, using platelet lysate as source of growth factor."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stromal cells"
                        ],
                        "InterventionOtherName": [
                              "TC-MSC"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02323789"
                        ]
                  },
                  {
                        "Rank": 312,
                        "InterventionArmGroupLabel": [
                              "Treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Hemat",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Hematinics",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M10262"
                        ],
                        "InterventionBrowseLeafName": [
                              "Liver Extracts"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Four doses of expanded human 1st trimester fetal liver-derived mesenchymal stem cells."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "BOOST cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04623606"
                        ]
                  },
                  {
                        "Rank": 313,
                        "InterventionArmGroupLabel": [
                              "Low Dose Mesenchymal Stem Cells (MSCs)",
                              "High Dose Mesenchymal Stem Cells (MSCs)",
                              "Plasma Lyte A Solution"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013",
                              "M85407"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions",
                              "Plasma-lyte 148"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Participants will receive a single IV infusion of Mesenchymal Stem Cells (MSCs) 1 x 10^6 cells/kg in Plasma-Lyte A solution. All participants will receive the infusion at the Baseline (Day 0) visit. All participants will continue on their standard-of-care therapy during the trial.",
                              "Participants will receive a single IV infusion of Mesenchymal Stem Cells MSCs 5 x 10^6 cells/kg in Plasma-Lyte A solution.",
                              "Participants will receive a placebo infusion that does not contain any mesenchymal stem cells.The placebo infusion will consist of Plasma-Lyte A, which is the same vehicle used to deliver the MSCs in the experimental groups."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Low Dose Mesenchymal Stem Cells (MSCs)",
                              "High Dose Mesenchymal Stem Cells (MSCs)",
                              "Placebo Infusion"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02633163"
                        ]
                  },
                  {
                        "Rank": 314,
                        "InterventionArmGroupLabel": [
                              "Postnatal",
                              "Prenatal"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Hemat",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Hematinics",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M10262"
                        ],
                        "InterventionBrowseLeafName": [
                              "Liver Extracts"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Four doses of expanded human 1st trimester fetal liver-derived mesenchymal stem cells."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "BOOST cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03706482"
                        ]
                  },
                  {
                        "Rank": 315,
                        "InterventionArmGroupLabel": [
                              "MSC infusion",
                              "SHAM infusion"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic bone marrow derived mesenchymal stem cells given in one dose 3-10 days after stroke symptom onset",
                              "Normal saline"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MSC Infusion",
                              "Placebo Comparator"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01922908"
                        ]
                  },
                  {
                        "Rank": 316,
                        "InterventionArmGroupLabel": [
                              "ULSC in Phase 1 Open Label",
                              "ULSC in Phase 2a Randomized",
                              "Placebo in Phase 2a Randomized"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "IV infusion of allogeneic ULSC (100 million cells per dose) in sterile saline for injection",
                              "IV infusion of carrier control consisting of sterile saline for injection"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical Cord Lining Stem Cells (ULSC)",
                              "Placebo (carrier control)"
                        ],
                        "InterventionOtherName": [
                              "Umbilical Cord Lining Stem Cells (ULSC), type of mesenchymal stem cells (MSC) derived from single donor umbilical cord tissue for allogeneic use"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04494386"
                        ]
                  },
                  {
                        "Rank": 317,
                        "InterventionArmGroupLabel": [
                              "Treatment",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "HB-adMSCs allogenic",
                              "Placebo comarator"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "HB-adMSCs (allogeneic)",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Hope Biosciences adipose derived mesenchymal stem cells",
                              "Sterile Normal Saline"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05126563"
                        ]
                  },
                  {
                        "Rank": 318,
                        "InterventionArmGroupLabel": [
                              "High-dose group",
                              "Low-dose group",
                              "Control group (placebo)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Assignment of Administration Group allogeneic mesenchymal stem cell:\n\nLow-dose group (5 x 10^7cells)\nHigh-dose group (1 x 10^8 cells)",
                              "Control group (placebo)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "allogeneic mesenchymal stem cell",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Investigational product"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04535856"
                        ]
                  },
                  {
                        "Rank": 319,
                        "InterventionArmGroupLabel": [
                              "GXCPC1",
                              "hyaluronic acid"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M9030"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hyaluronic Acid"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "The dose regimen is one single intra-articular injection of GXCPC1 containing 6.7\u00d710^6 or 4\u00d710^7 ADSCs in 3 mL saline. (allogeneic injection)",
                              "Hya Joint Plus synovial fluid supplement 3mL"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "GXCPC1",
                              "HA"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Device"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03943576"
                        ]
                  },
                  {
                        "Rank": 320,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cell Infusion"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00314483"
                        ]
                  },
                  {
                        "Rank": 321,
                        "InterventionArmGroupLabel": [
                              "Cohort 1",
                              "Cohort 2"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Single Intravenous Infusion of MPCs Dose 1 or Placebo",
                              "Single Intravenous Infusion of MPCs Dose 2 or Placebo"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Precursor Cells (MPCs)",
                              "Mesenchymal Precursor Cells (MPCs)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01843387"
                        ]
                  },
                  {
                        "Rank": 322,
                        "InterventionArmGroupLabel": [
                              "allo-APZ2-EB"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "intravenous infusion of allo-APZ2-EB"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "allo-APZ2-EB"
                        ],
                        "InterventionOtherName": [
                              "allogeneic ABCB5-positive mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03529877"
                        ]
                  },
                  {
                        "Rank": 323,
                        "InterventionArmGroupLabel": [
                              "HSCT-recipients",
                              "Kidney transplant recipients",
                              "Liver transplant recipients",
                              "MSCT-recipients"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Hemat",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Hematinics",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M10262"
                        ],
                        "InterventionBrowseLeafName": [
                              "Liver Extracts"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Fecal samples collected at baseline pre-transplant and post-transplant, new generation 16s RNA sequencing performed."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Intestinal microbiome new generation sequencing"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Diagnostic Test"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04281797"
                        ]
                  },
                  {
                        "Rank": 324,
                        "InterventionArmGroupLabel": [
                              "Double-Blind,Randomized,Placebo Phase",
                              "Pilot Phase Cohort B & C",
                              "Pilot Phase- Cohort A",
                              "Double-Blind,Randomized,Placebo Phase",
                              "Pilot Phase Cohort B & C",
                              "Pilot Phase- Cohort A"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M16512",
                              "M9336",
                              "M3377"
                        ],
                        "InterventionBrowseLeafName": [
                              "Vaccines",
                              "Immunoglobulins",
                              "Antibodies"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Intravenously delivered",
                              "Intramuscular injection"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Longeveron Mesenchymal Stem Cells (LMSCs)",
                              "Fluzone High Dose Vaccine"
                        ],
                        "InterventionOtherName": [
                              "Lomecel-B"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02982915"
                        ]
                  },
                  {
                        "Rank": 325,
                        "InterventionArmGroupLabel": [
                              "Arm C: Re-Transplant with 300 cGy of TBI",
                              "Arm D: HCT with 200 cGy BID of TBI",
                              "Arm E: HCT plus MSC, 200 cGy BID of TBI",
                              "Arm F: HCT Alone, 200 cGy BID of TBI",
                              "Arm G: HCT plus MSC, 200 cGy",
                              "CLOSED TO ACCRUAL Arm A: HCT with 300 cGy of TBI",
                              "CLOSED TO ACCRUAL Arm B: HCT plus MSC, 300 cGy of TBI",
                              "Arm C: Re-Transplant with 300 cGy of TBI",
                              "Arm D: HCT with 200 cGy BID of TBI",
                              "Arm E: HCT plus MSC, 200 cGy BID of TBI",
                              "Arm F: HCT Alone, 200 cGy BID of TBI",
                              "Arm G: HCT plus MSC, 200 cGy",
                              "CLOSED TO ACCRUAL Arm A: HCT with 300 cGy of TBI",
                              "CLOSED TO ACCRUAL Arm B: HCT plus MSC, 300 cGy of TBI",
                              "Arm C: Re-Transplant with 300 cGy of TBI",
                              "Arm D: HCT with 200 cGy BID of TBI",
                              "Arm E: HCT plus MSC, 200 cGy BID of TBI",
                              "Arm F: HCT Alone, 200 cGy BID of TBI",
                              "Arm G: HCT plus MSC, 200 cGy",
                              "CLOSED TO ACCRUAL Arm A: HCT with 300 cGy of TBI",
                              "CLOSED TO ACCRUAL Arm B: HCT plus MSC, 300 cGy of TBI",
                              "Arm C: Re-Transplant with 300 cGy of TBI",
                              "Arm D: HCT with 200 cGy BID of TBI",
                              "Arm E: HCT plus MSC, 200 cGy BID of TBI",
                              "Arm F: HCT Alone, 200 cGy BID of TBI",
                              "Arm G: HCT plus MSC, 200 cGy",
                              "CLOSED TO ACCRUAL Arm A: HCT with 300 cGy of TBI",
                              "CLOSED TO ACCRUAL Arm B: HCT plus MSC, 300 cGy of TBI",
                              "Arm C: Re-Transplant with 300 cGy of TBI",
                              "Arm D: HCT with 200 cGy BID of TBI",
                              "Arm E: HCT plus MSC, 200 cGy BID of TBI",
                              "Arm F: HCT Alone, 200 cGy BID of TBI",
                              "Arm G: HCT plus MSC, 200 cGy",
                              "CLOSED TO ACCRUAL Arm A: HCT with 300 cGy of TBI",
                              "CLOSED TO ACCRUAL Arm B: HCT plus MSC, 300 cGy of TBI",
                              "Arm C: Re-Transplant with 300 cGy of TBI",
                              "Arm F: HCT Alone, 200 cGy BID of TBI",
                              "Arm G: HCT plus MSC, 200 cGy",
                              "CLOSED TO ACCRUAL Arm A: HCT with 300 cGy of TBI",
                              "CLOSED TO ACCRUAL Arm B: HCT plus MSC, 300 cGy of TBI",
                              "Arm C: Re-Transplant with 300 cGy of TBI",
                              "Arm D: HCT with 200 cGy BID of TBI",
                              "Arm E: HCT plus MSC, 200 cGy BID of TBI",
                              "Arm F: HCT Alone, 200 cGy BID of TBI",
                              "Arm G: HCT plus MSC, 200 cGy",
                              "CLOSED TO ACCRUAL Arm A: HCT with 300 cGy of TBI",
                              "CLOSED TO ACCRUAL Arm B: HCT plus MSC, 300 cGy of TBI",
                              "Arm C: Re-Transplant with 300 cGy of TBI",
                              "Arm E: HCT plus MSC, 200 cGy BID of TBI",
                              "Arm G: HCT plus MSC, 200 cGy",
                              "CLOSED TO ACCRUAL Arm B: HCT plus MSC, 300 cGy of TBI",
                              "Arm F: HCT Alone, 200 cGy BID of TBI",
                              "Arm G: HCT plus MSC, 200 cGy"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "ANeo",
                              "All",
                              "Infl",
                              "AnEm",
                              "NeuroAg",
                              "Gast",
                              "ARhu"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Antineoplastic Agents",
                              "All Drugs and Chemicals",
                              "Anti-Inflammatory Agents",
                              "Antiemetics",
                              "Neuroprotective Agents",
                              "Gastrointestinal Agents",
                              "Antirheumatic Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Bolus",
                              "Under",
                              "Men",
                              "Tablet",
                              "Under",
                              "Continuous",
                              "Stenosis",
                              "Indicated",
                              "Under"
                        ],
                        "InterventionBrowseLeafId": [
                              "M11280",
                              "M13272",
                              "M1833",
                              "M10901",
                              "M10902",
                              "M229437",
                              "M211896",
                              "M248768",
                              "M283219",
                              "M4488",
                              "M5879",
                              "M225481",
                              "M18102",
                              "M255749",
                              "M3431",
                              "M16963",
                              "M16637",
                              "M9364",
                              "M9353",
                              "M19757",
                              "M20095",
                              "M2972",
                              "M3433",
                              "M3466",
                              "M3366",
                              "M29605",
                              "M3374",
                              "M3376",
                              "M3463"
                        ],
                        "InterventionBrowseLeafName": [
                              "Mycophenolic Acid",
                              "Prednisolone",
                              "Methylprednisolone Acetate",
                              "Methylprednisolone",
                              "Methylprednisolone Hemisuccinate",
                              "Prednisolone acetate",
                              "Prednisolone hemisuccinate",
                              "Prednisolone phosphate",
                              "Fludarabine",
                              "Busulfan",
                              "Cyclophosphamide",
                              "Fludarabine phosphate",
                              "Tacrolimus",
                              "Thymoglobulin",
                              "Antilymphocyte Serum",
                              "Mesna",
                              "Vidarabine",
                              "Immunosuppressive Agents",
                              "Immunologic Factors",
                              "Antirheumatic Agents",
                              "Antineoplastic Agents, Alkylating",
                              "Alkylating Agents",
                              "Antimetabolites",
                              "Antiviral Agents",
                              "Anti-Infective Agents",
                              "Calcineurin Inhibitors",
                              "Anti-Bacterial Agents",
                              "Antibiotics, Antitubercular",
                              "Antitubercular Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "high",
                              "high",
                              "high",
                              "high",
                              "high",
                              "high",
                              "high",
                              "low",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "0.5 mg/kg IV over 6 hours on day -9 and 2 mg/kg IV over 4 hours on day -8 and day -7 with premeds and solumedrol through day -2",
                              "14.5 mg/kg IV over 1 hour day -6 and -5 50 mg/kg IV over 2 hours with mesna 40 mg/kg IV day +2 and +3",
                              "30 mg/m2 IV over 60 minutes days -6 through day -2",
                              "See arm description for dosing.",
                              "Bone marrow infusion on Day 0",
                              "Day +5 through day +100 with goals of 5-10 ug/L (not used for HLA-identical related donors)",
                              "15 mg/kg IV q8h (based upon actual body weight) with the maximum total daily dose not to exceed 3 grams. Day +5 through day 35",
                              "Day 60, 100 and 180 (collected during donor BM harvest for graft)",
                              "busulfan IV over 3 hours on days -3 and -2 for HLA-mismatched BM recipients only (Arms F and G)"
                        ],
                        "InterventionMeshId": [
                              "D000014740",
                              "D000009173",
                              "D000003520",
                              "D000002066",
                              "C000024352",
                              "C000042382",
                              "D000016559",
                              "C000512542",
                              "D000000961"
                        ],
                        "InterventionMeshTerm": [
                              "Vidarabine",
                              "Mycophenolic Acid",
                              "Cyclophosphamide",
                              "Busulfan",
                              "Fludarabine",
                              "Fludarabine phosphate",
                              "Tacrolimus",
                              "Thymoglobulin",
                              "Antilymphocyte Serum"
                        ],
                        "InterventionName": [
                              "Thymoglobulin",
                              "Cyclophosphamide",
                              "Fludarabine",
                              "Total Body Irradiation",
                              "Bone marrow infusion",
                              "Tacrolimus",
                              "Mycophenolate Mofetil",
                              "Donor mesenchymal stem cell infusions",
                              "Busulfan"
                        ],
                        "InterventionOtherName": [
                              "ATG",
                              "anti-thymocyte globulin",
                              "Cytoxan",
                              "fludarabine phosphate",
                              "Fludara",
                              "TBI",
                              "HCT",
                              "Prograf",
                              "MMF"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Drug",
                              "Radiation",
                              "Procedure",
                              "Drug",
                              "Drug",
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02582775"
                        ]
                  },
                  {
                        "Rank": 326,
                        "InterventionArmGroupLabel": [
                              "100M of OSSM-001",
                              "300M of OSSM-001",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Single injection of OSSM-001 at dose of 100M or 300M cells",
                              "Single injection of placebo (saline)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "OSSM-001",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05407766"
                        ]
                  },
                  {
                        "Rank": 327,
                        "InterventionArmGroupLabel": [
                              "Low Dose Group",
                              "High Dose Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M9336",
                              "M3377"
                        ],
                        "InterventionBrowseLeafName": [
                              "Immunoglobulins",
                              "Antibodies"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Single intra-arterial infusion of 1 x 10^5 cells/kg",
                              "Single intra-arterial infusion of 5 x 10^5 cells/kg infused over 5 minutes"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Low dose adipose tissue derived mesenchymal stromal cells (A-MSC)",
                              "High dose adipose tissue derived mesenchymal stromal cells (A-MSC)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05456243"
                        ]
                  },
                  {
                        "Rank": 328,
                        "InterventionArmGroupLabel": [
                              "MSC and PRP"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "MSC are collected from autologous bone marrow mononuclear cells (BMNC) and allogeneic umbilical cord tissue (UC-MSC) under sterile conditions and combined with activated platelet-rich plasma (PRP) to treat this disease."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MSC and PRP"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03484741"
                        ]
                  },
                  {
                        "Rank": 329,
                        "InterventionArmGroupLabel": [
                              "RECLAIM"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Treating cartilage defects with autologous (your own) cartilage cells mixed with allogeneic (from someone else) adipose-derived mesenchymal stem cells (AMSCs)."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "REcycled CartiLage Auto/Allo IMplantation"
                        ],
                        "InterventionOtherName": [
                              "RECLAIM"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03672825"
                        ]
                  },
                  {
                        "Rank": 330,
                        "InterventionArmGroupLabel": [
                              "AD-MSCs plus Calcipotriol ointment group",
                              "AD-MSCs plus Calcipotriol ointment group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Derm",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Dermatologic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Amputation"
                        ],
                        "InterventionBrowseLeafId": [
                              "M347448",
                              "M6226"
                        ],
                        "InterventionBrowseLeafName": [
                              "Calcipotriene",
                              "Dermatologic Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low"
                        ],
                        "InterventionDescription": [
                              "The topical treatment in the study was calcipotriol ointment(Dovonex;LEO Laboratories Ltd, Ireland) twice daily for 12 weeks.",
                              "AD-MSCs(adipose-derived multipotent mesenchymal stem cells) were infused intravenously at a dose of 2 million cells/kg."
                        ],
                        "InterventionMeshId": [
                              "C000055085"
                        ],
                        "InterventionMeshTerm": [
                              "Calcipotriene"
                        ],
                        "InterventionName": [
                              "Calcipotriol ointment",
                              "adipose-derived multipotent mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [
                              "AD-MSCs"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03392311"
                        ]
                  },
                  {
                        "Rank": 331,
                        "InterventionArmGroupLabel": [
                              "hUC-MSCs+Injectable collagen scaffold+CABG",
                              "hUC-MSCs+CABG",
                              "CABG"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Patients underwent Coronary Artery Bypass Surgery (CABG) with 10^8 allogeneic human umbilical cord mesenchymal stem cells (hUC-MSCs) in collagen scaffold injecting in the infarct region.",
                              "Patients underwent Coronary Artery Bypass Surgery (CABG) with 10^8 allogeneic human umbilical cord mesenchymal stem cells (hUC-MSCs) injecting in the infarct region.",
                              "Patients underwent CABG alone."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "hUC-MSCs+Injectable collagen scaffold+CABG",
                              "hUC-MSCs+CABG",
                              "CABG"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02635464"
                        ]
                  },
                  {
                        "Rank": 332,
                        "InterventionArmGroupLabel": [
                              "Placebo, then Umbilical Cord-Derived Mesenchymal Stem Cell (group B)",
                              "Umbilical Cord-Derived Mesenchymal Stem Cell, then Placebo (group A)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All",
                              "Infe"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals",
                              "Anti-Infective Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M8941",
                              "M3374",
                              "M3376"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hormones",
                              "Anti-Bacterial Agents",
                              "Antibiotics, Antitubercular"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Patients will receive two administrations at a dose of 1.5 million cells/kg patient bodyweight via the IV route with a 3-month intervening interval. A validated umbilical cord blood mesenchymal stem cells (UC-MSC) line was selected from the Vinmec Tissue Bank and cultured under xeno-free, serum-free and antibiotic-free conditions as previously described. To prepare UC-MSCs for therapy, aliquots of Passage 3 (P3) UC-MSCs will be thawed and cultured to P5 to get approximately 500 million cells and dispensed to 10 million UC-MSCs/ml/vial for cryopreservation. Upon request from the clinical team, aliquots of P5 UC-MSCs will be thawed in a temperature control water bath or incubator on the infusion day. The UC-MSCs will be washed and suspended in Ringer Lactate."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical Cord-Derived Mesenchymal Stem Cell for Male Patients with Sexual Deficiency"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05345418"
                        ]
                  },
                  {
                        "Rank": 333,
                        "InterventionArmGroupLabel": [
                              "ABDM-MSC"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "10-20 x 10^6 cells/20mL"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ABMD-MSC"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01686139"
                        ]
                  },
                  {
                        "Rank": 334,
                        "InterventionArmGroupLabel": [
                              "Cohort 1",
                              "Cohort 2",
                              "Cohort 3"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Hypo",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Hypoglycemic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M10819"
                        ],
                        "InterventionBrowseLeafName": [
                              "Metformin"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Single intravenous infusion of MPCs Dose 1",
                              "Single intravenous infusion of MPCs Dose 2",
                              "Single intravenous infusion of MPCs Dose 3"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Precursor Cells (MPCs)",
                              "Mesenchymal Precursor Cells (MPCs)",
                              "Mesenchymal Precursor Cells (MPCs)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01576328"
                        ]
                  },
                  {
                        "Rank": 335,
                        "InterventionArmGroupLabel": [
                              "0.5 M PLX-PAD",
                              "1 M PLX-PAD",
                              "2 M PLX-PAD"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "intravenous administration of a single dose of PLX-PAD cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "PLX-PAD"
                        ],
                        "InterventionOtherName": [
                              "allogeneic Mesenchymal-like Adherent Stromal Cells (ASCs)"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01795950"
                        ]
                  },
                  {
                        "Rank": 336,
                        "InterventionArmGroupLabel": [
                              "Prochymal\u00ae - 2 Million cells/kg",
                              "Prochymal\u00ae - 8 Million cells/kg",
                              "Prochymal\u00ae - 2 Million cells/kg",
                              "Prochymal\u00ae - 8 Million cells/kg",
                              "Prochymal\u00ae - 2 Million cells/kg",
                              "Prochymal\u00ae - 8 Million cells/kg",
                              "Prochymal\u00ae - 2 Million cells/kg",
                              "Prochymal\u00ae - 8 Million cells/kg",
                              "Prochymal\u00ae - 2 Million cells/kg",
                              "Prochymal\u00ae - 8 Million cells/kg",
                              "Prochymal\u00ae - 2 Million cells/kg",
                              "Prochymal\u00ae - 8 Million cells/kg"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "ARhu",
                              "Derm",
                              "All",
                              "ANeo",
                              "Infl",
                              "AnEm",
                              "NeuroAg",
                              "Gast"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Antirheumatic Agents",
                              "Dermatologic Agents",
                              "All Drugs and Chemicals",
                              "Antineoplastic Agents",
                              "Anti-Inflammatory Agents",
                              "Antiemetics",
                              "Neuroprotective Agents",
                              "Gastrointestinal Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Term",
                              "Term",
                              "Bolus",
                              "Hand",
                              "Continuous",
                              "Saline",
                              "Rimegepant"
                        ],
                        "InterventionBrowseLeafId": [
                              "M18113",
                              "M5882",
                              "M11280",
                              "M13272",
                              "M1833",
                              "M10901",
                              "M10902",
                              "M229437",
                              "M211896",
                              "M248768",
                              "M18102",
                              "M13273",
                              "M186752",
                              "M3369",
                              "M8199",
                              "M8941",
                              "M8940",
                              "M20119",
                              "M9364",
                              "M9353",
                              "M29605",
                              "M3406",
                              "M5404",
                              "M10948",
                              "M3366",
                              "M6226",
                              "M19757",
                              "M3374",
                              "M3376",
                              "M3463",
                              "M3403",
                              "M8033",
                              "M19926",
                              "M21022",
                              "M3466"
                        ],
                        "InterventionBrowseLeafName": [
                              "Cyclosporine",
                              "Cyclosporins",
                              "Mycophenolic Acid",
                              "Prednisolone",
                              "Methylprednisolone Acetate",
                              "Methylprednisolone",
                              "Methylprednisolone Hemisuccinate",
                              "Prednisolone acetate",
                              "Prednisolone hemisuccinate",
                              "Prednisolone phosphate",
                              "Tacrolimus",
                              "Prednisone",
                              "Remestemcel-l",
                              "Anti-Inflammatory Agents",
                              "Glucocorticoids",
                              "Hormones",
                              "Hormone Antagonists",
                              "Antineoplastic Agents, Hormonal",
                              "Immunosuppressive Agents",
                              "Immunologic Factors",
                              "Calcineurin Inhibitors",
                              "Antifungal Agents",
                              "Clotrimazole",
                              "Miconazole",
                              "Anti-Infective Agents",
                              "Dermatologic Agents",
                              "Antirheumatic Agents",
                              "Anti-Bacterial Agents",
                              "Antibiotics, Antitubercular",
                              "Antitubercular Agents",
                              "Antiemetics",
                              "Gastrointestinal Agents",
                              "Neuroprotective Agents",
                              "Protective Agents",
                              "Antiviral Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "high",
                              "high",
                              "low",
                              "low",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "high",
                              "high",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "2 million hMSCs/kg actual body weight, IV on study Days 1 and 4",
                              "8 million hMSCs/kg actual body weight IV on study Days 1 and 4",
                              "Methylprednisolone 2 mg/kg administered intravenously.",
                              "Prednisone 2.5 mg/kg administered orally.",
                              "Administered as prescribed by the caregiver.",
                              "Administered as prescribed by the caregiver.",
                              "Administered as prescribed by the caregiver."
                        ],
                        "InterventionMeshId": [
                              "D000016572",
                              "D000009173",
                              "C000711674",
                              "D000011241",
                              "D000008775",
                              "D000016559",
                              "D000003524"
                        ],
                        "InterventionMeshTerm": [
                              "Cyclosporine",
                              "Mycophenolic Acid",
                              "Remestemcel-l",
                              "Prednisone",
                              "Methylprednisolone",
                              "Tacrolimus",
                              "Cyclosporins"
                        ],
                        "InterventionName": [
                              "Prochymal\u00ae - 2 Million cells/kg",
                              "Prochymal\u00ae- 8 Million cells/kg",
                              "Methylprednisolone",
                              "Prednisone",
                              "Cyclosporine",
                              "Tacrolimus",
                              "Mycophenolate Mofetil"
                        ],
                        "InterventionOtherName": [
                              "Remestemcel-L",
                              "ex-vivo cultured adult human mesenchymal stem cells",
                              "hMSCs",
                              "Remestemcel-L",
                              "ex-vivo cultured adult human mesenchymal stem cells",
                              "hMSCs"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Drug",
                              "Drug",
                              "Drug",
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT00136903"
                        ]
                  },
                  {
                        "Rank": 337,
                        "InterventionArmGroupLabel": [
                              "MSC Treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "infusion of allogeneic bone marrow-derived human mesenchymal stem (stromal) cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MSC"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04377334"
                        ]
                  },
                  {
                        "Rank": 338,
                        "InterventionArmGroupLabel": [
                              "Arm I (hMSCs IV)",
                              "Arm II (hMSCs transendocardially)",
                              "Arm III (standard of care)",
                              "Arm I (hMSCs IV)",
                              "Arm II (hMSCs transendocardially)",
                              "Arm III (standard of care)",
                              "Arm I (hMSCs IV)",
                              "Arm II (hMSCs transendocardially)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Given standard of care",
                              "Correlative studies",
                              "Given IV",
                              "Given transendocardially"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Best Practice",
                              "Laboratory Biomarker Analysis",
                              "Mesenchymal Stem Cell Transplantation",
                              "Mesenchymal Stem Cell Transplantation"
                        ],
                        "InterventionOtherName": [
                              "standard of care",
                              "standard therapy"
                        ],
                        "InterventionType": [
                              "Other",
                              "Other",
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02962661"
                        ]
                  },
                  {
                        "Rank": 339,
                        "InterventionArmGroupLabel": [
                              "ALLO-ASC-DFU",
                              "Standard therapy"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Application of ALLO-ASC-DFU sheet to diabetic foot ulcer",
                              "Standard therapy conducted for patients with diabetic foot ulcer"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ALLO-ASC-DFU",
                              "Standard therapy"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02619877"
                        ]
                  },
                  {
                        "Rank": 340,
                        "InterventionArmGroupLabel": [
                              "ALLO-ASC-DFU",
                              "Conventional Therapy"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Dressing for Second Deep degree Burn injury",
                              "Typical therapy conducted for burn injury patients"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ALLO-ASC-DFU",
                              "Conventional Therapy"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Device"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02619851"
                        ]
                  },
                  {
                        "Rank": 341,
                        "InterventionArmGroupLabel": [
                              "FAB117-HC (Ph 1)",
                              "Control group (Ph 2)",
                              "FAB117-HC (Ph 2)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M9070"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hydrogen Peroxide"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "(Ph 1) Intramedullary administration. Open label dose escalation, 3 patients in cohort 1 (20 million cells) and 5 patients in cohort 2 (40 million cells)",
                              "(Ph 2) No treatment will be administered",
                              "(Ph 2) Intramedullary administration of the maximum tolerated dose (20 or 40 million cells)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "FAB117-HC",
                              "Control group",
                              "FAB117-HC"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Other",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02917291"
                        ]
                  },
                  {
                        "Rank": 342,
                        "InterventionArmGroupLabel": [
                              "MSCs group",
                              "Control group",
                              "Control group",
                              "MSCs group",
                              "Control group",
                              "MSCs group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "ANeo",
                              "All",
                              "Infl"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Antineoplastic Agents",
                              "All Drugs and Chemicals",
                              "Anti-Inflammatory Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Metoclopramide",
                              "Continuous",
                              "Tislelizumab"
                        ],
                        "InterventionBrowseLeafId": [
                              "M11280",
                              "M9336",
                              "M3377",
                              "M18102",
                              "M13273",
                              "M9364",
                              "M3431",
                              "M1830",
                              "M9353",
                              "M29605",
                              "M3374",
                              "M3376",
                              "M3463",
                              "M3366"
                        ],
                        "InterventionBrowseLeafName": [
                              "Mycophenolic Acid",
                              "Immunoglobulins",
                              "Antibodies",
                              "Tacrolimus",
                              "Prednisone",
                              "Immunosuppressive Agents",
                              "Antilymphocyte Serum",
                              "Basiliximab",
                              "Immunologic Factors",
                              "Calcineurin Inhibitors",
                              "Anti-Bacterial Agents",
                              "Antibiotics, Antitubercular",
                              "Antitubercular Agents",
                              "Anti-Infective Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "high",
                              "low",
                              "low",
                              "low",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "BM-MSCs is harvested from third-party health volunteer donors.",
                              "Saline as placebo of MSCs",
                              "ATG, antithymocyte globulin; Basiliximab, anti-CD25 mAb. Recipients receive ATG or Basiliximab as induction therapy in both MSCs group and control group.",
                              "Maintenance immunosuppressive therapy consists of low-dose tacrolimus and mycophenolic acid and steroids. Recipients receive the same maintenance therapy in both MSCs group and control group."
                        ],
                        "InterventionMeshId": [
                              "D000009173",
                              "D000016559",
                              "D000077552"
                        ],
                        "InterventionMeshTerm": [
                              "Mycophenolic Acid",
                              "Tacrolimus",
                              "Basiliximab"
                        ],
                        "InterventionName": [
                              "bone marrow-derived mesenchymal stem cells",
                              "Saline",
                              "Induction therapy (ATG or Basiliximab)",
                              "Maintenance therapy (Low-dose CNI + MPA + steroids)"
                        ],
                        "InterventionOtherName": [
                              "BM-MSCs",
                              "ATG or Basiliximab",
                              "Low-dose tacrolimus + Mycophenolic acid (MPA) + steroids"
                        ],
                        "InterventionType": [
                              "Other",
                              "Other",
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02561767"
                        ]
                  },
                  {
                        "Rank": 343,
                        "InterventionArmGroupLabel": [
                              "Conventional plus BM-MSC treatment",
                              "Conventional plus UC-MSC treatment",
                              "Conventional treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "All",
                              "Hemat",
                              "Lipd",
                              "Ot"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "All Drugs and Chemicals",
                              "Hematinics",
                              "Lipid Regulating Agents",
                              "Other Dietary Supplements"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Cytotoxic T-Lymphocyte-Associated Antigen-4"
                        ],
                        "InterventionBrowseLeafId": [
                              "M3466",
                              "M10262",
                              "M230376",
                              "M20396",
                              "M34170",
                              "M219479",
                              "M341471",
                              "M3366",
                              "T404"
                        ],
                        "InterventionBrowseLeafName": [
                              "Antiviral Agents",
                              "Liver Extracts",
                              "Entecavir",
                              "Lamivudine",
                              "Polyene phosphatidylcholine",
                              "Adefovir",
                              "Adefovir dipivoxil",
                              "Anti-Infective Agents",
                              "Lecithin"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Received conventional treatment and bone marrow mesenchymal stem cells transplantation by peripheral vein slowly for 30minutes. (1\u00d710e5/Kg,1\u00d710e6/Kg,or 1\u00d710e7/Kg, once a week, 8 times).",
                              "Received conventional treatment and bone marrow mesenchymal stem cells transplantation by peripheral vein slowly for 30minutes. (1\u00d710e5/Kg,1\u00d710e6/Kg,or 1\u00d710e7/Kg, once a week, 8 times)",
                              "Received conventional treatment including:\n\nA.antiviral drugs(Entecavir,Lamivudine,Adefovir dipivoxil,et al); B.Hepatoprotective drugs(Ademetionine1,4-butanethiosulfonate for Injection, Reduced Glutathione for Injection,Polyene Phosphatidylcholine, et al); C.Plasma."
                        ],
                        "InterventionMeshId": [
                              "D000000998"
                        ],
                        "InterventionMeshTerm": [
                              "Antiviral Agents"
                        ],
                        "InterventionName": [
                              "Conventional plus BM-MSC treatment",
                              "Conventional plus UC-MSC treatment",
                              "Conventional treatment"
                        ],
                        "InterventionOtherName": [
                              "Antiviral drugs",
                              "Hepatoprotective drugs",
                              "Plasma"
                        ],
                        "InterventionType": [
                              "Genetic",
                              "Genetic",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01844063"
                        ]
                  },
                  {
                        "Rank": 344,
                        "InterventionArmGroupLabel": [
                              "Neural progenitor cell",
                              "Paracrine factors",
                              "Progenitor cell and paracrine factors"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Neural progenitor cells are derived from the same aborted human fetal forebrain.",
                              "The factors obtained from cultured human mesenchymal stem cells were concentrated 50 times",
                              "Neural progenitor cells will be received after paracrine factors therapy"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "neural progenitor cell",
                              "Paracrine factors",
                              "progenitor cell and paracrine factors"
                        ],
                        "InterventionOtherName": [
                              "paracrine factor of human mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02854579"
                        ]
                  },
                  {
                        "Rank": 345,
                        "InterventionArmGroupLabel": [
                              "MSCs + ECP",
                              "MSCs + ECP"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Treatment dose 2 x10^6 cells/kg (+/- 20%)",
                              "Blood is collected through an intravenous (IV) line which is connected to an apheresis machine.The machine adds a chemical that makes the white blood cells sensitive to light. Then the machine shines a light on the cells and then returns the blood to the participant"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic mesenchymal stromal cells (MSCs)",
                              "Extracorporeal photopheresis (ECP)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05333029"
                        ]
                  },
                  {
                        "Rank": 346,
                        "InterventionArmGroupLabel": [
                              "Transplant in Epidermolysis Bullosa",
                              "Transplant in Epidermolysis Bullosa",
                              "Transplant in Epidermolysis Bullosa",
                              "Transplant in Epidermolysis Bullosa",
                              "Transplant in Epidermolysis Bullosa",
                              "Transplant in Epidermolysis Bullosa",
                              "Transplant in Epidermolysis Bullosa",
                              "Transplant in Epidermolysis Bullosa"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "ARhu",
                              "Derm",
                              "All",
                              "ANeo",
                              "CNSDep",
                              "Ot"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Antirheumatic Agents",
                              "Dermatologic Agents",
                              "All Drugs and Chemicals",
                              "Antineoplastic Agents",
                              "Central Nervous System Depressants",
                              "Other Dietary Supplements"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Term",
                              "Term",
                              "Bolus",
                              "Under",
                              "Tablet",
                              "Indicated"
                        ],
                        "InterventionBrowseLeafId": [
                              "M18113",
                              "M5882",
                              "M11280",
                              "M283219",
                              "M5879",
                              "M4006",
                              "M225481",
                              "M3431",
                              "M9364",
                              "M9353",
                              "M19757",
                              "M20095",
                              "M2972",
                              "M3406",
                              "M5404",
                              "M10948",
                              "M3366",
                              "M6226",
                              "M29605",
                              "M3374",
                              "M3376",
                              "M3463",
                              "T433"
                        ],
                        "InterventionBrowseLeafName": [
                              "Cyclosporine",
                              "Cyclosporins",
                              "Mycophenolic Acid",
                              "Fludarabine",
                              "Cyclophosphamide",
                              "Benzocaine",
                              "Fludarabine phosphate",
                              "Antilymphocyte Serum",
                              "Immunosuppressive Agents",
                              "Immunologic Factors",
                              "Antirheumatic Agents",
                              "Antineoplastic Agents, Alkylating",
                              "Alkylating Agents",
                              "Antifungal Agents",
                              "Clotrimazole",
                              "Miconazole",
                              "Anti-Infective Agents",
                              "Dermatologic Agents",
                              "Calcineurin Inhibitors",
                              "Anti-Bacterial Agents",
                              "Antibiotics, Antitubercular",
                              "Antitubercular Agents",
                              "Tannic Acid"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "high",
                              "high",
                              "high",
                              "high",
                              "low",
                              "low",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Cyclophosphamide 50 mg/kg/day IV over 2 hours x 1 day, total dose 50 mg/kg will be administered on Day -6.",
                              "40 mg/m^2/day intravenously on Days -6, -5, -4, -3 and -2.",
                              "30 mg/kg on Days -4, -3 and -2.",
                              "Days -3 to 100+ to maintain a level of >200 ng/ml; initial dose 2.5 mg/kg over 2 hours every 8-12 hours for children.",
                              "15 mg/kg intravenous twice per day on days -3 through 30.",
                              "infused via intravenous drip on Day 0",
                              "300 cGY on Day -1 administered in a single fraction at a dose rate of 10-19 cGy/minute prescribed to the midplane of the patient at the level of the umbilicus.",
                              "Bone marrow or UCB products will be infused as soon as the product arrives and within 30 minutes. The product is infused via IV drip."
                        ],
                        "InterventionMeshId": [
                              "D000016572",
                              "D000009173",
                              "D000003520",
                              "C000024352",
                              "D000003524",
                              "D000000961"
                        ],
                        "InterventionMeshTerm": [
                              "Cyclosporine",
                              "Mycophenolic Acid",
                              "Cyclophosphamide",
                              "Fludarabine",
                              "Cyclosporins",
                              "Antilymphocyte Serum"
                        ],
                        "InterventionName": [
                              "Cyclophosphamide",
                              "Fludarabine",
                              "Anti-thymocyte globulin",
                              "Cyclosporine A",
                              "Mycophenolate mofetil",
                              "Mesenchymal stem cell transplantation",
                              "Total body irradiation",
                              "Bone marrow or umbilical cord blood (UCG) stem cell transplantation"
                        ],
                        "InterventionOtherName": [
                              "Cytoxan",
                              "Fludara",
                              "ATG",
                              "CSA",
                              "CellCept(R)",
                              "MSCT",
                              "UCBSCT"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug",
                              "Drug",
                              "Drug",
                              "Drug",
                              "Procedure",
                              "Radiation",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT01033552"
                        ]
                  },
                  {
                        "Rank": 347,
                        "InterventionArmGroupLabel": [
                              "Stratum A",
                              "Stratum B"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Both cohorts will receive multiple infusions of ex-vivo expanded MSCs. Stratum A may use previously harvested and cryopreserved bone marrow mononuclear cells from original BMT donor or freshly harvested or cryopreserved bone marrow mononuclear cells obtained from a haploidentical healthy parent or sibling. Stratum B will only receive freshly harvested or cryopreserved bone marrow"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stromal Cells"
                        ],
                        "InterventionOtherName": [
                              "ex-vivo expanded MSCs"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01061099"
                        ]
                  },
                  {
                        "Rank": 348,
                        "InterventionArmGroupLabel": [
                              "ucMSC",
                              "Controls"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "1 million mesenchymal cells per Kg weight injected intravenously in allogenic AB plasma",
                              "Autologous Serum will administrated as placebo"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ucMSC",
                              "Controls"
                        ],
                        "InterventionOtherName": [
                              "Umbilical Cord Mesenchymal Stem Cells"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01739777"
                        ]
                  },
                  {
                        "Rank": 349,
                        "InterventionArmGroupLabel": [
                              "immune escape mecanims",
                              "immune escape mecanims"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "20 ml at inclusion, and 20ml at 1, 3, 6 and 12 months after allo HSCT",
                              "3 ml at inclusion, and 3 ml at 1, 3, 6 and 12 months after allo HSCT"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "blood sample",
                              "bone marrow sample"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03964922"
                        ]
                  },
                  {
                        "Rank": 350,
                        "InterventionArmGroupLabel": [
                              "MPCs-derived exosomes Dosage 1",
                              "MPCs-derived exosomes Dosage 2",
                              "No exosomes"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "7 times aerosol inhalation of MPCs-derived exosomes (8.0*108 nano vesicles/3 ml at Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7).",
                              "7 times aerosol inhalation of MPCs-derived exosomes (16.0*108 nano vesicles/3 ml at Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7).",
                              "No aerosol inhalation of MPCs-derived exosomes"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Dosage 1 of MPCs-derived exosomes",
                              "Dosage 2 of MPCs-derived exosomes",
                              "No MPCs-derived exosomes"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04544215"
                        ]
                  },
                  {
                        "Rank": 351,
                        "InterventionArmGroupLabel": [
                              "MSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MSCs"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02083731"
                        ]
                  },
                  {
                        "Rank": 352,
                        "InterventionArmGroupLabel": [
                              "Stem cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Ex vivo cultured adult bone marrow derived allogeneic mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Stempeucel(R)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03056742"
                        ]
                  },
                  {
                        "Rank": 353,
                        "InterventionArmGroupLabel": [
                              "Stem cell therapy"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Culture expanded allogeneic adipose derive stem cells (CSCC_ASC)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic adipose derived stem cells (CSCC_ASC)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02387723"
                        ]
                  },
                  {
                        "Rank": 354,
                        "InterventionArmGroupLabel": [
                              "UMSC01"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "FiAg",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Fibrinolytic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M13001"
                        ],
                        "InterventionBrowseLeafName": [
                              "Tissue Plasminogen Activator"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "There will be one dose of IV administration in patients with acute ischemic stroke, or one dose of IV administration followed by low or high doses of IA infusion for acute ischemic stroke with or without bridging therapy (i.e. Intravenous rt-PA thrombolysis or intraarterial thrombectomy) with 12 months of follow up after the first treatment."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "UMSC01"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04434768"
                        ]
                  },
                  {
                        "Rank": 355,
                        "InterventionArmGroupLabel": [
                              "BM-MNC and UC-MSC",
                              "Stand medicines"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Autologous bone marrow mononuclear cells (BM-MNCs) and allogeneic umbilical cord tissue-derived mesenchymal stem cells (UC-MSCs) under sterile conditions to treat this disease.\n\nUC-MSC: 1-2 x 10^6 cells/kg",
                              "Standard medicine"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "BM-MNC and UC-MSC",
                              "Control"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03943940"
                        ]
                  },
                  {
                        "Rank": 356,
                        "InterventionArmGroupLabel": [
                              "Mensenchymal Stem Cells",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "ANeo",
                              "All",
                              "PhSol"
                        ],
                        "InterventionBrowseBranchName": [
                              "Antineoplastic Agents",
                              "All Drugs and Chemicals",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M283219",
                              "M21013",
                              "M225481"
                        ],
                        "InterventionBrowseLeafName": [
                              "Fludarabine",
                              "Pharmaceutical Solutions",
                              "Fludarabine phosphate"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Mesenchymal stem cell injection",
                              "Isotonic solution injection"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stem cells",
                              "Isotonic solution"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01045382"
                        ]
                  },
                  {
                        "Rank": 357,
                        "InterventionArmGroupLabel": [
                              "Treated group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Coag",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Coagulants",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M203827"
                        ],
                        "InterventionBrowseLeafName": [
                              "Fibrin fragment D"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Mesenchymal Stem cells from bank will be applied IV, at dose 1 million xKg in a single dose"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Infusion IV of Mesenchymal Stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04416139"
                        ]
                  },
                  {
                        "Rank": 358,
                        "InterventionArmGroupLabel": [
                              "XSTEM-OA"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "XSTEM-OA is an allogeneic, adipose tissue-derived, integrin alpha10beta1-selected and expanded mesenchymal stem cell (MSC) product for the treatment of osteoarthritis."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "XSTEM-OA"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05344157"
                        ]
                  },
                  {
                        "Rank": 359,
                        "InterventionArmGroupLabel": [
                              "High dose cohort",
                              "Low dose cohort"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "SBI-101 is a biologic/device combination product that combines two components: allogeneic human mesenchymal stromal cells (MSCs) and an FDA-approved plasmapheresis device. SBI-101 is administered via integration into a Continuous Renal Replacement Therapy circuit and is designed to regulate inflammation and promote repair of injured tissue."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "SBI-101"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04445220"
                        ]
                  },
                  {
                        "Rank": 360,
                        "InterventionArmGroupLabel": [
                              "1",
                              "2",
                              "2",
                              "1",
                              "2",
                              "1",
                              "1",
                              "2",
                              "1",
                              "2"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "ARhu",
                              "Derm",
                              "All",
                              "ANeo"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Antirheumatic Agents",
                              "Dermatologic Agents",
                              "All Drugs and Chemicals",
                              "Antineoplastic Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Term",
                              "Term",
                              "Men",
                              "Tablet"
                        ],
                        "InterventionBrowseLeafId": [
                              "M18113",
                              "M5882",
                              "M4488",
                              "M5879",
                              "M9364",
                              "M9353",
                              "M19757",
                              "M20095",
                              "M2972",
                              "M3406",
                              "M5404",
                              "M10948",
                              "M3366",
                              "M6226",
                              "M29605"
                        ],
                        "InterventionBrowseLeafName": [
                              "Cyclosporine",
                              "Cyclosporins",
                              "Busulfan",
                              "Cyclophosphamide",
                              "Immunosuppressive Agents",
                              "Immunologic Factors",
                              "Antirheumatic Agents",
                              "Antineoplastic Agents, Alkylating",
                              "Alkylating Agents",
                              "Antifungal Agents",
                              "Clotrimazole",
                              "Miconazole",
                              "Anti-Infective Agents",
                              "Dermatologic Agents",
                              "Calcineurin Inhibitors"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "high",
                              "high",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [],
                        "InterventionMeshId": [
                              "D000016572",
                              "D000003520",
                              "D000002066",
                              "D000003524"
                        ],
                        "InterventionMeshTerm": [
                              "Cyclosporine",
                              "Cyclophosphamide",
                              "Busulfan",
                              "Cyclosporins"
                        ],
                        "InterventionName": [
                              "Bone Marrow Cell Transplantation",
                              "Irradiation, Total Body",
                              "Cyclophosphamide",
                              "Cyclosporin",
                              "Mesenchymal Stem Cell Transplantation",
                              "Busulfan"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other",
                              "Radiation",
                              "Drug",
                              "Drug",
                              "Procedure",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00705120"
                        ]
                  },
                  {
                        "Rank": 361,
                        "InterventionArmGroupLabel": [
                              "MSC+CY",
                              "MSC+CY"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "ANeo",
                              "ARhu",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Antineoplastic Agents",
                              "Antirheumatic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Tablet"
                        ],
                        "InterventionBrowseLeafId": [
                              "M5879",
                              "M9364",
                              "M9353",
                              "M19757",
                              "M20095",
                              "M2972"
                        ],
                        "InterventionBrowseLeafName": [
                              "Cyclophosphamide",
                              "Immunosuppressive Agents",
                              "Immunologic Factors",
                              "Antirheumatic Agents",
                              "Antineoplastic Agents, Alkylating",
                              "Alkylating Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Dose 50 mg/kg at day +3,+4 once daily",
                              "Dose 1 million per kg, at day of recovery once"
                        ],
                        "InterventionMeshId": [
                              "D000003520"
                        ],
                        "InterventionMeshTerm": [
                              "Cyclophosphamide"
                        ],
                        "InterventionName": [
                              "Cyclophosphamide",
                              "Mesenchymal stromal cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02270307"
                        ]
                  },
                  {
                        "Rank": 362,
                        "InterventionArmGroupLabel": [
                              "human umbilical cord-derived mesenchymal stem cell transplantation for patients with liver cirrhosis"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Hemat",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Hematinics",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M10262"
                        ],
                        "InterventionBrowseLeafName": [
                              "Liver Extracts"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Human umbilical cord-derived mesenchymal stem cell infusion in the management of adult liver cirrhosis"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Human umbilical cord-derived mesenchymal stem cell infusion"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05331872"
                        ]
                  },
                  {
                        "Rank": 363,
                        "InterventionArmGroupLabel": [
                              "Intra-nasal infusion of MTF"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Trophic factors from umbilical cord mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02192736"
                        ]
                  },
                  {
                        "Rank": 364,
                        "InterventionArmGroupLabel": [
                              "hUC-MSC Transplantation"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Four times of intrathecal administrations of hUC-MSCs"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "human umbilical cord mesenchymal stem cells (hUC-MSCs)"
                        ],
                        "InterventionOtherName": [
                              "umbilical cord mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT02481440"
                        ]
                  },
                  {
                        "Rank": 365,
                        "InterventionArmGroupLabel": [
                              "Umbilical cord mesenchymal stem cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical cord mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02034188"
                        ]
                  },
                  {
                        "Rank": 366,
                        "InterventionArmGroupLabel": [
                              "COVI-MSC",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "COVI-MSC are allogeneic culture-expanded adipose-derived mesenchymal stem cells",
                              "Excipient solution"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "COVI-MSC",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04903327"
                        ]
                  },
                  {
                        "Rank": 367,
                        "InterventionArmGroupLabel": [
                              "Intra-articular knee injection of MTF",
                              "Subcutaneous injection of MTF"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Trophic factors from umbilical cord mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02003131"
                        ]
                  },
                  {
                        "Rank": 368,
                        "InterventionArmGroupLabel": [
                              "Umbilical cord mesenchymal stem cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "ARhu",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Antirheumatic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M19757"
                        ],
                        "InterventionBrowseLeafName": [
                              "Antirheumatic Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical cord mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01985464"
                        ]
                  },
                  {
                        "Rank": 369,
                        "InterventionArmGroupLabel": [
                              "MC0518",
                              "Best Available Therapy (BAT)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "ANeo",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Antineoplastic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M11280",
                              "M255",
                              "M3431"
                        ],
                        "InterventionBrowseLeafName": [
                              "Mycophenolic Acid",
                              "Everolimus",
                              "Antilymphocyte Serum"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "MC0518 will be intravenously infused immediately after thawing.",
                              "BAT including MMF, ECP, ATG, everolimus, and RUX will be administered based on Investigator's decision."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MC0518",
                              "BAT"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04629833"
                        ]
                  },
                  {
                        "Rank": 370,
                        "InterventionArmGroupLabel": [
                              "High dose cohort",
                              "Low dose cohort",
                              "Control"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "SBI-101 is a biologic/device combination product that combines two components: allogeneic human mesenchymal stromal cells (MSCs) and an FDA-approved plasmapheresis device. SBI-101 is administered via integration into a Continuous Renal Replacement Therapy circuit and is designed to regulate inflammation and promote repair of injured tissue.",
                              "The sham control is an FDA-approved plasmapheresis device, without MSCs, which is integrated into a Continuous Renal Replacement Therapy circuit."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "SBI-101",
                              "Sham"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Device"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03015623"
                        ]
                  },
                  {
                        "Rank": 371,
                        "InterventionArmGroupLabel": [
                              "hUC-MSCs combined with glucocorticoids group.",
                              "glucocorticoids group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Diffusion"
                        ],
                        "InterventionBrowseLeafId": [
                              "M8199",
                              "M8941",
                              "M8940"
                        ],
                        "InterventionBrowseLeafName": [
                              "Glucocorticoids",
                              "Hormones",
                              "Hormone Antagonists"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Participants will be treated with hUC-MSCs at a dose of 1\u00d710^6 /kilogram (kg) actual body weight at Screening for twice per week in 1-2 weeks and once a week in 3-4 weeks after being rolled into this study. At the same time, patients will be treated with glucocorticoids according to patients' condition.",
                              "Participants were treated with glucocorticoids only."
                        ],
                        "InterventionMeshId": [
                              "D000005938"
                        ],
                        "InterventionMeshTerm": [
                              "Glucocorticoids"
                        ],
                        "InterventionName": [
                              "hUC-MSCs",
                              "glucocorticoids"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05531266"
                        ]
                  },
                  {
                        "Rank": 372,
                        "InterventionArmGroupLabel": [
                              "IV injection of UC-MSC",
                              "Intra-articular knee injection of UC-MSC"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Human umbilical cord tissue-derived mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02237846"
                        ]
                  },
                  {
                        "Rank": 373,
                        "InterventionArmGroupLabel": [
                              "Arthroscopy + Booster",
                              "Arthroscopy + Pre-Conditioning",
                              "Non Arthroscopy + Booster",
                              "Non Arthroscopy + Pre-Conditioning"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "After Arthroscopy intervention, patient recieve 10 million Allogeneic Umbilical Cord Mesenchymal Stem Cells in 2 cc NaCl, two weeks afterward, patient receive 2 cc Secretome, and four weeks later, patient receive another 2 cc Secretome. All intervention will be done via Intra-articular.",
                              "After Arthroscopy intervention, patient recieve 2 cc Secretome, two weeks afterward patient receive 10 million Allogeneic Umbilical Cord Mesenchymal Stem Cells in 2 cc NaCl, and four weeks later, patient receive another 2 cc Secretome. All intervention will be done via Intra-articular.",
                              "Without Arthroscopy intervention, patient recieve 10 million Allogeneic Umbilical Cord Mesenchymal Stem Cells in 2 cc NaCl, two weeks afterward, patient receive 2 cc Secretome, and four weeks later, patient receive another 2 cc Secretome. All intervention will be done via Intra-articular.",
                              "Without Arthroscopy intervention, patient recieve 2 cc Secretome, two weeks afterward patient receive 10 million Allogeneic Umbilical Cord Mesenchymal Stem Cells in 2 cc NaCl, and four weeks later, patient receive another 2 cc Secretome. All intervention will be done via Intra-articular."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Arthroscopy with Mesenchymal Stem Cells + Secretome + Secretome",
                              "Arthroscopy with Secretome + Mesenchymal Stem Cells + Secretome",
                              "Non Arthroscopy with Mesenchymal Stem Cells + Secretome + Secretome",
                              "Non Arthroscopy with Secretome + Mesenchymal Stem Cells + Secretome"
                        ],
                        "InterventionOtherName": [
                              "Secretome"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04314661"
                        ]
                  },
                  {
                        "Rank": 374,
                        "InterventionArmGroupLabel": [
                              "Treatment (UC-MSC trasnplatation)",
                              "Treatment (UC-MSC trasnplatation)",
                              "control arm"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All",
                              "BDCA"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals",
                              "Bone Density Conservation Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M4533",
                              "M4550"
                        ],
                        "InterventionBrowseLeafName": [
                              "Calcium",
                              "Calcium, Dietary"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Patients assigned to UC-MSC administration groups will receive two administrations at a dose of 1.5 million cells/kg patient body weight via the IV route with a 3-month intervening interval",
                              "Hightamine (Hankook Korus Pharm, Korea), Total calcium (Nugale Pharmaceutical, Canada), Bioflex (Ausbiomed, Australia)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical Cord Mesenchymal Stem Cells transplantation",
                              "standard frailty treatment and supplementary medication"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04919135"
                        ]
                  },
                  {
                        "Rank": 375,
                        "InterventionArmGroupLabel": [
                              "PLX-PAD high dose",
                              "PLX-PAD low dose"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "IM injection"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "PLX-PAD"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00951210"
                        ]
                  },
                  {
                        "Rank": 376,
                        "InterventionArmGroupLabel": [
                              "XSTEM-VLU",
                              "Vehicle"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "XSTEM-VLU is an allogeneic, adipose tissue-derived, integrin alpha10beta1-selected and expanded mesenchymal stem cell (MSC) product for the treatment of venous leg ulcers.",
                              "CryoStor CS10 cryomedium"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "XSTEM-VLU",
                              "Vehicle"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05549609"
                        ]
                  },
                  {
                        "Rank": 377,
                        "InterventionArmGroupLabel": [
                              "Stem cell group",
                              "Placebo group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M6457"
                        ],
                        "InterventionBrowseLeafName": [
                              "Dimethyl Sulfoxide"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Each participant will be double-blindly randomized to receive either adipose-derived allogeneic stem cells or placebo consisting of CryoStor10 (BiolifeSolutions), the freeze media for ASCs containing 10% Dimethyl sulfoxide (DMSO).",
                              "Each participant will be double-blindly randomized to receive either adipose-derived allogeneic stem cells or placebo consisting of CryoStor10 (BiolifeSolutions), the freeze media for ASCs containing 10% Dimethyl sulfoxide (DMSO)."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Stem cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04776538"
                        ]
                  },
                  {
                        "Rank": 378,
                        "InterventionArmGroupLabel": [
                              "1X level",
                              "2X level",
                              "4X level",
                              "6X level",
                              "8X level"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Once aerosol inhalation of MSCs-derived exosomes (2.0*10^8 nano vesicles/3 ml)",
                              "Once aerosol inhalation of MSCs-derived exosomes (4.0*10^8 nano vesicles/3 ml)",
                              "Once aerosol inhalation of MSCs-derived exosomes (8.0*10^8 nano vesicles/3 ml)",
                              "Once aerosol inhalation of MSCs-derived exosomes (12.0*10^8 nano vesicles/3 ml)",
                              "Once aerosol inhalation of MSCs-derived exosomes (16.0*10^8 nano vesicles/3 ml)"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "1X level of MSCs-Exo",
                              "2X level of MSCs-Exo",
                              "4X level of MSCs-Exo",
                              "6X level of MSCs-Exo",
                              "8X level of MSCs-Exo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Biological",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04313647"
                        ]
                  },
                  {
                        "Rank": 379,
                        "InterventionArmGroupLabel": [
                              "Treatment Arm"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "MPCs will be injected into the patient's myocardium during planned surgical procedures."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MPC; rexlemestrocel-L"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic Mesenchymal Precursor Cell"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03079401"
                        ]
                  },
                  {
                        "Rank": 380,
                        "InterventionArmGroupLabel": [
                              "Osteoarthritic knee patients"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All",
                              "CNSDep"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals",
                              "Central Nervous System Depressants"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M9030",
                              "M3259"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hyaluronic Acid",
                              "Anesthetics"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "The arthroscopic procedure is performed in the supine position after spinal anesthesia. Once the chondral lesion is identified through a standard anteromedial and lateral portal, meniscectomy, meniscal repair, and lateral retinacular release are performed if necessary. microfracture is performed using a microfracture awl.\n\nOnce both the unstable cartilage and subchondral bone are removed in the lesion area and the sclerotic bone is peeled slightly by using a burr, hole(s) are created for implantation by using a drill bit(diameter 4; depth: 4mm). After implantation is performed in the hole by injecting the mixture of sodium hyaluronate and hUCB-MSCs, it is trimmed to the height of the surrounding articular surface."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "umbilical cord blood stem cell implantation for osteoarthritis treatment"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04234412"
                        ]
                  },
                  {
                        "Rank": 381,
                        "InterventionArmGroupLabel": [
                              "Cartistem",
                              "Microfracture treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "allogeneic-unrelated umbilical cord blood-derived mesenchymal stem cell product"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Cartistem",
                              "Microfracture treatment"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01041001"
                        ]
                  },
                  {
                        "Rank": 382,
                        "InterventionArmGroupLabel": [
                              "UC-MSCs + CM",
                              "CM + CM",
                              "UC-MSCs + CM",
                              "Triamcinolon acetonide"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infl",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Inflammatory Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Traditional",
                              "Interactive",
                              "Interactive",
                              "Interactive"
                        ],
                        "InterventionBrowseLeafId": [
                              "M16126",
                              "M16127",
                              "M237968",
                              "M209570",
                              "M3369",
                              "M8199",
                              "M8941",
                              "M8940",
                              "M9364",
                              "M9353"
                        ],
                        "InterventionBrowseLeafName": [
                              "Triamcinolone",
                              "Triamcinolone Acetonide",
                              "Triamcinolone hexacetonide",
                              "Triamcinolone diacetate",
                              "Anti-Inflammatory Agents",
                              "Glucocorticoids",
                              "Hormones",
                              "Hormone Antagonists",
                              "Immunosuppressive Agents",
                              "Immunologic Factors"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "high",
                              "high",
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Injection of Allogeneic Umbilical Cord Mesenchymal Stem Cells 2 million cell/cm3 in Nacl 1 cc/million cell and booster with Conditioned Medium 1 cc/cm3 in 3 weeks later. All treatment via intralesional injection. The maximum size of the keloid is 15 cm.",
                              "Injection of Conditioned Medium 1 cc/cm3 and booster with Conditioned Medium 1 cc/cm3 in 3 weeks later. All treatment via intralesional injection. The maximum size of the keloid is 15 cm.",
                              "Injection of Triamcinolone Acetonide 40 mg/cc/cm3 and booster in 3 weeks later. All treatment via intralesional injection. The maximum size of the keloid is 15 cm."
                        ],
                        "InterventionMeshId": [
                              "D000014221",
                              "D000014222",
                              "C000005900",
                              "C000030262"
                        ],
                        "InterventionMeshTerm": [
                              "Triamcinolone",
                              "Triamcinolone Acetonide",
                              "Triamcinolone hexacetonide",
                              "Triamcinolone diacetate"
                        ],
                        "InterventionName": [
                              "Umbilical Cord-Mesenchymal Stem Cells and Conditioned Medium",
                              "Conditioned Medium",
                              "Triamcinolone Acetonide"
                        ],
                        "InterventionOtherName": [
                              "Secretome"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04326959"
                        ]
                  },
                  {
                        "Rank": 383,
                        "InterventionArmGroupLabel": [
                              "Group A",
                              "Group B"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Umbilical cord derived mesenchymal stem cell",
                              "Normal saline"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical cord derived mesenchymal stem cell",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Cyto-MSC"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03847844"
                        ]
                  },
                  {
                        "Rank": 384,
                        "InterventionArmGroupLabel": [
                              "Open Label infusion of hCT-MSC",
                              "Randomized infusion of hCT-MSC",
                              "Randomized infusion of Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M85407"
                        ],
                        "InterventionBrowseLeafName": [
                              "Plasma-lyte 148"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Human cord tissue mesenchymal stromal cells (hCT-MSC) manufactured by Duke University or University of Miami.",
                              "Placebo will be comprised of 40-80 mL of Plasmalyte-A + 1% Human Serum Albumin (HAS) prepared in an identical container to the one used for cell administration. The placebo product will undergo the same process of sterility testing including release inspection, transport and product custodian."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Human cord tissue mesenchymal stromal cells (hCT-MSC) manufactured by Duke University.",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "hCT-MSC"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04399889"
                        ]
                  },
                  {
                        "Rank": 385,
                        "InterventionArmGroupLabel": [
                              "Allogeniec Mesenchymal Stem Cells",
                              "Autologus Mesenchymal Stem Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "These Mesenchymal stem cells are derived from bone marrow of either renal transplant patients or their donors depending upon the group of study."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [
                              "Mesenchymal Stromal Cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02409940"
                        ]
                  },
                  {
                        "Rank": 386,
                        "InterventionArmGroupLabel": [
                              "Umbilical Cord Mesenchymal Stem Cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intrathecal Transplantation of Umbilical Cord Mesenchymal Stem Cells, 1*10^6 cells/kg, once a month for 4 months"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical Cord Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [
                              "UC-MSC"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03505034"
                        ]
                  },
                  {
                        "Rank": 387,
                        "InterventionArmGroupLabel": [
                              "Human Umbilical Cord Derived MSC"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "1\u00d710^6 UC-MSCs per kg intravenous injection the number of infusions: once a week, for four weeks in a row Time interval: estimate the condition of follow-up visit afer 28 days"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Human Umbilical Cord Derived MSC"
                        ],
                        "InterventionOtherName": [
                              "UC-MSC"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01754454"
                        ]
                  },
                  {
                        "Rank": 388,
                        "InterventionArmGroupLabel": [
                              "PLX-PAD high dose",
                              "PLX-PAD intermediate dose",
                              "PLX-PAD low dose"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Single treatment; multiple injections"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "PLX-PAD IM injection"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00919958"
                        ]
                  },
                  {
                        "Rank": 389,
                        "InterventionArmGroupLabel": [
                              "Group A Treatment",
                              "Group B Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All",
                              "PhSol"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "AKT"
                        ],
                        "InterventionBrowseLeafId": [
                              "M3777",
                              "M85407",
                              "M11966",
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Autoantibodies",
                              "Plasma-lyte 148",
                              "Ophthalmic Solutions",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Patients in Group A will receive a single MSCs infusion",
                              "Patients in Group B will receive a single infusion of placebo (Plasmalyte A with 0.5% human serum albumin)"
                        ],
                        "InterventionMeshId": [
                              "C000012499"
                        ],
                        "InterventionMeshTerm": [
                              "Plasma-lyte 148"
                        ],
                        "InterventionName": [
                              "Mesenchymal Stem Cells (MSCs)",
                              "Placebo Infusion (Plasmalyte A with 0.5% human serum albumin)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04061746"
                        ]
                  },
                  {
                        "Rank": 390,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stromal cell treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "CNSDep",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Central Nervous System Depressants",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M3259",
                              "M3261"
                        ],
                        "InterventionBrowseLeafName": [
                              "Anesthetics",
                              "Anesthetics, Local"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Allogenous mesenchymal stromal cells will be injected directly underneath the mucosal lesions at one side under local anesthetic at 2.5-4 million cells/ml. A total of approximately 1.7 ml will be injected divided in 2-3 injections around the lesion. Patients will be followed every second day up to 7 days afterwards and then routinely at 14 days, 1 month, 2 months and 6 months to assess the healing process."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stromal cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02055625"
                        ]
                  },
                  {
                        "Rank": 391,
                        "InterventionArmGroupLabel": [
                              "mesenchymal stem cells",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "bone marrow-derived mesenchymal stem cells",
                              "Placebo"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "bone marrow-derived mesenchymal stem cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01849887"
                        ]
                  },
                  {
                        "Rank": 392,
                        "InterventionArmGroupLabel": [
                              "Human Umbilical Cord derived MSCs",
                              "Cyclophosphamide"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "ANeo",
                              "ARhu",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Antineoplastic Agents",
                              "Antirheumatic Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Tablet"
                        ],
                        "InterventionBrowseLeafId": [
                              "M5879",
                              "M9364",
                              "M9353",
                              "M19757",
                              "M20095",
                              "M2972"
                        ],
                        "InterventionBrowseLeafName": [
                              "Cyclophosphamide",
                              "Immunosuppressive Agents",
                              "Immunologic Factors",
                              "Antirheumatic Agents",
                              "Antineoplastic Agents, Alkylating",
                              "Alkylating Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Human Umbilical Cord derived MSCs treatment for lupus nephritis via infusion",
                              "Cyclophosphamide based immunosuppressive agent for treatment for lupus nephritis"
                        ],
                        "InterventionMeshId": [
                              "D000003520"
                        ],
                        "InterventionMeshTerm": [
                              "Cyclophosphamide"
                        ],
                        "InterventionName": [
                              "Human Umbilical Cord derived MSCs",
                              "Cyclophosphamide"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic stem cells derived from umbilical cord",
                              "Immunosupressive agent"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01539902"
                        ]
                  },
                  {
                        "Rank": 393,
                        "InterventionArmGroupLabel": [
                              "Umbilical Cord Mesenchymal Stem Cells",
                              "Control"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intrathecal Transplantation of Umbilical Cord Mesenchymal Stem Cells",
                              "Saline\uff0cSham operation"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical Cord Mesenchymal Stem Cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "UC-MSC",
                              "Sham operation"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03521336"
                        ]
                  },
                  {
                        "Rank": 394,
                        "InterventionArmGroupLabel": [
                              "Umbilical Cord Mesenchymal Stem Cells",
                              "Control"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intrathecal Transplantation of Umbilical Cord Mesenchymal Stem Cells",
                              "Placebos: Saline\uff0cSham operation"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical Cord Mesenchymal Stem Cells",
                              "Placebos"
                        ],
                        "InterventionOtherName": [
                              "UC-MSC",
                              "Sham operation"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03521323"
                        ]
                  },
                  {
                        "Rank": 395,
                        "InterventionArmGroupLabel": [
                              "Treatment",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "first cohort: 1 million stem cells/kg administered at days 1, 8 and 15\nsecond cohort: 2 million stem cells / kg administered at days 1, 8 and 15\nthird cohort: 4 million stem cells / kg administered at days 1, 8 and 15",
                              "first cohort: 20 ml administered at days 1, 8 and 15\nsecond cohort: 40 ml administered at days 1, 8 and 15\nthird cohort: 80 ml administered at days 1, 8 and 15"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Stem cells",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Genetic",
                              "Genetic"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01663116"
                        ]
                  },
                  {
                        "Rank": 396,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stem cell treatment group",
                              "Control group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Antipy",
                              "Infl",
                              "ARhu",
                              "FiAg",
                              "Analg",
                              "PlAggInh",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Antipyretics",
                              "Anti-Inflammatory Agents",
                              "Antirheumatic Agents",
                              "Fibrinolytic Agents",
                              "Analgesics",
                              "Platelet Aggregation Inhibitors",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M3700",
                              "M1669"
                        ],
                        "InterventionBrowseLeafName": [
                              "Aspirin",
                              "Clopidogrel"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Route : intracoronary injection Frequency : single dose of autologous bone-marrow derived mesenchymal stem cells Dosage : 1x1000000 cells/kg Duration : mean injection duration approximately 4 weeks after primary percutaneous coronary intervention",
                              "No additional treatment of mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stem cell",
                              "Control group"
                        ],
                        "InterventionOtherName": [
                              "Hearticellgram-AMI"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01392105"
                        ]
                  },
                  {
                        "Rank": 397,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Treatment with MSCs (hPPL) is indicated as soon as steroid refractory acute GVHD is diagnosed"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MSC (hPPL)"
                        ],
                        "InterventionOtherName": [
                              "Mesenchymal Stem Cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00827398"
                        ]
                  },
                  {
                        "Rank": 398,
                        "InterventionArmGroupLabel": [
                              "CLT high-dose",
                              "CLT low-dose",
                              "CLT medium-dose"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intra-articular infiltration of umbilical cord derived-mesenchymal stromal cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "umbilical cord derived-mesenchymal stromal cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03810521"
                        ]
                  },
                  {
                        "Rank": 399,
                        "InterventionArmGroupLabel": [
                              "Treatment Arm",
                              "Placebo-control group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "120 million cells administered by intralesional injection.",
                              "24 mL saline solution by intralesional injection"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Cx601",
                              "Saline solution"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01541579"
                        ]
                  },
                  {
                        "Rank": 400,
                        "InterventionArmGroupLabel": [
                              "hUC-MSC infusion (BC-U001)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "The participants are intravenously administered a single infusion of hUC-MSC at 0.5x10^6 cells/kg body weight, 1.0x10^6 cells/kg body weight, 1.5x10^6 cells/kg body weight for low-dose cohort, medium-dose cohort and high-dose cohort respectively."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "hUC-MSC infusion (BC-U001)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04971980"
                        ]
                  },
                  {
                        "Rank": 401,
                        "InterventionArmGroupLabel": [
                              "Vertebral Bone Marrow Derived Mesenchymal Stem Cells (vBM-MSC)",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Vertebral bone marrow derived mesenchymal stem cells",
                              "Normal Saline"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Ossium vBM-MSC",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Ossium Vertebral Bone Marrow Derived Mesenchymal Stem Cells"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05075811"
                        ]
                  },
                  {
                        "Rank": 402,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal Stromal Cells (MSC)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Hemat",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Hematinics",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M10262"
                        ],
                        "InterventionBrowseLeafName": [
                              "Liver Extracts"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stromal Cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02260375"
                        ]
                  },
                  {
                        "Rank": 403,
                        "InterventionArmGroupLabel": [
                              "High dose group",
                              "Highest dose cell group",
                              "Low dose group",
                              "Middle dose group",
                              "Sub high dose cell group",
                              "placebo group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Different doses of it-hMSC"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "it-hMSC"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04953663"
                        ]
                  },
                  {
                        "Rank": 404,
                        "InterventionArmGroupLabel": [
                              "Laparoscopic surgery",
                              "NeuroRegen scaffold transplantation",
                              "NeuroRegen scaffold/BMMCs transplantation",
                              "NeuroRegen scaffold/HUC-MSCs transplantation"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Completely resected rectal tumor.",
                              "After completely resected rectal tumor, exposed pelvic autonomic nerves, and then transplanted NeuroRegen scaffold to the nerve.",
                              "Completely resected rectal tumor, exposed pelvic autonomic nerves, and then transplanted NeuroRegen scaffold loaded with 5 million bone marrow mononuclear cells to the nerve.",
                              "Completely resected rectal tumor, exposed pelvic autonomic nerves, and then transplanted NeuroRegen scaffold loaded with 5 million human umbilical cord mesenchymal cells to the nerve."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Laparoscopic surgery",
                              "NeuroRegen scaffold transplantation",
                              "NeuroRegen scaffold/BMMCs transplantation",
                              "NeuroRegen scaffold/HUC-MSCs transplantation"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure",
                              "Device",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02648386"
                        ]
                  },
                  {
                        "Rank": 405,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "An allogeneic Mesenchymal Stem Cell product."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Descartes-25"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05113342"
                        ]
                  },
                  {
                        "Rank": 406,
                        "InterventionArmGroupLabel": [
                              "MSCs group",
                              "control group",
                              "MSCs group",
                              "control group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "The MSCs was intravenous transplanted to acute cerebral infarction patients as a single dose.",
                              "Placebo",
                              "standardized treatment"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "human umbilical cord mesenchymal stem cells",
                              "Placebo",
                              "standardized treatment"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04093336"
                        ]
                  },
                  {
                        "Rank": 407,
                        "InterventionArmGroupLabel": [
                              "AD-MSCs infusions, then Placebo",
                              "Placebo, then AD-MSCs infusions"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M8941"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hormones"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Patients in the two groups will receive two autologous AD-MSC administrations: the group A on day 0 and day 90 \u00b1 7; the group B on day 180 \u00b1 14 and day 270 \u00b1 14.\nDose: 1.0 x 106 cells/kg patient bodyweight.\nRoute: intravenous infusion\n\nADSCs were collected after the third passage. On the day of transplantation, the ADSCs were harvested, washed twice with NaCl 0.9%, counted and resuspended in NaCl 0.9% in a total volume of 20 ml. Each participant received a dose of 1x10^6 cells/kg body weight infused through the intravenous route within 30 minutes before being discharged after 24 hours"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Autologous adipose-derived mesenchymal stem cell administration for female with sexual functional deficiency"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05329662"
                        ]
                  },
                  {
                        "Rank": 408,
                        "InterventionArmGroupLabel": [
                              "Study Group 1: SMUP-IA-01 (low dose)",
                              "Study Group 2:SMUP-IA-01 (mid dose)",
                              "Active Control Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M9030"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hyaluronic Acid"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "A single knee administration of SMUP-IA-01(low-dose, 4.0 x 10^6 cells/2mL)",
                              "A single knee administration of SMUP-IA-01(mid-dose, 1.0 x 10^7 cells/2mL)",
                              "A single knee administration of Sodium chloride"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "SMUP-IA-01(low dose)",
                              "SMUP-IA-01(mid dose)",
                              "Active Control Group Sodium chloride"
                        ],
                        "InterventionOtherName": [
                              "SMUP allogenic cord blood-derived mesenchymal stem cell (SMUP-Cell)",
                              "SMUP allogenic cord blood-derived mesenchymal stem cell (SMUP-Cell)",
                              "Sodium chloride"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05182034"
                        ]
                  },
                  {
                        "Rank": 409,
                        "InterventionArmGroupLabel": [
                              "High Dose MPCs",
                              "Low Dose MPCs",
                              "Saline injection",
                              "Hyaluronic acid injection",
                              "High Dose MPCs",
                              "Low Dose MPCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All",
                              "PhSol"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Ratio"
                        ],
                        "InterventionBrowseLeafId": [
                              "M9030",
                              "M21013",
                              "M2780",
                              "M9353",
                              "M27448",
                              "M21022"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hyaluronic Acid",
                              "Pharmaceutical Solutions",
                              "Adjuvants, Immunologic",
                              "Immunologic Factors",
                              "Viscosupplements",
                              "Protective Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Injection of Low Dose MPCs with Hyaluronic Acid into the degenerated lumbar disc's nucleus pulposus.",
                              "Intradiscal control injection with saline solution",
                              "Intradiscal control injection with hyaluronic acid",
                              "Injection of HighDose MPCs with Hyaluronic Acid into the degenerated lumbar disc's nucleus pulposus."
                        ],
                        "InterventionMeshId": [
                              "D000006820"
                        ],
                        "InterventionMeshTerm": [
                              "Hyaluronic Acid"
                        ],
                        "InterventionName": [
                              "Single Dose MPCs Injection",
                              "Single injection of saline solution",
                              "Single injection of hyaluronic acid",
                              "Single Dose MPCs Injection"
                        ],
                        "InterventionOtherName": [
                              "Direct MPCs Lumbar Disc Injection.",
                              "Stem Cells",
                              "Saline injection",
                              "Sham control",
                              "Hyaluronic acid injection",
                              "Vehicle control",
                              "Stem Cells"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Procedure",
                              "Procedure",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01290367"
                        ]
                  },
                  {
                        "Rank": 410,
                        "InterventionArmGroupLabel": [
                              "Experimental: it-hMSC",
                              "Placebo-controlled: Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Single intravenous infusion of it-hMSC for ischemic stroke patients",
                              "Single intravenous infusion of 1 ml/kg placebo"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "it-hMSC",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04590118"
                        ]
                  },
                  {
                        "Rank": 411,
                        "InterventionArmGroupLabel": [
                              "UC-MSCs treatment group",
                              "Control group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "1*10E6 UC-MSCs /kg body weight suspended in 100mL saline",
                              "100mL saline intravenously"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "UC-MSCs",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04339660"
                        ]
                  },
                  {
                        "Rank": 412,
                        "InterventionArmGroupLabel": [
                              "Treatment Arm"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Expanded somatic mesenchymal stromal cells (MSCs) seeded onto a decellularised human tracheal-scaffold"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "BPF-001"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04435249"
                        ]
                  },
                  {
                        "Rank": 413,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal Stem Cell"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02410239"
                        ]
                  },
                  {
                        "Rank": 414,
                        "InterventionArmGroupLabel": [
                              "mesenchymal stem cells"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "SLE patients in the treated group were given human umbilical cord derived mesenchymal stem cells by intravenous infusion and conventional therapy. There was only conventional treatment in the control group. All patients after treatment for 1, 3 and 6months were evaluated respectively the curative effect."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03219801"
                        ]
                  },
                  {
                        "Rank": 415,
                        "InterventionArmGroupLabel": [
                              "Placebo/XCEL-UMC-BETA",
                              "XCEL-UMC-BETA/placebo",
                              "Placebo/XCEL-UMC-BETA",
                              "XCEL-UMC-BETA/placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Intrathecal allogeneic cell therapy in a blinded syringe",
                              "Placebo in a blinded syringe"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "XCEL-UMC-BETA",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Expanded MSC from Wharton Jelly"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT03003364"
                        ]
                  },
                  {
                        "Rank": 416,
                        "InterventionArmGroupLabel": [
                              "Trinity Evolution"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Novel Allogeneic, Cancellous, Bone Matrix Containing Viable Stem and Osteoprogenitor Cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Trinity Evolution"
                        ],
                        "InterventionOtherName": [
                              "Allograft",
                              "Mesenchymal Stem Cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00988338"
                        ]
                  },
                  {
                        "Rank": 417,
                        "InterventionArmGroupLabel": [
                              "1",
                              "3",
                              "5",
                              "2",
                              "4",
                              "6"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "immunoselected, culture-expanded, nucleated, allogeneic MPCs (NeoFuse) combined with MasterGraft Resorbable Ceramic Granules in subjects requiring posterior lumbar interbody fusion with NuVasive's radiolucent PEEK OPTIMA cage",
                              "autograft in subjects requiring posterior lumbar interbody fusion with NuVasive's radiolucent PEEK OPTIMA cage"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "NeoFuse",
                              "posterolateral spinal fusion with instrumentation"
                        ],
                        "InterventionOtherName": [
                              "Spinal Fusion",
                              "Stem Cells",
                              "Spinal Fusion",
                              "Controls"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00549913"
                        ]
                  },
                  {
                        "Rank": 418,
                        "InterventionArmGroupLabel": [
                              "AC607",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "AC607 will be a single administration at a target dose of 2 x 10E6 hMSC/kg body weight",
                              "The dose will be calculated and recorded in the same way as for AC607."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AC607",
                              "Vehicle Only"
                        ],
                        "InterventionOtherName": [
                              "allogeneic bone marrow-derived human mesenchymal",
                              "stem cells"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01602328"
                        ]
                  },
                  {
                        "Rank": 419,
                        "InterventionArmGroupLabel": [
                              "Experimental: allo-APZ2-DFU"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Suspension of ABCB5-positive mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "allo-APZ2-DFU"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03267784"
                        ]
                  },
                  {
                        "Rank": 420,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Chirurgical procedure to treat pseudo-arthrosis, with of osseous matrix implantation and autologous bone marrow injection."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Chirurgical procedure"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT00557635"
                        ]
                  },
                  {
                        "Rank": 421,
                        "InterventionArmGroupLabel": [
                              "Treatment Population"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Subjects will be infused with 100million human MSCs"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "human Mesenchymal Stem Cell (MSC) infusion therapy"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04174898"
                        ]
                  },
                  {
                        "Rank": 422,
                        "InterventionArmGroupLabel": [
                              "Treatment Arm - Low Dose",
                              "Treatment arm - High dose",
                              "Treatment arm - Mid dose"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Cryopreserved allogeneic, enhanced MSCs administered as a single intravenous infusion"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "GEM00220"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04961658"
                        ]
                  },
                  {
                        "Rank": 423,
                        "InterventionArmGroupLabel": [
                              "ALLO-ASC-DFU",
                              "Standard therapy"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Application of ALLO-ASC-DFU sheet to diabetic foot ulcer. This study is a follow-up study without intervention.",
                              "Standard therapy conducted for patients with diabetic foot ulcer. This study is a follow-up study without intervention."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ALLO-ASC-DFU",
                              "Standard therapy"
                        ],
                        "InterventionOtherName": [
                              "Allogeneic mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT03183804"
                        ]
                  },
                  {
                        "Rank": 424,
                        "InterventionArmGroupLabel": [
                              "Dose Level 1: Infusion of MSCs",
                              "Dose Level 2: Infusion of MSCs",
                              "Dose Level 3: Infusion of MSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Infusion of MSCs delivered to each patient will depend on their weight and assigned dose level. The maximal individual dose of MSCs any patient will receive is 2 x 1000000 cells/kg."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Autologous mesenchymal stromal cells (MSCs)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02359929"
                        ]
                  },
                  {
                        "Rank": 425,
                        "InterventionArmGroupLabel": [
                              "Remestemcel-L 2\u00d710^6 MSCs/kg"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "Infl",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "Anti-Inflammatory Agents",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Rimegepant"
                        ],
                        "InterventionBrowseLeafId": [
                              "M186752",
                              "M3369",
                              "M3466",
                              "M3366"
                        ],
                        "InterventionBrowseLeafName": [
                              "Remestemcel-l",
                              "Anti-Inflammatory Agents",
                              "Antiviral Agents",
                              "Anti-Infective Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Participants were treated with IV remestemcel-L at a dose of 2 x 10^6 MSC/kg (actual body weight at screening) twice per week for each of 4 consecutive weeks. Infusions were administered at least 3 days apart and no more than 5 days apart for any infusion."
                        ],
                        "InterventionMeshId": [
                              "C000711674"
                        ],
                        "InterventionMeshTerm": [
                              "Remestemcel-l"
                        ],
                        "InterventionName": [
                              "remestemcel-L"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02336230"
                        ]
                  },
                  {
                        "Rank": 426,
                        "InterventionArmGroupLabel": [
                              "Experimental"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "A single application in the context of a single surgical intervention."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "HC-SVT-1001(initial protocol); HC-SVT-1002 (protocol amendment)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02483364"
                        ]
                  },
                  {
                        "Rank": 427,
                        "InterventionArmGroupLabel": [
                              "Long Term Follow-up after Jointstem Transplantation"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "JOINTSTEM is an OA treatment that uses autologous adipose-derived mesenchymal stem cells. As it does not use allogenic tissues and is incubated without additional genetic modification or mechanical and chemical modification through differentiation, it is classified as 'autologous cell therapy' and is completely free of immunologic rejection."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Jointstem"
                        ],
                        "InterventionOtherName": [
                              "autologous adipose-derived mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03509025"
                        ]
                  },
                  {
                        "Rank": 428,
                        "InterventionArmGroupLabel": [],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Application of Darvadstrocel locally, after fistula tract curettage and internal opening closure."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Stem Cell Therapy"
                        ],
                        "InterventionOtherName": [
                              "Darvadstrocel"
                        ],
                        "InterventionType": [
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05210309"
                        ]
                  },
                  {
                        "Rank": 429,
                        "InterventionArmGroupLabel": [
                              "Treatment"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic Wharton's jelly (WJ) Mesenchymal Stromal Cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ProTrans\u00ae"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04896853"
                        ]
                  },
                  {
                        "Rank": 430,
                        "InterventionArmGroupLabel": [
                              "MSCs treated"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "mesenchymal stem cells therapy"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MSCs"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03631589"
                        ]
                  },
                  {
                        "Rank": 431,
                        "InterventionArmGroupLabel": [
                              "The MSCs group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Hemat",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Hematinics",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M10262"
                        ],
                        "InterventionBrowseLeafName": [
                              "Liver Extracts"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Six doses of 1*10^6/kg body weight MSCs are given, intravenously."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal Stem Cells(MSCs)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02706132"
                        ]
                  },
                  {
                        "Rank": 432,
                        "InterventionArmGroupLabel": [
                              "Mesenchymal stem cells cohort",
                              "Saline cohort"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "In experimental group, patients receive standard treatment and allogeneic human umbilical cord derived-mesenchymal stem cells (MSCs) is administered via intravenous infusion on day 0 and day 7",
                              "In placebo control group, patients receive standard treatment and saline is administered via intravenous infusion on day 0 and day 7"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymal stem cells",
                              "Saline"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04194671"
                        ]
                  },
                  {
                        "Rank": 433,
                        "InterventionArmGroupLabel": [
                              "Group B (BMSC Transplantion)",
                              "Group A(conserved therapy )"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "All",
                              "Hemat"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "All Drugs and Chemicals",
                              "Hematinics"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M3466",
                              "M10262"
                        ],
                        "InterventionBrowseLeafName": [
                              "Antiviral Agents",
                              "Liver Extracts"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "30ml allogenic bone marrow stem cells were infused to patients using interventional method via portal vein or hepatic artery as well as conserved therapy",
                              "Oral or intravenous administration"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogenic bone marrow stem cells transplantation",
                              "Conserved therapy"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01221454"
                        ]
                  },
                  {
                        "Rank": 434,
                        "InterventionArmGroupLabel": [
                              "Intervention group",
                              "Control group"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Ratio"
                        ],
                        "InterventionBrowseLeafId": [
                              "M9030",
                              "M2780",
                              "M9353",
                              "M27448",
                              "M21022"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hyaluronic Acid",
                              "Adjuvants, Immunologic",
                              "Immunologic Factors",
                              "Viscosupplements",
                              "Protective Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Allogeneic UC-MSCs 1 x 10~7 diluted on 5 mL of Platelet Rich Plasma",
                              "intra-articular injection of Hyaluronic Acid"
                        ],
                        "InterventionMeshId": [
                              "D000006820"
                        ],
                        "InterventionMeshTerm": [
                              "Hyaluronic Acid"
                        ],
                        "InterventionName": [
                              "Umbilical-cord mesenchymal stromal cells (UC-MSCs)",
                              "Hyaluronic acid"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03166865"
                        ]
                  },
                  {
                        "Rank": 435,
                        "InterventionArmGroupLabel": [
                              "Group B (BMSC Transplantion)",
                              "Group A(conserved therapy )"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Infe",
                              "All",
                              "Hemat"
                        ],
                        "InterventionBrowseBranchName": [
                              "Anti-Infective Agents",
                              "All Drugs and Chemicals",
                              "Hematinics"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M3466",
                              "M10262"
                        ],
                        "InterventionBrowseLeafName": [
                              "Antiviral Agents",
                              "Liver Extracts"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "30ml allogenic bone marrow stem cells were infused to patients using interventional method via portal vein or hepatic artery as well as conserved therapy",
                              "Oral or intravenous administration"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogenic bone marrow stem cells transplantation",
                              "Conserved therapy"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Procedure",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01223664"
                        ]
                  },
                  {
                        "Rank": 436,
                        "InterventionArmGroupLabel": [
                              "PNEUMOSTEM\u00ae"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells:\n\nDose A: 10 million cells per kg / Dose B: 20 million cells per kg"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [
                              "PNEUMOSTEM\u00ae"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02381366"
                        ]
                  },
                  {
                        "Rank": 437,
                        "InterventionArmGroupLabel": [
                              "Experimental group - sEVs"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Exosomes 3-5x10e11 particles/dose"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Exosomes (sEVs)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05060107"
                        ]
                  },
                  {
                        "Rank": 438,
                        "InterventionArmGroupLabel": [
                              "12M cells/kg",
                              "24M cells/kg",
                              "2M cells/kg",
                              "6M cells/kg"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Direct IV infusion of OSSM-001"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "OSSM-001"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05443464"
                        ]
                  },
                  {
                        "Rank": 439,
                        "InterventionArmGroupLabel": [
                              "Cohort 1",
                              "Cohort 2",
                              "Cohort 3",
                              "Cohort 1",
                              "Cohort 2",
                              "Cohort 3"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "2 million hMSCs/kg infusion",
                              "4 million hMSC/kg infusion",
                              "6 million hMSC/kg infusion",
                              "placebo infusion"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "2 million hMSC/kg",
                              "4 million hMSC/kg",
                              "6 million hMSC/kg",
                              "placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03186417"
                        ]
                  },
                  {
                        "Rank": 440,
                        "InterventionArmGroupLabel": [
                              "Stem cell transplantation"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "The patients accepted 4 times stem cell transplantations through lumbar puncture, the time is 3-5days between two treatments and the dose is about 2 ml(including 1\u00d710'7 cells)."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "stem cell transplantation"
                        ],
                        "InterventionOtherName": [
                              "Cell therapy."
                        ],
                        "InterventionType": [
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01489267"
                        ]
                  },
                  {
                        "Rank": 441,
                        "InterventionArmGroupLabel": [
                              "Microfracture + CARTISTEM\u00ae",
                              "Microfracture"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "HB",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Herbal and Botanical",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "T63"
                        ],
                        "InterventionBrowseLeafName": [
                              "Astragalus"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "*Stratified randomization by lesion size below 1.5\u33a0 or more than 1.5\u33a0\n\nProcedure: Microfracture\nBiological: CARTISTEM\u00ae(Human Umbilical Cord Blood-derived Mesenchymal Stem Cell product)",
                              "*Stratified randomization by lesion size below 1.5\u33a0 or more than 1.5\u33a0\n\n1. Procedure: Microfracture"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "CARTISTEM\u00ae",
                              "Microfracture"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04310215"
                        ]
                  },
                  {
                        "Rank": 442,
                        "InterventionArmGroupLabel": [
                              "RAPA-501 cells",
                              "Single agent RAPA-501 cells (dose level 1)",
                              "Single agent RAPA-501 cells (dose level 2)",
                              "Placebo-control Cohort"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic off-the-shelf RAPA-501 cells",
                              "RAPA-501-Allo cell placebo"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "RAPA-501-Allo off-the-shelf Therapy of COVID-19",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "RAPA-501-Allo cells"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04482699"
                        ]
                  },
                  {
                        "Rank": 443,
                        "InterventionArmGroupLabel": [
                              "Comparison/control group",
                              "Experimental group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Revascularization surgery, placement of an extracellular matrix patch with WJ-MSCs cultured on the epicardial surface and injection of WJ-MSC around the infarcted zone."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Wharton's jelly-derived mesenchymal cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04011059"
                        ]
                  },
                  {
                        "Rank": 444,
                        "InterventionArmGroupLabel": [
                              "HUC-MSCs Transplantation",
                              "HUC-MSCs with Injectable Collagen Scaffold Transplantation"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "The patients with POF that will undergo bilateral ovaries injection of 10 million allogeneic HUC-MSCs.",
                              "The patients with POF that will undergo bilateral ovaries injection of 10 million allogeneic HUC-MSCs with injectable collagen scaffold."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "HUC-MSCs Transplantation",
                              "HUC-MSCs with Injectable Collagen Scaffold Transplantation"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02644447"
                        ]
                  },
                  {
                        "Rank": 445,
                        "InterventionArmGroupLabel": [
                              "Cartilage repair surgery"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Coag",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Coagulants",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M17443"
                        ],
                        "InterventionBrowseLeafName": [
                              "Fibrin Tissue Adhesive"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Single-stage surgery, After debridement, the cartilage defect is filled with the fibrin glue carrier containing autologous chondrons and allogeneic MSCs"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Cartilage repair surgery"
                        ],
                        "InterventionOtherName": [
                              "Single-stage",
                              "Cartilage repair",
                              "IMPACT"
                        ],
                        "InterventionType": [
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02037204"
                        ]
                  },
                  {
                        "Rank": 446,
                        "InterventionArmGroupLabel": [
                              "UC-MSC + NaCl",
                              "UC-MSC+CM",
                              "Conditioned Medium (CM)",
                              "UC-MSC+CM"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Umbilical Cord Mesenchymal Stem Cell (UC-MSC) injected by peribulbar",
                              "Conditioned Medium (CM) injected by peribulbar"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Umbilical Cord Mesenchymal Stem Cell (UC-MSC)",
                              "Conditioned Medium (CM)"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04315025"
                        ]
                  },
                  {
                        "Rank": 447,
                        "InterventionArmGroupLabel": [
                              "1"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "MSC are an adherent, fibroblast-like cell population found in the bone marrow. Allogeneic MSC for treatment can be grown from bone marrow aspirates or biopsies of normal donors."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MSC"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02379442"
                        ]
                  },
                  {
                        "Rank": 448,
                        "InterventionArmGroupLabel": [
                              "treatment",
                              "control"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Enhanced mesenchymal cell-based product",
                              "Saline"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "MesenCure",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT05497401"
                        ]
                  },
                  {
                        "Rank": 449,
                        "InterventionArmGroupLabel": [
                              "ALLO-ASC"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Infusion for Crohn's disease"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ALLO-ASC"
                        ],
                        "InterventionOtherName": [
                              "ALLO-ASC-CD"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02580617"
                        ]
                  },
                  {
                        "Rank": 450,
                        "InterventionArmGroupLabel": [
                              "Dose group A (Low dose)",
                              "Dose group B (High dose)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Antipy",
                              "Analg",
                              "All",
                              "AnEm",
                              "CNSDep",
                              "PsychDr",
                              "Derm",
                              "Gast",
                              "Infl",
                              "AAll",
                              "AntiConv"
                        ],
                        "InterventionBrowseBranchName": [
                              "Antipyretics",
                              "Analgesics",
                              "All Drugs and Chemicals",
                              "Antiemetics",
                              "Central Nervous System Depressants",
                              "Psychotropic Drugs",
                              "Dermatologic Agents",
                              "Gastrointestinal Agents",
                              "Anti-Inflammatory Agents",
                              "Anti-Allergic Agents",
                              "Anticonvulsants"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M2341",
                              "M18740",
                              "M9064",
                              "M155022",
                              "M228602",
                              "M263157",
                              "M5137",
                              "M10292"
                        ],
                        "InterventionBrowseLeafName": [
                              "Acetaminophen",
                              "Ondansetron",
                              "Hydrocortisone",
                              "Hydrocortisone 17-butyrate 21-propionate",
                              "Hydrocortisone acetate",
                              "Hydrocortisone hemisuccinate",
                              "Chlorpheniramine",
                              "Lorazepam"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "EN001 intravenously (IV) in the treatment of Duchenne Muscular Dystrophy (DMD) Dosage for each group is as follows.\n\nDose group A (Low dose): 5.0x10^5 cells/kg",
                              "EN001 intravenously (IV) in the treatment of Duchenne Muscular Dystrophy (DMD) Dosage for each group is as follows.\n\nDose group B (High dose): 2.5x10^6 cells/kg"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "EN001",
                              "EN001"
                        ],
                        "InterventionOtherName": [
                              "EN001 (allogeneic umbilical cord-derived mesenchymal stem cells)",
                              "EN001 (allogeneic umbilical cord-derived mesenchymal stem cells)"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05338099"
                        ]
                  },
                  {
                        "Rank": 451,
                        "InterventionArmGroupLabel": [
                              "Dose group A (Low dose)",
                              "Dose group B (High dose)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "EN001 intravenously (IV) in the treatment of Charcot-Marie-Tooth disease (CMT) type 1A Dosage for each group is as follows.\n\nDose group A (Low dose): 5.0x10^5 cells/kg",
                              "EN001 intravenously (IV) in the treatment of Charcot-Marie-Tooth disease (CMT) type 1A Dosage for each group is as follows.\n\nDose group B (High dose): 2.5x10^6 cells/kg"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "EN001",
                              "EN001"
                        ],
                        "InterventionOtherName": [
                              "EN001 (allogeneic umbilical cord-derived mesenchymal stem cells)",
                              "EN001 (allogeneic umbilical cord-derived mesenchymal stem cells)"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05333406"
                        ]
                  },
                  {
                        "Rank": 452,
                        "InterventionArmGroupLabel": [
                              "UC-MSC infusion via intravenous route",
                              "UC-MSC infusion via intrathecal route",
                              "UC-MSC infusion via intrathecal route",
                              "UC-MSC infusion via intravenous route",
                              "control arm"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Patients assigned to UC-MSC administration groups will receive two administrations at a dose of 1.5 million cells/kg patient body weight via the intravenous (IV) route with a 3-month intervening interval",
                              "Patients assigned to UC-MSC administration groups will receive two administrations at a dose of 1.5 million cells/kg patient body weight via the intrathecal route with a 3-month intervening interval",
                              "Each patient can receive up to 30 days of rehabilitation therapy"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "UC-MSC infusion via intravenous route",
                              "UC-MSC infusion via intrathecal route",
                              "standard stroke treatment and rehabilitation therapy"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05292625"
                        ]
                  },
                  {
                        "Rank": 453,
                        "InterventionArmGroupLabel": [
                              "Intramuscular injection of ERC"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Patients will be treated with either 25 million, 50 million, or 100 million ERC by intramuscular injection."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Administration of ERC"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01558908"
                        ]
                  },
                  {
                        "Rank": 454,
                        "InterventionArmGroupLabel": [
                              "Cohort A - Phase 1 (Open Label)",
                              "Cohort B - Phase 2 Treatment Group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Allogeneic bone marrow-derived mesenchymal stem cell"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Longeveron Mesenchymal Stem Cells"
                        ],
                        "InterventionOtherName": [
                              "LMSCs"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03525418"
                        ]
                  },
                  {
                        "Rank": 455,
                        "InterventionArmGroupLabel": [
                              "GD2 CAR modified Tri-virus CTL infusion"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "This is a feasibility study to assess safety of an infusion of chimeric-antigen receptor gene modified allogeneic virus specific T lymphocytes after reduced intensity allogeneic stem cell transplant. Three patients were treated and safety was evaluated. Patients received a single infusion of 2x10e6/m2 donor derived, GD2 CAR modified, tri-virus specific CTL performed 30-120 days after allogeneic stem cell transplantation"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "GD2 CAR modified Tri-virus specific cytotoxic t-cells"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01460901"
                        ]
                  },
                  {
                        "Rank": 456,
                        "InterventionArmGroupLabel": [
                              "hUC-MSC treatment",
                              "Placebo control"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Patients will be treated at dose of 0.75\u00d710^6 cells/kg of body weight (Cohort 1) or 1.5\u00d710^6 cells/kg of body weight (Cohort 2) via a single IV infusion using a blood transfusion kit.",
                              "Placebo contains the same cell suspension as BX-U001 but without cells."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "hUC-MSC suspension",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "BX-U001"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03828344"
                        ]
                  },
                  {
                        "Rank": 457,
                        "InterventionArmGroupLabel": [
                              "Long Term Follow-up after Jointstem Transplantation"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "JOINTSTEM is an OA treatment that uses autologous adipose-derived mesenchymal stem cells. As it does not use allogenic tissues and is incubated without additional genetic modification or mechanical and chemical modification through differentiation, it is classified as 'autologous cell therapy' and is completely free of immunologic rejection."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "JOINTSTEM"
                        ],
                        "InterventionOtherName": [
                              "autologous adipose-derived mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04825730"
                        ]
                  },
                  {
                        "Rank": 458,
                        "InterventionArmGroupLabel": [
                              "Active Participant of Phase 2B Clinical Study Chondrogen",
                              "Placebo Participant of Phase 2B Clinical Study Chondrogen"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M9030"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hyaluronic Acid"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Mesenchymal stem cell-derived from umbilical cord Wharton Jelly and hyaluronic acid",
                              "Consist of saline and hyaluronic acid"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Chondrogen",
                              "Placebo"
                        ],
                        "InterventionOtherName": [
                              "Mesenchymal Stem Cell"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04520945"
                        ]
                  },
                  {
                        "Rank": 459,
                        "InterventionArmGroupLabel": [
                              "ALLO-ASC-DFU"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Dressing for second-degree burn wound."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "ALLO-ASC-DFU"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02394873"
                        ]
                  },
                  {
                        "Rank": 460,
                        "InterventionArmGroupLabel": [
                              "Stemchymal\u00ae"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "Hemat",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Hematinics",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M10262"
                        ],
                        "InterventionBrowseLeafName": [
                              "Liver Extracts"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "ALF/ ACLF patients will receive Stemchymal\u00ae through intravenous infusion"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Stemchymal\u00ae"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03629015"
                        ]
                  },
                  {
                        "Rank": 461,
                        "InterventionArmGroupLabel": [
                              "Umbilical-cord mesenchymal stromal cells",
                              "Hyaluronic Acid (HA)"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All",
                              "PhSol"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals",
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Ratio"
                        ],
                        "InterventionBrowseLeafId": [
                              "M9030",
                              "M21013",
                              "M2780",
                              "M9353",
                              "M27448",
                              "M21022"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hyaluronic Acid",
                              "Pharmaceutical Solutions",
                              "Adjuvants, Immunologic",
                              "Immunologic Factors",
                              "Viscosupplements",
                              "Protective Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Intra-articular knee injection of UC-MSC 20x10e6 at 0 and 6 months",
                              "Intra-articular knee injection of Hyaluronic Acid (3ml) at 0 and 6 months"
                        ],
                        "InterventionMeshId": [
                              "D000006820"
                        ],
                        "InterventionMeshTerm": [
                              "Hyaluronic Acid"
                        ],
                        "InterventionName": [
                              "umbilical-cord mesenchymal stromal cells",
                              "Hyaluronic Acid"
                        ],
                        "InterventionOtherName": [
                              "UC-MSCs",
                              "Durolane"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02580695"
                        ]
                  },
                  {
                        "Rank": 462,
                        "InterventionArmGroupLabel": [
                              "allo-APZ2-CVU"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Suspension of ABCB5-positive mesenchymal stem cells"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "allo-APZ2-CVU"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03257098"
                        ]
                  },
                  {
                        "Rank": 463,
                        "InterventionArmGroupLabel": [
                              "Part I (oncolytic adenovirus Ad5-DNX-2401)",
                              "Part II (oncolytic adenovirus Ad5-DNX-2401, surgery)",
                              "Part II (oncolytic adenovirus Ad5-DNX-2401, surgery)"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Given IA",
                              "Undergo surgery"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Oncolytic Adenovirus Ad5-DNX-2401",
                              "Therapeutic Conventional Surgery"
                        ],
                        "InterventionOtherName": [
                              "Ad5-Delta24RGD",
                              "DNX-2401",
                              "DNX2401",
                              "Oncolytic Ad5-Delta 24RGD",
                              "Oncolytic Adenovirus Ad5-Delta 24RGD"
                        ],
                        "InterventionType": [
                              "Biological",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03896568"
                        ]
                  },
                  {
                        "Rank": 464,
                        "InterventionArmGroupLabel": [
                              "transplantation of mesenchymal stem cell",
                              "no transplantation of mesenchymal stem cell"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "allogeneic human umbilical cord blood (hUCB)-derived mesenchymal stem cell (MSC) transplantation will be given to preterm infants",
                              "MSC transplantation will be not given to preterm infants"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "transplantation of mesenchymal stem cell",
                              "no transplantation of mesenchymal stem cell"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03378063"
                        ]
                  },
                  {
                        "Rank": 465,
                        "InterventionArmGroupLabel": [
                              "MSC",
                              "Placebo Infusion"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Human Umbilical Cord Tissue Derived Mesenchymal Stromal Cells (hCT-MSC), isolated and expanded from umbilical cord tissue from allogeneic unrelated donors. One dose of 6x10e6 cells/kg administered intravenously.",
                              "Placebo comparative infusion"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Cord Tissue Mesenchymal Stromal Cells",
                              "Placebo Infusion"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04089579"
                        ]
                  },
                  {
                        "Rank": 466,
                        "InterventionArmGroupLabel": [
                              "Rabbit ATG & AD-HSCs",
                              "Rabbit ATG & AD-MSCs",
                              "Rabbit antithymoglobulin \uff08ATG\uff09",
                              "Rabbit ATG & AD-MSCs",
                              "Rabbit ATG & AD-HSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "One repetition maximum tests"
                        ],
                        "InterventionBrowseLeafId": [
                              "M255749",
                              "M3431",
                              "M9353",
                              "M9364"
                        ],
                        "InterventionBrowseLeafName": [
                              "Thymoglobulin",
                              "Antilymphocyte Serum",
                              "Immunologic Factors",
                              "Immunosuppressive Agents"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low",
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "Rabbit ATG at 3.5 mg/kg/dose IV is given from day -6 to -2.",
                              "Participants will receive rabbit ATG at 3.5 mg/kg/dose IV from day -6 to -2, and then patient's own AD-MSCs at a dose of 3000000 cells/kg/d on day 1-3.",
                              "Participants will receive rabbit anti-thymocyte globulin at 3.5 mg/kg/dose IV from day -6 to -2, and then patient's own AD-HSCs at a dose of 3000000 cells/kg/d from day 1 to 4."
                        ],
                        "InterventionMeshId": [
                              "D000000961"
                        ],
                        "InterventionMeshTerm": [
                              "Antilymphocyte Serum"
                        ],
                        "InterventionName": [
                              "Rabbit antithymoglobulin (ATG)",
                              "Adipose derived mesenchymal stem cells ( AD-MSCs)",
                              "AD-MSC transdifferentiated HSCs (AD-HSCs)"
                        ],
                        "InterventionOtherName": [
                              "ATG",
                              "AD-MSCs",
                              "AD-HSCs"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Procedure",
                              "Procedure"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02407470"
                        ]
                  },
                  {
                        "Rank": 467,
                        "InterventionArmGroupLabel": [
                              "MSCs",
                              "MSCs",
                              "Non-MSCs",
                              "MSCs",
                              "Non-MSCs"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All",
                              "Infe"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals",
                              "Anti-Infective Agents"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Diffusion"
                        ],
                        "InterventionBrowseLeafId": [
                              "M8199",
                              "M19284",
                              "M8941",
                              "M8940"
                        ],
                        "InterventionBrowseLeafName": [
                              "Glucocorticoids",
                              "Azithromycin",
                              "Hormones",
                              "Hormone Antagonists"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "MSCs will be given at a median dose of 1\u00d710^6 cells/kg once weekly for 4 weeks as one cycle treatment.",
                              "AZM will be given \uff080.25g qd\uff09for 4 weeks as one cycle treatment.",
                              "Glucocorticoid (prednison) will be given at the starting dose of 1mg/kg for 4 weeks as one cycle treatment."
                        ],
                        "InterventionMeshId": [
                              "D000005938"
                        ],
                        "InterventionMeshTerm": [
                              "Glucocorticoids"
                        ],
                        "InterventionName": [
                              "MSCs",
                              "AZM",
                              "Glucocorticoid"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02543073"
                        ]
                  },
                  {
                        "Rank": 468,
                        "InterventionArmGroupLabel": [
                              "UC-MSC and anti-CD25 mAb",
                              "Anti-CD25 mAb",
                              "UC-MSC and anti-CD25 mAb"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [
                              "Tislelizumab"
                        ],
                        "InterventionBrowseLeafId": [
                              "M1830",
                              "M9364",
                              "M9353"
                        ],
                        "InterventionBrowseLeafName": [
                              "Basiliximab",
                              "Immunosuppressive Agents",
                              "Immunologic Factors"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "high",
                              "low",
                              "low"
                        ],
                        "InterventionDescription": [
                              "UC-MSC, iv, 1\u00d710^6 cells/kg, once a week, for 4 weeks.",
                              "Anti-CD25 mAb, iv, 20mg\uff0ctwice in first week and once a week thereafter, for 4 weeks."
                        ],
                        "InterventionMeshId": [
                              "D000077552"
                        ],
                        "InterventionMeshTerm": [
                              "Basiliximab"
                        ],
                        "InterventionName": [
                              "UC-MSC",
                              "Anti-CD25 mAb"
                        ],
                        "InterventionOtherName": [
                              "Umbilical cord-derived mesenchymal stem cells",
                              "Basiliximab"
                        ],
                        "InterventionType": [
                              "Drug",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT04738981"
                        ]
                  },
                  {
                        "Rank": 469,
                        "InterventionArmGroupLabel": [
                              "Cohort A",
                              "Cohort B"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "The active agent in CYP-001 is allogeneic mesenchymoangioblast-derived mesenchymal stem cells (MCA-derived MSCs), which are produced using the proprietary Cymerus\u2122 platform technology. Cymerus\u2122 refers to the process of generating cell-based products from intermediate cells, MCAs, which in turn are derived from induced pluripotent stem cells or iPSCs. The iPSCs used in the Cymerus\u2122 process were derived from blood donated by a fully-consented healthy adult donor, and were reprogrammed using a transgene-free, viral-free and feeder-free technique."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Mesenchymoangioblast-derived mesenchymal stem cells"
                        ],
                        "InterventionOtherName": [
                              "CYP-001"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT02923375"
                        ]
                  },
                  {
                        "Rank": 470,
                        "InterventionArmGroupLabel": [
                              "Menstrual blood stem cell secretome group",
                              "Control group"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "This COVID-19 Study intervention consists of Intravenous Allogeneic human menstrual blood stem cell (MenSC) secretome injection in addition to standard care. The MenSC were characterized as CD90+, CD73+, CD105+, and CD45-based on multiparameter flow cytometry.",
                              "Intravenous saline injection in addition to standard care"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic human menstrual blood stem cells secretome",
                              "Intravenous saline injection"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Other"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT05019287"
                        ]
                  },
                  {
                        "Rank": 471,
                        "InterventionArmGroupLabel": [
                              "AGLE 102"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Exosomes from MSCs"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "AGLE 102"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT04173650"
                        ]
                  },
                  {
                        "Rank": 472,
                        "InterventionArmGroupLabel": [
                              "ALLO-ASC-DFU",
                              "Conventional Therapy"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "Dressing for Dystrophic Epidermolysis Bullosa wound.",
                              "Dressing for Dystrophic Epidermolysis Bullosa wound."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "Allogeneic mesenchymal stem cells",
                              "Polyurethene Film"
                        ],
                        "InterventionOtherName": [
                              "ALLO-ASC-DFU"
                        ],
                        "InterventionType": [
                              "Other",
                              "Device"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT02579369"
                        ]
                  },
                  {
                        "Rank": 473,
                        "InterventionArmGroupLabel": [
                              "Single hCT-MSC infusion",
                              "Three hCT-MSC infusions",
                              "Two hCT-MSC infusions"
                        ],
                        "InterventionBrowseBranchAbbrev": [],
                        "InterventionBrowseBranchName": [],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [],
                        "InterventionBrowseLeafName": [],
                        "InterventionBrowseLeafRelevance": [],
                        "InterventionDescription": [
                              "hCT-MSCs are a product of allogeneic cells manufactured from digested umbilical cord tissue that is expanded in culture, cryopreserved and banked."
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "hCT-MSC infusion"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "Yes"
                        ],
                        "NCTId": [
                              "NCT03099239"
                        ]
                  },
                  {
                        "Rank": 474,
                        "InterventionArmGroupLabel": [
                              "CARTISTEM\u00ae"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M9030"
                        ],
                        "InterventionBrowseLeafName": [
                              "Hyaluronic Acid"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "CARTISTEM\u00ae"
                        ],
                        "InterventionOtherName": [
                              "human umbilical cord blood-derived mesenchymal stem cells"
                        ],
                        "InterventionType": [
                              "Biological"
                        ],
                        "IsFDARegulatedDevice": [],
                        "IsFDARegulatedDrug": [],
                        "NCTId": [
                              "NCT01733186"
                        ]
                  },
                  {
                        "Rank": 475,
                        "InterventionArmGroupLabel": [
                              "allo-APZ2-PAOD",
                              "Placebo"
                        ],
                        "InterventionBrowseBranchAbbrev": [
                              "PhSol",
                              "All"
                        ],
                        "InterventionBrowseBranchName": [
                              "Pharmaceutical Solutions",
                              "All Drugs and Chemicals"
                        ],
                        "InterventionBrowseLeafAsFound": [],
                        "InterventionBrowseLeafId": [
                              "M21013"
                        ],
                        "InterventionBrowseLeafName": [
                              "Pharmaceutical Solutions"
                        ],
                        "InterventionBrowseLeafRelevance": [
                              "low"
                        ],
                        "InterventionDescription": [
                              "Suspension of ABCB5-positive mesenchymal stem cells in pre-filled syringe",
                              "Solution for injection in pre-filled syringe"
                        ],
                        "InterventionMeshId": [],
                        "InterventionMeshTerm": [],
                        "InterventionName": [
                              "allo-APZ2-PAOD",
                              "Placebo"
                        ],
                        "InterventionOtherName": [],
                        "InterventionType": [
                              "Biological",
                              "Drug"
                        ],
                        "IsFDARegulatedDevice": [
                              "No"
                        ],
                        "IsFDARegulatedDrug": [
                              "No"
                        ],
                        "NCTId": [
                              "NCT03339973"
                        ]
                  }
            ]
      }
}